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Preface and contents of this thesis 
 
In the immune system and especially in the immune surveillance exerted by T lymphocytes 
cell-cell contacts play a key role: The principal mode of T cell activation occurs by 
interactions of the T cell receptors (TCR) with pathogen-associated peptides presented by 
major histocompatibility molecules (MHC) on a target cell 2. The activation of a T cell is 
highly regulated, depending on the affinity of the interaction of the TCR with the MHC-
peptide combination, the density of specific MHC-peptide combination on the cell surface, 
the differentiation and activation state of the T cell and on the participation of costimuli 3. The 
past years have provided a wealth of information on the membrane-associated and 
cytoplasmic proteins in T cells and target cells that are involved in these interactions. Now, 
the events leading to cell-cell contact formation and T cell activation need to be analyzed in 
detail with respect to signal intensity and kinetics. Due to the significance of extracellular 
stimuli in health and disease there is a keen interest in the development of analytical 
techniques that enable the quantitative analysis of cellular interactions and the underlying 
molecular processes and to enable the systematic integration of these individual events into 
signalling networks. 
 
Binding of T cell receptors (TCR) to agonistic MHC-peptide complexes initiates a cascade of 
signalling events central to the execution of the adaptive immune response 4. A contact 
between T cell and antigen presenting cell characterized by a distinct array of surface proteins 
at the interface has been termed the ‘immunological synapse’ 5. Upon TCR engagement the 
Src-family kinase LCK, a kinase recruited by CD4 or CD8 and associated with the immature 
immunological synapse, phosphorylates tyrosines of the immunoreceptor tyrosine-based 
activation motifs (ITAMs) within the TCR/CD3 complex, forming sites for the recruitment of 
the tyrosine kinase ZAP-70 within the first seconds of T cell activation 6. Activation of ZAP-
70 leads to the propagation of the signal via multiple pathways that culminate in gene 
expression and the cytoskeletal rearrangements stabilizing cellular contacts. Concomitant with 
the redistribution of transmembrane molecules, proteins involved in cell adhesion and 
intracellular signalling as well as actin and associated proteins are concentrated at the contact 
site. In addition to the TCR stimulation, engagement of coreceptors, most prominently CD28, 
is necessary for full T cell activation, leading to cell proliferation and cytokine expression.  
In the context of this thesis, the events of T cell contact formation and activation were 
analyzed from the cell-morphological perspective and the protein interaction perspective 
applying microscopic and microstructural methods. First, the formation of the immunological 
Preface 
 2 
synapse and its pharmacological susceptibility to chemical inhibitors over time was analyzed 
morphologically (Chapter 3 of this thesis). In order investigate the role of LCK in the 
maintenance of T cell contacts, we analyzed the time-dependent localization of a ZAP-70-
YFP fusion protein and its sensitivity to disturbances by kinase inhibitors as readouts for 
changes in activities that impact the activation of TCR-dependent complexes. As a strong and 
well-defined model system for the MHC/peptide stimulus, we stimulated T cells on CD3-
functionalized surfaces, a stimulus able to recapitulate essential events of T cell activation 7. 
For the analysis of the time-dependence of TCR engagement on LCK activity and formation 
of signalling-active multiprotein complexes, we added PP2, a specific inhibitor of Src family 
kinases to the cells at various stages after TCR engagement. We showed that the maintenance 
of signalling contacts and clusters in early stages of contact formation, up to about 5 min of 
TCR engagement, is sensitive to LCK inhibition, in contrast to later time points.  
 
After the evaluation of the time-dependence of effects of signalling inhibitors on T cell 
activation, it was our goal to evaluate the dependence of the inhibitor effects on cells exposed 
to a variety of stimuli. For this purpose, we sought to develop a strategy by which the 
interplay of different signalling pathways in generating a cellular response could be applied 
systematically to the testing of low molecular weight inhibitors (Chapter 4). The method of T 
cell stimulation by stimulatory antibodies was extended to a format allowing parallel testing 
of both stimuli and stimulation conditions. For this experiment, we spotted stimulatory 
antibody microarrays of antibodies against CD3 and the CD28 costimulatory molecule in 
different intensities and exposed Jurkat cells in combination with T cell signalling inhibitors 
to this stimulus. As readouts for activation, we analyzed cell spreading, the clustering and 
phosphorylation of signalling proteins, and the translocation of the transcription factor NFAT 
using fluorescence microscopy followed by automated, quantitative image analysis. We found 
remarkable differences in the response profiles of inhibitors with overlapping target profiles, 
illustrating the potential of the approach in a functional profiling of drug candidates, and 
providing new information on the specificity of these compounds.  
 
The combination of imaging-based readouts for cell activation with micropatterned stimuli 
offers a new perspective for the analysis of T cell activation taking into account geometrical 
stimulus parameters in the subcellular range (Chapter 5). This approach adresses the influence 
of spatially distinct stimuli and of the stimulus size on T cell activation. In order to spatially 
separate the stimuli applied to a single cell, stimulatory antibodies were transferred to a glass 
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surface in a microstructured format. Using immunofluorescent staining and image analysis, 
we analyzed the interplay of the TCR/CD3 stimulus and CD28 costimulus for the local and 
global activation states of the cell.   
 
Next, the time-dependent morphological changes in T cell contact formation were analyzed 
using a label-free biophysical method, Reflectometric Interference Spectroscopy (RIfS) 
(Chapter 6)8;9. To our knowledge, the application of RIfS for monitoring the contact of T cells 
with stimulatory antibody surfaces represents the first application of a label-free optical 
spectroscopy technique for the analysis of activation-dependent cellular interactions. The 
different spreading morphologies of Jurkat cells perfused over anti-CD3- and anti-CD28-
functionalized surfaces correlated with differences in the slope and amplitude of the RIfS 
curve. Imaging-based quantification of cell spreading and actin polymerization correlated 
with RIfS results and yielded the morphological basis for the observed differences. In a 
parallelizable format, RIfS should also allow the application for the screening of compounds 
that interfere with APC/T cell contact formation in a flow system. 
 
The biochemical aspect of the microstructured approach to T cell signalling addressed in this 
thesis analyzes the interactions between proteins on a molecular scale (Chapter 7). Since the 
early steps in T cell activation-dependent signalling are also mediated by numerous protein-
protein interactions via different domains, a focus in our group is the analysis of protein-
protein interactions in this context. A systematic understanding of these signal transduction 
processes requires the development of methods for the parallel analysis of the protein-protein 
interactions involved. Fluorescence correlation spectroscopy allows the quantitative analysis 
of the binding constants of single interactions 10 and allows the screening and characterization 
of interaction inhibitors. In complementation to this method which enables the quantitative 
analysis of protein-protein interaction in solution, our group established an approach based on 
microarrayed peptides representative of specific protein-derived binding motifs, which 
interact with proteins from cell lysates and hence offers the possibility to analyze dozens of 
interactions under tens of conditions in one experiment. Here, the interplay of stimulatory and 
costimulatory signals concerning T cell signalling was analyzed on a protein-protein 
interaction scale. The peptide array method enables the qualitative analysis of the constituents 
of multiprotein complexes. Moreover, it also enables the quantitative analysis of stimulation-
dependent changes in protein interactions, depending on stimuli, kinetics and inhibitors. 
Taken together, the methods applied here allow the observation of the features of T cell 
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signalling on different levels in a parallel format. Moreover, by obtaining quantitative data of 
activation parameters they are applicable for the screening of inhibitors and gene effects of T 
cell activation. 
 
 
 
 
 
1 Introduction 
 
1.1 TCR-proximal signalling components 
 
The adaptive immune response is centrally controlled by T lymphocytes, or T cells, a 
subset of lymphocytes characterized by their development in the thymus and the 
expression of heterodimeric receptors that are associated with the CD3 complex.  These 
membrane-expressed receptors, the T cell receptor (TCR)/CD3 complex, consist of highly 
variable αβ (clonotypic) or γδ chains in a noncovalent complex with the invariant CD3γ, 
δ and ε subunits and the dimeric CD3ζ chains. T cells continuously circulate in the blood 
and lymphatic system, and engage in transient contacts with other cells mediated by 
interactions of their TCRs with major histocompatibility molecule (MHC)/peptide 
combinations on the target cells 2. MHC molecules are highly polymorphic membrane 
glycoproteins involved in the presentation of peptide antigens. MHC class I molecules, 
expressed in different quantities by nearly all cell types, are involved in the presentation 
of peptides generated by the cytosolic pathways to T cells expressing the CD8 coreceptor 
(CD8 T cells, precursors of cytotoxic T cells).  Cytotoxic T cells mediate the destruction 
of cells that present fragments of intracellular pathogens, such as proteins involved in 
viral infection, or malignant transformation. MHC class I molecules consist of 2 subunits, 
the transmembraneous, highly polymorphic α chain (MW 43 kDa), which forms the 
peptide-binding cleft, and the conserved β2 microglobulin chain (MW 12 kDa). MHC 
class II molecules are expressed by “professional antigen presenting cells”, such as 
dendritic cells and B cells (lymphocytes characterized by their development in the bone 
marrow).  MHC class II molecules are composed of two transmembrane glycoprotein 
chains (α 34 kDa, β 29 kDa), which together form the peptide-presenting cleft.  Peptides 
that are generated by protein degradation in intracellular vesicles are presented by MHC 
class II to T helper cells, which express the CD4 coreceptor. T helper cells are involved in 
the orchestration of the immune responses characterized by the activation of macrophages 
and the “humoral” response characterized by secretion of antibodies by B cells. MHC 
restriction characterizes the effect that a T cell clone can only recognize a peptide antigen 
if bound to a particular MHC molecule.  
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Activation of a T cell by contact with an agonistic MHC/peptide complex is 
mediated via the activation of protein tyrosine kinases (PTKs) that associate with 
phosphorylated motifs the invariant units of the T cell receptor (TCR)/CD3 complex and 
the coreceptors CD4 or CD8. Activating signals are transduced from the extracellular 
moiety of the TCR via the immunoreceptor tyrosine-based activatory motifs (ITAMs) of 
the CD3 -γ, -δ, -ε (one ITAM each) and the ζ chains (three ITAMs). The consensus 
sequence of an ITAM is defined by the sequence YXX(L/I)X6-8YXX(L/I). The two 
tyrosine residues within each ITAM are subject to phosphorylation by the Src family 
kinases LCK and/or Fyn. 
 
The leukocyte-specific protein tyrosine kinase (LCK) is an acylated enzyme of the 
Src kinases family (SFK), which is localized in glycolipid membrane microdomains 
(GEMs), also known as lipid rafts. Lipid rafts are membrane microdomains with about 70 
nm diameter that contain an enhanced concentration of unsaturated phospholipids, 
cholesterol and sphingolipids 11. The extent of ITAM phosphorylation correlates to the 
TCR interaction intensity with the peptide/MHC complex. In unstimulated cells, the 
ITAM phosphorylation by SFK is neutralized by the excess of the activity of various 
tyrosine phosphatases 12. One model for the activation of T cell by APC contact assumes 
that TCR triggering can shift this balance towards phosphorylation by excluding 
phosphatases from or recruiting kinases towards the contact site. For example, CD45, a 
transmembrane phosphatase that deactivates LCK by dephosphorylating pY394, contains 
a large extracellular cellular domain. This domain excludes CD45 from the much 
narrower cleft between T cell and APC generated by TCR and/or CD28 engagement 13;14 
in which the TCR extends only about 7-10 nm from the cell surface. On the other hand, 
the kinase LCK is recruited towards the TCR/MHC contact site by engagement of the 
CD4/CD8 coreceptors 15. Also, LCK activity is regulated negatively by Csk- mediated 
phosphorylation on tyrosine 505, which leads to intramolecular SH2 binding and to the 
covering of the active site of LCK 16. Together, the recruitment of CD4/CD8 towards and 
of CD45 away from the TCR shifts the balance of kinase-phosphatase activity towards 
phosphorylation of the ITAM domains upon TCR engagement, which peaks already after 
about 30 seconds of TCR engagement 17. 
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The Syk-family ζ-associated protein of 70 kDa (ZAP-70) PTK is a central enzyme 
in TCR dependent signal transduction. ZAP-70 is recruited to dual-phosphorylated 
ITAMs via its tandem SH2 domains with very high affinity 18, and then phosphorylated 
within its activation loop by LCK and ZAP-70 itself 19. A further site of ZAP-70 
regulation is the interdomain tyrosine residue 319, which is involved in the recruitment of 
the SH2 domain of the SFK LCK, resulting in augmentation or ZAP-70 activity 20. In 
contrast, ZAP-70 is negatively regulated by phosphorylation of Tyr 292, which forms a 
site for Cbl recruitment 21. ZAP-70 catalyzes the tyrosine phosphorylation of various 
downstream effector proteins, among them the transmembrane adapter linker of activation 
in T cells (LAT) 22. Also, the SH2-domain containing leukocyte phosphoprotein of 76 
kDa (SLP-76), and the inhibitory adapter Gab2, which are involved in the scaffolding of 
different downstream signalling complexes are discussed as ZAP-70 substrates 23;24 
 
1.2 Adapter proteins in T cell activation 
 
The TCR-dependent activation pathway is mediated to a large extent by adapter 
proteins. In most cases lacking enzymatic activity themselves, adapters possess binding 
sites or modules that directly or indirectly mediate the binding of proteins to other 
proteins, and thus form the scaffold for signalling complexes (reviewed in 25). The most 
important domains involved in T cell signalling are src-homology domains 2 (SH2) and 
phosphotyrosine binding (PTB) domains that both recognize phosphotyrosine motifs, 
SH3 domains recognizing polyproline motifs (polyP), PDZ domains (recognizing 
hydrophobic motifs at the C-terminus), WW domains (recognizing proline-rich regions 
and also phosphoserine motifs), and pleckstrine homology (PH) domains that interact 
with membrane lipids. LAT is an example for a scaffold protein that does not contain 
domains interacting with recognition motifs, but provides motifs for the recognition by 
the SH2 domains of other proteins. 
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Table 1.1: Selection of binding motif subtypes for protein domains; X defines a relative independence 
of domain binding from the amino acid at that position, pY represents a phosphorylated tyrosine residue, 
and COOH a free carboxy-terminus.  
Domain Name Binding Motif 
PDZ PSD 95/Disk Large/ZO-1-like X(S/T)X(V/I/L)-COOH 
PTB  Phospho Tyrosine Binding D(N/D)XpY  
SH2 
Src Homology 2 
 
GRB2-like:pYXNX 
ITAM (tandem SH2): pYXXLX6-8pYXXL  
SFK-like: 
pY(Q/D/E/V/A/I/L)(D/E/N/P/Y/H/I)(I/P/V/G/A/H/S) 
SHP/PLC-like: pY(I/V)X(V/I/L/P) 
SH3 Src Homology 3 
Type I: (R/K/Y)XXPXXP 
Type II: PXXPX(K/R)  
Atypical I: (P/V)XXP 
Atypical II: KPXX(Q/K) 
Atypical, Hbp-type: PX(V/I)(D/N)RXXKP  
Atypical, EVH-type: (E/D)FPPPPXDEE 
WH1 WASP Homology 1 ES(R/K)(F/Y)(Y/S/T)FH(P/S)(I/V)(E/S)D 
 
LAT (linker for activation in T cells) is a transmembrane adapter protein expressed 
in T cells, which is palmitoylated on two juxtamembrane cysteine residues, mediating its 
recruitment into glycolipid-enriched microdomains and thus into the proximity of critical 
signalling molecules. LAT is phosphorylated by ZAP-70/Syk-family PTKs within the 
first 15 s of the TCR crosslinking and rapidly dephosphorylated after 5 min 17. Certain 
phosphotyrosine residues of LAT form binding sites for different SH2 domains of several 
proteins. The phosporylated tyrosine residue of LAT 132 constitutes the centre of a SH2 
binding motif of the SHP/PLCγ type (see table 1.1) and has been reported to directly 
interact with PLCγ; LAT pY226 represents a Grb2 and SFK type binding motif with 
reported interactions with Grb2 and Gads, while LAT phosphotyrosine 191 represents a 
consensus motif for the SH2 domains of SHP/PLCγ, SFK and Grb2 and has been reported 
to interact in vivo with Gads, Grb2 and  phosphatidylinositol 3-kinase (PI3K) 22;26;27. 
Containing other binding motifs such as SH3 domains, those proteins are in turn involved 
in the indirect recruitment of further molecules to the LAT-scaffolded complex. 
Secondary associations with Grb2 or Gads binding proteins may also facilitate the 
interaction of LAT with other proteins, such as PLCγ1 26.  
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SLP-76 is a cytosolic adapter protein with an amino-terminal region containing 
regulatory tyrosine phosphorylation sites, a central proline-rich region and a carboxy-
terminal SH2 domain 28.  SLP-76 is subject to phosphorylation by SFK and Syk kinases, 
with the amino-terminal phosphotyrosines described to be bound by the SH2 domains of 
Vav and Nck 29, and the carboxy-terminal phosphotyrosines to be bound by Fyb 30. By 
recruiting Itk kinases, SLP-76 is involved in the activation of PLCγ 31. Also, SLP-76 
constitutively binds to Gads via its SH3 domain and thus indirectly binds to LAT 32.The 
trimolecular SLP76-Vav-Nck complex is involved in Pak recruitment, actin recruitment 
and NFAT activation 29.  
 
Grb2 is an adapter protein containing two SH3 domains and one Grb-type SH2 
domain. Grb2 has been reported to bind to the TCR ITAMs indirectly by binding the 
adapter Shc, which in turn binds via its SH2 domains to pYs of the ITAM 33. The 
Grb2/Shc complex has been described to mediate the recruitment and activation of the 
Ras guanine nucleotide exchange factor SOS, leading to Ras activation 34. GADS (Grb2-
related adaptor downstream of Shc, also known as Grap-2) is an adapter protein which 
shows high homology to Grb2, but additionally contains a proline-rich sequence between 
its SH2- and its carboxy-terminal SH3 domain. While the C-terminal SH3 domain of 
GADS constitutively binds a proline-rich domain of SLP-76 35, the SH2-domain binds to 
LAT. The tetrameric LAT centered complex including SLP-76, GADS and PLCγ1 is 
known as the LAT signalosome 36. It forms a scaffold for the recruitment of other linker 
proteins, such as Vav, Gab2 and Fyb 37, which can further expand the scaffold. Also, 
GADS contains a cleavage site for caspases. Upon caspase activation, induced e.g. by 
TCR or Fas stimulation, the disintegrated GADS fragments may function as competitive 
inhibitors for GADS 38. 
 
Fyb (also known as ADAP and SLAP-130), is a cytosolic adapter protein containing 
a proline-rich region and a SH3 domain (binding sites for SKAP-55), phosphotyrosine 
motifs (binding sites for Fyn and SLP-76) and an Ena/VASP homology domain (binding 
sites for Ena/VASP proteins) 39. Via recruitment of the SKAP-55 protein, Fyb is a 
possible linker from T cell activation to the activation of integrins.    
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Nck is a cytosolic adapter protein consisting of three SH3 domains and one SH2 
domain, which binds to an SFK type consensus sequence pYDE(P/D/V) 40. The three 
distinct SH3 domains each have characteristic binding specificities. While all three SH3 
domains associate with Cbl 41, the third SH3 domain associates with WASP 42, and the 
second one with SOS and PAK 43.  PAK is a serine/threonine kinase involved in the 
regulation of JNK and p38 kinase signalling 44. Also, Nck has been described to bind via 
its N-terminal SH3 domains to the proline-rich regions of the TCRε complexes, which are 
supposedly exposed upon TCR crosslinking 45. 
 
1.3 Negative regulation of the early steps in TCR signalling 
 
As a counterbalance to the activating components, the extent and/or duration of T cell 
stimulation is regulated by inhibiting signalling components. As antagonists to the protein 
kinase activities in T cell signalling, phosphotyrosine phosphatases (PTPases) play a key 
role, particularly the SH2 domain-containing PTPases SHP1 and SHP2 (also known as 
SHPTP1 and 2 ). In analogy to the recruitment of PTKs to the ITAMs of the TCR, SHP1 
is recruited to the contact site by different inhibitory receptors containing ITIMs 
(immunoreceptor tyrosine-based inhibition motifs), where SHP1 directly 
dephosphorylates its SFK and Syk antagonists. In contrast, depending on its recruitment 
mediated by adapter proteins, SHP2 can both act as a positive or negative regulator of T 
cell signalling. Also, SHP2 has been reported to dephosphorylate and inactivate CD3ζ 46, 
depending on Gab2 activity 47. Different types of adapters are involved in the recruitment 
of SHPs, among them membrane-associated ones, like SIT and LAX, and cytoplasmic 
adapters like SLAP-2, Cbl, Grap2 and Gab2.   
 
Kinases can be involved in negative signalling as well. Csk is a negative regulatory 
tyrosine kinase catalyzing the inhibitory phosphorylation of LCK. In the resting cell, Csk 
is associated with the transmembrane protein Cbp/PAG and localized in lipid rafts 48. 
TCR stimulation induces the dephosphorylation of Cbp, followed by the dissociation of 
Csk and thus the activation of LCK 16. A c-terminal VTRL/ITRL motive of Cbp/PAG 
also interacts with a PDZ domain of ezrin-radixin-moesin binding protein EBP50, which 
limits lipid raft aggregation by anchoring lipid rafts to the cytoskeleton 49. TCR 
stimulation abrogates the interaction between Cbp/PAG and EBP50, a possible 
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mechanism for the induction of lipid raft coalescence.  
 
Cbl is an adapter protein containing, among other domains, one atypical 
phosphotyrosin binding domain (also known as PTB domain), proline- and pY- rich 
motifs and an ubiquitin-ligase domain. Cbl is tyrosine-phosphorylated upon engagement 
of several receptors, including the TCR and acts as a negative regulator of tyrosine-kinase 
signalling pathways 50. Via its PTB domain, Cbl is recruited to the pY292 of ZAP-70 and 
thereby a ternary inhibitory complex between ZAP-70, Cbl and CD3ζ is formed 51. 
Together with the Src-like adapter protein SLAP-2, Cbl may be involved in the 
ubiquitinylation, internalization, and degradation of CD3ζ and ZAP-70 52. 
 
Gab2 is a member of the Gab (Grb2-associated binder) adapter proteins, consisting 
of a pleckstrin homology (PH) domain, phosphotyrosine-motifs for SH2 binding, and the 
PxxxR sequence, which forms an atypical binding motif for the SH3 domains of Gads and 
Grb2 53, and also occurs on SLP-76. Phosphorylated by ZAP-70 54, pY 614 of Gab2 forms 
a binding site for the SH2-domain-containing phosphatase 2 (SHP2).  SHP2 is believed to 
dephosphorylate and thus inactivate positive signalling molecules when located to the 
LAT signalling complex by Gab2 50 via Grb2 or GADS.  
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LAT pYTM
SLP-76 pY SH2PR
Grb2 SH3 SH2 SH3
GADS SH3 SH2 PR SH3
Vav
PLC 1γ
Lck/Fyn Lip kinaseSH3 SH2
Cbl PRPRSH2 pYRING
Gab2 pYPH pYPR
Nck SH3 SH3SH3 SH2
Fyb pY pYPRSH3pYPR
ZAP-70 SH2 SH2 pY kinase
SHP-2 PTPaseSH2 SH2 pY
SH3PH SH3SH2GEF pY PR
li- pYSH3 SH2 SH3PH P- H paseSH2
PI3K IA p85 SH3 SH2PR SH2
 
Figure 1.1 Simplified overview of the structure of some proteins involved in TCR dependent complex 
formation. (GEF = guanine nucleotide exchange factor ; Lip = acylation; PH = pleckstrin homology 
domain; PR = polyP motif; pY = phosphotyrosine motif ; PTPase = phosphatase; TM = transmembrane 
region; li-pase = discontinuous lipase domain) 
 
1.4 Lipid- and calcium-associated signals in T cell signalling   
 
Phosphoinositide-3-kinases (PI3K) are an enzyme family involved in various 
pathways, with the class IA PI3K activated by tyrosine-kinase-associated receptors like 
the TCR. Class IA PI3Ks are heterodimeric enzymes containing of a regulatory subunit 
(p85) and a catalytic subunit (p110), each in various isoforms. In T cells, Class I PI3K are 
recruited by to membrane-associated molecules by interacting with phosphotyrosines in 
YXXM, such as in CD28 55 and the T cell receptor interacting molecule TRIM, and also 
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in the adapter proteins in the Gab family. Upon binding the pYXXM motifs with its SH2 
domains and association with the membrane, PI3K phosphorylates the membrane lipid 
phosphatidylinositol-(4,5)-bisphosphate (PIP2) on the D3-position of its inositol ring to 
generate phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) on the inner leaflet of the 
plasma membrane. PIP3 is selectively bound by various intracellular proteins via their 
pleckstrin PH domains, prominently among them the serine/threonine kinase Akt/PKB 56. 
One main substrate of Akt is the glycogen-synthase kinase-3 (GSK-3), a kinase which is 
in its active state in resting cells, and inactivated by serine phosphorylation 57. 
Additionally to modulating glycogen metabolism, activated GSK-3 mediates the nuclear 
export of the nuclear factor of activated T cells. 
 
TCR engagement induces the activation of three members of the Tec/Btk kinase 
family: Inducible T cell kinase (Itk), Tec, and Rlk, of which the former two are also 
activated by CD28 stimulation. Like Akt, Itk and Tec are also recruited to the membrane 
by interactions of their amino-terminal pleckstrin-homology domains with products of 
PI3K 58, and by association of their SH2 and SH3 domains with SLP-76 31;59. Tec family 
kinases are subsequently activated by SFK-mediated tyrosine phosphorylation 60. Also, 
the activity of Tec kinases is positively regulated by Vav, involving PI3K dependent and 
–independent mechanisms 61. 
 
Phospholipase C γ1 (PLCγ1) is a lipase containing two SH2 domains and one SH3 
domain. One feature of PLCγ1 activation is initiated by the recruitment to phosphorylated 
LAT-mediated and thus to its lipid substrate in the membrane. On the other hand, PLCγ1 
activity is dependent on a Itk-dependent stimulatory phosphorylation on tyrosine 783, 17. 
Itk itself is recruited to the SLP-76 molecule in the LAT signalosome, which, in concert 
with the PIP3 in the lipid rafts exposes the activation loop tyrosine to phosphorylation by 
LCK 32. Upon activation, PLCγ1 catalyzes the hydrolysis of the lipid phosphatidyl-
inositol-4,5-bisphosphate (PIP2) to the second messenger molecules inositol-1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG). IP3 releases calcium from intracellular 
stores and the extracellular space. Cytoplasmic calcium activates various proteins, among 
them protein kinase C (PKC), of which PKCθ is the most prominent effector in 
lymphocytes, and the serine/threonine phosphatase calcineurin (see below).  PKCθ is a 
PKC isoform which is expressed in lymphoid tissue with the exception of B cells, and can 
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be alternatively activated independently from the calcium signal 62. Upon TCR 
engagement, PKCθ is recruited to the lipid rafts, where it interacts with LCK and is 
phosphorylated 63. The protein remains associated in the immunological synapse 
throughout the later stages of contact formation. Activated PKCθ then phosphorylates 
RasGRP, leading to the activation of the Ras/Raf/Erk pathway 64.  PKCθ  signalling is 
critical for the induction of IL-2-expression, via the transcription factors AP1 (a dimer of 
Fos and Jun) and NFκB, possibly via Akt or MAP3K65. 
 
 
1.5 Cytoskeletal effects and G proteins 
 
The products of PI3K activity also recruit a PH-containing group of proteins that are 
known as guanine nucleotide exchange factors (GEFs) for Rho GTPases like Rac, Rho, 
Cdc42. Additionally to regulating lymphocyte proliferation and differentiation, Rho 
GTPases are responsible for the initiation of the formation of different cytoskeletal 
patterns: RhoA regulates actin stress fiber formation, Rac1 lamellapodia and focal contact 
formation, and Cdc42 microspikes and filopodia, but consecutively also induce Rac- and 
Rho-mediated responses 66. The complex of Cdc42 with its effector WASP has been 
reported to be involved in actin nucleation via the Arp2/3 complex 67 and T cell 
polarization towards the APC. The WASP-interacting protein (WIP) mediates the Arp 2/3 
mediated actin polymerization by interacting with actin and profilin 68. 
 
The Vav family proteins are involved in various signalling pathways acting as 
cytoplasmic guanine nucleotide exchange factors (GEFs) for Rho family GTPases and 
exerting additional functions as an adapter protein. In TCR signalling, Vav1 is required 
for the initiation of a calcium flux by activating of Tec family kinases and thus indirectly 
of PLCγ 69. Also, Vav seems to be involved in the stabilization of the LAT signalosome 
70. After WASP is recruited towards the cell-cell contact by Nck 71, Vav activates WASP, 
which in turn binds and activates the actin nucleation comples Arp2/3. Also, Vav 
inactivates the actin-crosslinking ezrin/radixin/moesin proteins, and thus enables actin 
remodelling 72. Vav seems also to be involved in actin reorganization via Rac-1 73. Also, 
Rac-1 induces the activation of the transcription factor AP1, which is a Fos/Jun/Dimer, 
which is mediated via JNK and MEKK 74. 
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1.6 Costimuli  
 
In addition to the activation of the TCR by a peptide/MHC complex, the ligation of 
costimulatory molecules is required for an effective immune response. The glycoprotein 
CD28 is the most effective and best characterized costimulatory receptor on T cells, and 
binds to the membrane proteins CD80 and CD86, expressed by activated antigen-
presenting cells. TCR crosslinking on a naïve cell in the absence of a CD28 costimulus 
results in either apoptosis or anergy. 
 
Signalling induced by CD28 triggering is thought to be mediated by components 
that are also involved in CD28 TCR-dependent signalling 75. Like the TCR, CD28 lacks 
an intrinsic kinase activity, and contains tyrosine residues in its intracellular tail, that are 
phosphorylated by kinases like SFK 76. Also, CD28 crosslinking is described to induce 
the activation of Tec kinases 77 which catalyze the phosphorylation of intracellular 
tyrosine residues in YMNM motifs. Phosphorylation of the pY173 of CD28 results in 
recruitment of SH2-containing proteins such as PI3K, GADS and Grb2 55;78. The co-
activation of the PI3K pathway by CD28 has been described to be necessary for the 
induction of IL-2 expression 79. Like the TCR-downstream pathway, the activation of the 
PI3K/Akt pathway leads to NFκB activation via PKCθ 80 and enhancement of NFAT 
nuclear import via GSK-3 inhibition 81. In contrast to the TCR, CD28 does not recruit 
ZAP-70 and does not initiate the formation of a LAT/SLP-76 complex 75.  
 
On regarding the effect of CD3 and CD28 signals for the integration of an 
immunological response, CD28 is required for the production of IL-2 by T helper cells 
via the so-called CD28 response element, which includes NFAT and AP1 82, and also 
stabilizes the mRNA of IL-2 83. CD28 was shown to sustain general tyrosine 
phosphorylation associated with TCR-induced aggregation of GEMs 84, and enhances the 
activation of the PLCγ1-signal 77. By recruiting the structural component Vav, CD28 
might enhance the stability of the signalosome and thus lower the threshold for the 
induction of cell activation with low TCR occupancy 75. The enhanced stability of T 
cell/APC contacts by engagement of coreceptors may also be involved in maintaining 
immunological synapse stability. Also, CD28 has been reported to mediate the PI3K/Akt 
dependent inactivation of glycogen-synthase-kinase 3 (GSK-3) 79. With most signalling 
Introduction 
 16
molecules in CD28 dependent signalling also playing a role in CD3-dependent signalling, 
it is still under dispute whether CD28 engagement only quantitatively enhances CD3-
dependent signalling or activates qualitatively different signalling activities.  
 
1.7 Transcription factors in T cell signalling 
 
T cells express the calcium-regulated NFAT proteins NFAT1 (also known as 
NFATc2), NFAT2 (=NFATc1), and NFAT4 (=NFATc3). NFATs are activated by 
dephosphorylation of their regulatory domains mediated by the serine/threonine 
phosphatase calcineurin 85. Calcineurin is activated by a complex of the regulatory protein 
calmodulin together with the increase of the intracellular free calcium 86. Upon activation, 
NFAT enters the nucleus and acts a transcriptional regulator for, the expression of 
different cytokines such as IL-2, IL-6 and TNFα 82. In a resting cell, nuclear NFAT is 
subject to phosphorylation by different kinases, like GSK-3 87, casein kinase 1 88, p38 89 
and Jun N-terminal kinase 90, which induce the nuclear export of NFAT. GSK-3 is 
inactivated by a serine phosphorylation mediated by Akt 80, which thus indirectly 
augments NFAT translocation and gene expression.   
 
 
Nuclear factor-κB (NFκB) is a family of transcription factors involved in the gene 
expression associated with immune, inflammatory and apoptotic responses (reviewed in 91 
Following different stimuli, the IκB kinase (IKK) phosphorylates the inhibitor of κB 
(IκB), which is subsequently degraded via the ubiquitin-pathway. For the initiation of 
IKK activation, the PKCθ-mediated recruitment of the proteins Carma1 and Bcl10 to the 
immunological synapse is under discussion, followed by a Bcl10 and MALT1-initiated 
activation of the IKK complex 92. The free NFκB translocates to the nucleus and activates 
the transcription of a large number of target genes, among them genes encoding cytokines 
(e.g. IL-2; IL-8, TNFα), immunoreceptors, transcription factors and regulators of 
apoptosis. 
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 1.8 The immunological synapse 
 
The stable contact between a T cell and an antigen-presenting cell is characterized 
by the ordered formation of supermolecular activation complexes (SMAC) at the contact 
site, and also known as the immunological synapse.  Contact formation depends on the 
recognition of MHC/peptide complexes by matching TCR receptors. The first step, T cell 
polarization before cell-cell contact formation, is still mediated by indirect interactions, 
for example by chemokines 93. This step is followed by initial adhesion, in which non-
antigen-specific adhesion molecules like LFA-1 interacting with ICAM and CD2 
interacting with CD58 are the central contact molecules and localize to the centre of the 
contact area. The next intermediate step, in which the first, but not spatially restrained 
TCR/MHC recognitions are occurring, is termed the “immature” immunological synapse. 
The interaction of MHC/peptide complexes and TCRs are stabilized and sustained by 
means of the cytoskeleton. Also, the activities of the early kinases such as LCK and ZAP-
70 in the first 2-5 minutes of receptor engagement are associated with the “immature 
synapse” 6. After about 10 minutes after T cell/APC contact, the ordered and stable 
“mature immunological synapse” is formed by an active reorganization of surface 
molecules and cytoskeletal rearrangements. Here, a central cluster of T cell, CD28 and 
CD2 molecules (cSMAC) is surrounded by a ring of adhesion molecules (pSMAC), the 
CD11/CD18 integrins, and LFA-1 94;95. Though protein phosphorylation already peaks at 
about the 2 minute time point, enhanced protein phosphorylation in signalling clusters is 
still detectable in the “mature immunological synapse”. 
 
1.9 Chemical biology 
 
The term “Chemical biology” defines a field at the interface between chemistry and 
biology in which chemicals are used to manipulate biological systems. The subfield 
“Chemical genetics” 96 characterizes an approach in which small molecule effectors 
generated or purified by chemical approaches are used to directly affect the functions of 
gene products. In contrast to the traditional genetics approach in which genes encoding 
the proteins are affected, the inhibitors can be applied in real time 97;98. The small 
molecule effectors are often supplied from large chemical libraries, and the phenotypic, 
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cell- or organism-based screening for inhibitor effects is usually done similar to genetic 
screens. Inhibitor-based analyses allow the analysis of dose-response functions, the 
combination of inhibitors, and the testing in different cell lines. The specificity of the 
inhibitors is a field of concern. For some inhibitors, a specificity comparable to a gene 
knockout has been described 96. An advantage difficult to achieve by gene knockouts or 
knockdowns is the applicability of chemical inhibitors at closely defined time points.  
 
Methods for the analysis of a cellular response are essential both for the analysis of 
the functions of a gene product and of the effects of pharmaceuticals interfering with this 
gene product. A phenotype-based testing of a chemical is able to give information about 
the functional effect of this component in the complex system of the whole cell. 
Fluorescence microscopy allows the detection of a number of different parameters, like 
protein phosphorylation, but also even more complex morphological parameters such as 
cell attachment and spreading, cytoskeletal reorganization and protein translocation.  An 
often used approach of phenotype-based screening leads to an active compound, the 
identification of the target of that compound and from there, to the gene product and its 
functional involvement. Due to the high number of different parameter information 
obtainable by image-based screening, this method is also referred to as “high content 
screening” 99. In the conventional manner, the microscopy-based testing of chemicals is 
time consuming, expensive, and, most importantly, limited to a small number of 
substances to be tested at a time. With the growing coverage of gene and chemical 
libraries to be tested, the parallelization of cellular assay system is an important task. This 
task involves the miniaturization of assay conditions, and the establishment of methods 
for quantitative analysis of the results. For the cellular testing of drugs, the parallelization 
applying multiwell systems (e.g. in microtiter plates) is a widely used method. In this 
manner, the group of Tim Mitchison screened a library of 16,000 compounds in 384-well 
plates for different complex parameters such as wound healing, and cytoskeletal 
reorganization using automated microscopy 100. 
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1.10 Cellular microarrays 
 
In its natural environment, a cell is exposed to a high number of external stimuli. For the 
analysis of the effects of surface stimuli on the activation state of a cell, the 
immobilization of cell-interacting substrate by microspotting is able to add another degree 
of complexity to cellular systems. For the manufacturing of the array, either cells or cell-
interacting substrates are immobilized. In this case, the use of stimuli immobilized in a 
miniaturized format in microarrays allows the additional testing of the effects of 
chemicals for a multitude of different surface stimuli using only a small number of cells. 
 
Arrays of immobilized cells in parallel have been employed for the phenotype-based 
screening of the functions of a library of gene products 101. On the other hand, a high 
number inhibitors has been immobilized by embedding in biodegradable polymers 102. As 
T cells interact with a high number of different stimuli in the context of the immune 
system, the testing of the effects of various stimuli, including combinations of stimuli, 
represents an important task. Microarrays of immobilized antibodies against CD antigens 
that induce cell attachment have been used for the parallel analysis of surface antigens in 
leukemias 103. In recent years, microarrays of stimuli, such as immobilized peptide/MHC 
complexes have been applied to cellular systems. Soen et al. immobilized different 
MHC/Peptide-complexes and analyzed the interaction with different antigen-specific T 
cells concerning contact formation and calcium influx as early readouts 104. Stone et al. 
have quantified the stimulation-dependent secretion of cytokines using co-immobilizing 
capture antibodies. Also, another late readout, the display of CD3 and CD69 antigens was 
analyzed, thereby monitoring readouts in the range of several hours after TCR 
engagement 105.  
 
Due to the different structural properties of proteins, an effective and reproducible 
substrate for protein immobilization is needed for the fabrication of protein microarrays. 
The firm attachment of the protein to its immobilization surface and the maintenance of 
the native structure of the protein have to be ensured. Since in experiments involving the 
stimulation of cells the reproducibility of the stimulation intensity concerning is essential 
both that within one spot and that on an array it is also necessary to provide a 
homogenous surface for protein immobilization.  
2. Contributions to other projects 
 
 
In the context of the research interest in the group of PD Dr. Roland Brock, one focus was 
the development of molecules selectively interfering into protein-protein interactions in a 
living system, and the analysis of these effects on the cellular level. Using peptides as 
interactors, our research involved the design of peptides corresponding to recognition 
motifs as well as the transport of these peptides to their place of effect. This task includes 
the analysis of the cellular import mechanisms and the intracellular processing of these 
cell-penetrating peptides.  
 
 
Fischer, R., Köhler, K., Fotin-Mleczek, M., Brock, R. (2004): A stepwise dissection of 
the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 26; 
279(13):12625-35  
 
The author of this thesis participated in the establishment and measurement of the effects 
of inhibitors of the pathways of proteasomal and lysosomal proteolysis on the import 
efficiency and import mechanism of cell-penetrating peptides. 
 
 
Stoevesandt, O., Köhler, K., Fischer, R., Johnston, I., Brock, R. (2005): One-step 
detection of protein complexes in microliters of cell lysate. Nature Methods 2 (11): 833-
835.  
 
In this paper, the tetrameric multiprotein complex called the “LAT signalosome” was 
selectively disrupted by peptides corresponding to protein-protein interaction motifs (see 
also part 7.3.4 of this thesis), and the effect monitored on by fluorescence- (cross-) 
correlation spectroscopy. The author of this thesis synthesized and purified the 
bisphosphorylated peptides used in this study. 
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3. Chemical genetics when timing is critical: A pharmacological concept 
for the maturation of T cell contacts 
 
3.1 Summary 
 
Cellular signal transduction proceeds through a complex network of molecular 
interactions and enzymatic activities. The timing of these molecular events is critical for 
the propagation of a signal and the generation of specific cellular response. Here we 
introduce the combination of high resolution confocal microscopy with the application of 
small molecule inhibitors at various stages of signal transduction in T cells to define the 
timing of signalling events. Inhibitors of Src-family tyrosine kinases and actin 
reorganization were employed to dissect the role of the lymphocyte-specific tyrosine 
kinase LCK in the formation and maintenance of T cell receptor/CD3-dependent T cell 
contacts. Anti-CD3-coated coverslips served as a highly defined stimulus. The kinetics of 
the recruitment of the yellow-fluorescent protein-tagged signalling protein ZAP-70 was 
detected by high resolution confocal microscopy. The analyses revealed that at 5 min 
after receptor engagement LCK activity was required for maintenance of contacts. In 
contrast, after 20 min of receptor engagement, the contacts were LCK-independent. The 
relevance of the timing of inhibitor application provides a pharmacological concept for 
the maturation of T cell-substrate contacts. 
 
This section has been adapted from: 
 
Köhler, K., Lellouch, A.C., Vollmer, S., Hoff, A., Peters, L., Rogl, H., Malissen, B., 
Stoevesandt, O., Brock, R. (2005): Chemical genetics when timing is critical: A 
pharmacological concept for the maturation of T cell contacts. Chembiochem 6(1):152-61 
 
 
For this paper, the generation of the fusion protein cell line was performed by Dr. Anne-
Marie C. Lellouch. Susanne Vollmer and Lasse Peters were involved in the establishment 
of the cellular readout system. Antje Hoff, Susanne Vollmer and Dr. Hans Rogl 
performed a part of microscopical analysis, and Oda Stoevesandt a part of the 
biochemical experiments. The work was supervised by PD Dr. Roland Brock and Prof. 
Dr. Bernard Malissen. The figures were prepared by the author unless indicated 
otherwise.   
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3.2 Introduction 
 
The interaction of a T lymphocyte with an antigen presenting cell (APC) is a 
primary example for a regulation of an intercellular interaction. The past years have 
provided a wealth of information on the molecules in the plasma membrane and inside the 
T cells and target cells that participate in and modulate these interactions. Now, the 
timing and contribution of individual molecular events to contact formation and 
generation and execution of a T cell response needs to be addressed in detail.  
Binding of T cell receptors (TCR) to agonistic peptide-major histocompatibility 
complex (MHC) complexes initiates a cascade of signalling events central to the 
execution of the adaptive immune response 106. Upon TCR engagement the Src-family 
kinase (SFK) LCK phosphorylates tyrosines of the immunoreceptor tyrosine-based 
activation motifs (ITAMs) within the TCR/CD3 complex 107. The cytoplasmic Syk family 
tyrosine kinase ZAP-70 is recruited to the TCR/CD3 complex by binding to the 
phosphorylated CD3ζ ITAMs. Activation of ZAP-70 leads to the progagation of the 
signal via multiple pathways that culminate in gene expression and the formation of a 
highly ordered supramolecular structure at the interface of the T lymphocyte and the 
APC, the ‘immunological synapse’ 94. Formation of the immunological synapse occurs 
through the rearrangement of transmembrane molecules in the T cell-APC contact 108. 
Concomitant with the redistribution of transmembrane molecules, factors involved in cell 
adhesion and intracellular signalling as well as microfilaments and associated proteins are 
concentrated at the contact site. 
Given the prominence of the redistribution of membrane proteins, to this end, 
research on the immunological synapse has been based on T cell-APC contacts or on 
model systems in which the APC was replaced by lipid bilayers incorporating membrane 
proteins 94; experimental approaches that allow for the lateral diffusion of membrane 
proteins. As a consequence synapse maturation has been associated with the 
morphological reorganization of the T cell-APC contact. Limited information exists on 
the individual contributions of signalling molecules to the transformation of the contact 
from a premature early stage into a mature late stage.  
In order to focus the analysis of contact maturation on the role of signalling 
activities, we selected anti-CD3 antibody-coated coverslips as a well defined stimulus for 
the activation of T cells 109. In contrast to stimuli provided by APCs or lipid bilayers, 
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surface-coated anti-CD3 antibodies are immobile, precluding the rearrangement of 
transmembrane receptors by lateral diffusion as a mechanism for contact maturation. As a 
consequence, stimulation of T cells with immobilized antibodies eliminates one level of 
complexity in the analysis of CD3-dependent signalling events. Coverslips coated with 
anti-CD3ε antibodies reproduce major events of T cell receptor-dependent signalling and 
enable the analysis of the recruitment of signalling molecules to the CD3 complex by 
high-resolution confocal microscopy 7. 
We applied a chemical genetics approach to investigate the role of LCK in the 
maintenance of T cell contacts at various stages after engagment of receptors 97;98 .  
Previously, it has been shown that active LCK is associated with the immature 
immunological synapse 6. However, cells lacking this kinase fail to establish stable 
contacts with anti-CD3-coated coverslips. Therefore, application of small molecule 
inhibitors after contact formation is the only way to analyse the functional role of LCK 
activity at later stages of signalling. 
T cell hybridoma cells stably expressing a YFP-fusion of ZAP-70 alone or in 
combination with a CD3ζ-cyan fluorescent protein (CFP) fusion protein were exposed to 
anti-CD3 coated coverslips and inhibitors were added at different time points before and 
after formation of contacts. ZAP-70 is recruited into the TCR signalling complexes within 
the first minutes of T cell activation and remains associated with the synapse through the 
early stages of immunological synapse formation 6. We therefore expected ZAP-70 
localization to be a sensitive readout for any changes in activities that have impact on the 
engagement and activation of CD3 complexes.  
3.3 Results 
 
We intended to elucidate the functional role of signalling active LCK in the early 
stages of CD3 engagement. Moreover, using anti-CD3 antibody-coated coverslips as a 
stimulus we intended to resolve whether a spatial rearrangement of transmembrane 
molecules was required for the transformation of a T cell contact from an immature to a 
mature stage. Hybridoma cells coexpressing the ZAP-70-YFP fusion protein alone or in 
combination with a CFP fusion protein of the CD3ζ-chain were generated as read-outs for 
signalling events affecting the CD3-complex. Cell lines applied in this study were 
generated by Anne-Marie Lellouch. 
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3.3.1 Functional integrity of fusion proteins. Fusion proteins of ZAP-70-YFP and 
CD3ζ-CFP were overexpressed in the 3A9 hybridoma cell line using a retroviral infection 
system affording efficient and highly stable expression. Western blotting of total cell 
lysates using an anti-GFP antibody revealed that both proteins were expressed at the 
expected molecular weights of 95 kDa and 41 kDa. No degradation products could be 
detected. Incubation of the coexpressing cells with 0.5 mM sodium pervanadate followed 
by anti-phosphotyrosine immunoprecipitation and western blotting against GFP revealed 
that both ZAP-70 and CD3ε fusion proteins were phosphorylated in an activation-
dependent manner (Fig. 3.1). Furthermore, using anti-CD3ε-coated coverslips as a 
stimulus, the recruitment of the ZAP-70 fusion protein to the CD3 complex was 
demonstrated by immunoprecipitation (see below). 
 
 
 
 Figure 3.1 Activation-dependent tyrosine 
phosphorylation of CD3ζ-CFP and ZAP-70-
YFP. Cell lysates from 3A9 cells alone (A,B) or 
coexpressing CD3ζ-CFP and ZAP-70-YFP 
(C,D) were immunoprecipitated with an anti-
phosphotyrosine mAb before (-) or after (+) a 5-
minute treatment with 0.5 mM sodium 
pervanadate. Immunoprecipitates were 
subsequently blotted with anti-GFP mAb. The 
bands at 25 kDa and 50 kDa probably result 
from cross-reactivity of the secondary anti-
mouse antibody with the antibody used for 
immunoprecipitation. Figure provided by Anne-
Marie Lellouch. 
 
 
 
3.3.2 Transient recruitment of ZAP-70-YFP to CD3 clusters. First, the dynamics 
of cell spreading and ZAP-70 recruitment were investigated by exposing 3A9 ZAP-70-
YFP transfectants to coverslips coated with anti-CD3ε antibodies. In contrast to work 
reported previously, in our case the adsorption of the antibodies was enhanced by 
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rendering the surface of the cover slip hydrophobic by silanization with octadecyl-
trimethoxysilane. In order to prevent surface functionalization with extracellular matrix 
proteins contained within the cell suspension that could mediate the attachment of cells 
via integrins, after incubation with antibody, coverslips were blocked by incubation with 
1 % BSA/PBS. In addition, cells were washed and added in serum-free medium. Upon 
contacting the anti-CD3ε-functionalized cover slip, the cells spread rapidly and small 
(approx. 0.5 µm) discrete clusters of ZAP-70-YFP began to form (Fig. 3.2). Analysis of 
the surface distribution of the anti-CD3ε antibodies by immunofluorescence excluded 
inhomogeneities as the the origin of ZAP-70-YFP clustering (data not shown). No cell 
spreading or ZAP-70-YFP clusters were observed for control coverslips coated with poly-
lysine, anti-CD4 antibodies or BSA.  
 
 
Figure 3.2 Cell spreading and clustering of ZAP-70-YFP fusion proteins in a ZAP-70-YFP transfected 3A9 
cell contacting an anti-CD3ε-coated coverslips. The cell was imaged by time-lapse confocal microscopy. In 
order to ensure recording of cover slip-proximal fluorescence, a confocal stack consisting of five slices was 
recorded for each time point and slices containing surface-proximal fluorescence were selected for the 
figure. Times are given in minutes in the figures. The bar denotes 10 µm. 
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Maximal cell spreading was detected within 5 min. Concomitant with cell 
spreading, clusters appeared at the leading edge of the cells culminating into a near 
complete peripheral ring of ZAP-70-YFP clusters at about 10 min. The time-lapse 
imaging demonstrated that the formation of clusters at the periphery resulted from 
engagement of CD3 complexes at newly formed contact sites, rather than lateral diffusion 
or transport of aggregated proteins along the proceeding cell edge. The ring of clusters 
started to disappear after about 15 min to become completely undetectable about 25 min 
after formation, i. e. about 30 to 40 min after the initial cell-substrate contact. At the same 
time, the cells slowly started to retract their extensions from the cover slip. Furthermore a 
dissipation of central ZAP-70-YFP clusters was observed, which remained barely visible 
after 60 min. The time frame of ZAP-70-YFP recruitment observed in our system 
resembles the dynamics of ZAP-70 association with a T cell-APC immunological synapse 
6. The dissipation of ZAP-70 clusters is indicative of the initiation of down-regulatory 
events limiting the duration of the ZAP-70-dependent signal. Functional TCR 
engagement by surface-coated anti-CD3ε antibodies was further confirmed for this 
system by the detection of the nuclear translocation of the transcription factor NFAT (data 
not shown). For experiments using fixed cells, the 40 min time point was chosen. At this 
stage, the cells still fully adhered but ZAP-70 clusters had partially dissipated. When 
using inhibitors of signalling, this time point should therefore reliably reflect changes in 
signalling activities that influence ZAP-70 recruitment and cell attachment.  
 
3.3.3 ZAP-70-YFP colocalizes with CD3 receptor complexes. In order to 
identify the molecular basis for the formation and dissipation of ZAP-70 clusters, we first 
determined whether the dynamics of ZAP-70-YFP clustering was correlated with the 
formation of CD3ζ-CFP clusters. For this purpose, 3A9 hybridoma cells coexpressing the 
ZAP-70-YFP fusion protein and a CD3ζ-CFP fusion protein were examined by confocal 
microscopy using the same stimulus (Fig. 3.3). CD3ζ-CFP formed discrete clusters, 
which fully colocalized with ZAP-70-YFP in the early stages of stimulation. This 
colocalization suggests that ZAP-70-YFP clustering resulted from recruitment to 
phosphorylated CD3 ITAMs, notably the CD3ζ chain. In contrast to ZAP-70, the CD3ζ 
clusters persisted over the whole 60 min time course of the experiment. The persistence of 
CD3ζ clusters indicates that the dissipation of ZAP-70-YFP clusters was not due to CD3ζ 
internalization but to other down-regulatory mechanisms that modulate ZAP-70 
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recruitment to the plasma membrane. These experiments, using fixed cells confirmed that 
the loss of YFP-fluorescence was not due to photobleaching. The confocal optics 
restricted the detection of fluorescence to an optical section next to the coverslip. It was 
therefore difficult to determine, whether the loss of YFP fluorescence was due to a 
redistribution of the fusion protein throughout the cell or due to a degradation of the 
fusion protein. For this purpose, cells were seeded onto anti-CD3ε-coated coverslips and 
the level of the fusion protein and endogeneous protein probed by Western blot. The 
ZAP-70 levels remained unchanged throughout the experiment (Figure 3.3 B).
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Figure 3.3 Corecruitment of TCR CD3ζ-chains and ZAP-70. (A) 3A9 cells cotransfected with CD3ζ-CFP 
and ZAP-70-YFP were exposed to anti-CD3ε-coated coverslips, fixed after 10, 20, 40, and 60 min of 
stimulation and imaged by confocal laser scanning microscopy. Left panels: CFP fluorescence (red); center 
panels: YFP fluorescence (green); right panels: superposition of both channels. A confocal section 
corresponding to the surface of the cover slip is shown in each case. The bar denotes 10 µm. (B) An anti-
ZAP-70 Western blot was performed in order to determine whether the decrease in fluorescence was due to 
a degradation of the fusion protein. 3A9 cells expressing ZAP-70 YFP and CD3ζ-CFP were left 
unstimulated (-), or stimulated on CD3ε-functionalized coverslips for 5, 10, 20, 40 and 60 min. Lysates 
were subsequently blotted with an anti-ZAP-70 antibody. An anti-GAPDH antibody served as a control for 
the amount of cellular protein. The band at 50 kDa likely resulted from the cross-reactivity of the secondary 
antibody with residual stimulatory antibody washed off the coverslip during lysis of cells. Image 3.3 A was 
generated by Antje Hoff. 
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3.3.4 Continuous Src-family kinase activity is required for maintenance 
of cell contacts only in the early phase of cell attachment. To this end we had 
established that anti-CD3ε-coated coverslips induced a focal engagement of CD3 
complexes leading to a transient recruitment of ZAP-70 with a time course similar to the 
one in the T cell APC contact 6. In order to reveal the role of LCK in the formation and 
maintenance of the clusters an inhibitor-based strategy was chosen. Small molecule 
inhibitors represent powerful tools for rapidly interfering with cellular signalling 
processes. The specificity of the effects observed for inhibition of LCK activity was 
established through a combination of results obtained with the Src-family kinase 
inhibitors PP2 and SU6656. Of the kinases involved in early signalling in T lymphocytes 
PP2 inhibits the Src-family kinases LCK and Fyn with an IC50 value of 4-5 nM110. In 
contrast, the Src-family kinase inhibitor SU6656 (Sigma) was applied at 1 µM, a 
concentration inhibiting the kinases Src (IC50=0.28 µM) and Fyn (IC50=0.17 µM), but 
insufficient to inhibit LCK (IC50=6.88 µM) 111. In addition, SU6656 and PP2 vary greatly 
in their activity profiles for inhibition of non-Src-family kinases 112. 
 
Pretreatment of the cells with 20 nM PP2 completely inhibited the capacity of the 
cells to adhere and spread on the anti-CD3ε-coated coverslips. Signalling-active LCK is 
associated with the immature immunological synapse for the first 10 min after contact 
formation. When PP2 was added 5 min after contact formation, ZAP-70 clusters, 
especially those in the periphery of the cells, dissipated. The cells retracted their contacts 
and the contour of the cell changed from a convex to a concave shape within 5 min (Fig. 
3.4). This rapid and strong retraction was a phenomenon observed exclusively for more 
than 60 % of the PP2-treated cells at this stage. The detachment of cells prompted us to 
also add the inhibitor at a time point, when the ZAP-70 clusters started to dissipate. We 
hypothesized that at a time point, when early signalling events had been passed, contacts 
might be functionally different. In fact, in contrast to addition after 5 min, addition of PP2 
20 min after contact formation had no significant effect on cell attachment. The size and 
distribution of the ZAP-70-YFP clusters corresponded to those of untreated cells (Fig. 
3.4). Furthermore, the kinetics of the dissipation of clusters was comparable to that of the 
control. Apparently, in the early phase of CD3 engagement a requirement for continuous 
Src-family kinase activity exists in order to maintain cell attachment and ZAP-70 
clustering. Later, this requirement vanishes. In order to validate biochemically the 
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inhibitor effects at the different time points, the interaction of the CD3-complex with 
ZAP-70 was probed by anti-CD3ε immunoprecipitation followed by an anti-ZAP-70 
Western blot. Considering the fact that the addition of 20 nM PP2 caused a dissipation of 
clusters over a time course of several minutes, first, the concentration dependence of the 
effect of PP2 was assessed (Figure 3.4 C). To this end in different cellular model systems 
this inhibitor has been used at very different concentrations, ranging from the lower 
nanomolar range, into the micromolar range 7;110;111;113. Cells were stimulated on the same 
anti-CD3ε-coated coverslips used for cell biological experiments and lysed after 10 min 
total time of stimulation. As expected, the recruitment of ZAP-70 to the CD3 complex 
was stimulus-dependent. To our surprise, no effect on ZAP-70 recruitment was detected 
at 20 nM PP2, neither when the inhibitor was added before initiation of stimulation nor 
afterwards. When the inhibitor was added at 200 nM or higher concentrations before the 
initiation of stimulation or 20 min afterwards, the ZAP-70 signal was strongly reduced. 
Interestingly, the inhibitory effect was even more pronounced when PP2 was applied at 
200 nM 5 min after initiation of stimulation (Figure 3.4 D). While the prominent 
sensitivity of cells, 5 min after initiation of stimulation, observed by microscopy was 
reproduced by the immunoprecipitation, these data suggest that the cellular response 
reacts more sensitively to a shift in the extent in the kinase activity than may be detected 
biochemically. 
Exposure of cells to SU6656 at a concentration of 1 µM had no effect neither on the 
attachment and spreading of cells, nor on ZAP-70 clusters, indicating that PP2-dependent 
effects are specifically related to the inhibition of LCK (not shown). In order to confirm 
that SU6656 had the potential to exert a specific inhibitory activity, human Jurkat 
lymphoma cells were exposed to coverslips coated with an antibody directed against the 
integrin LFA-1. This integrin acts as a coreceptor in T cell signalling 114. Propagation of 
integrin-dependent signals is Src-kinase dependent. As expected, preincubation with both 
PP2 (20 nM) and SU6656 (1 µM) strongly reduced the attachment of Jurkat cells. On 
anti-CD3-coated coverslips, PP2 exerted a significant effect, while SU6656 showed a 
weak effect at best (not shown).  
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Figure 3.4 Effect of Src-family kinase inhibition on cell attachment and ZAP-70 clustering. (A, B) Time-
lapse confocal microscopy of ZAP-70-YFP expressing cells before and after addition of 20 nM of the SFK 
PP2. Cells were allowed to establish contacts with the coverslips for (A) 5 min and (B) 20 min before 
addition of the inhibitor. A confocal section corresponding to the surface of the cover slip is shown in each 
case. The time points after the addition of the inhibitor are shown. The bar denotes 10 µm. (C) Biochemical 
validation of the effect of PP2 on ZAP-70 recruitment. 3A9 cells expressing ZAP-70-YFP were left 
unstimulated (-), or stimulated on CD3ε-functionalized coverslips without inhibitor (+) or with 20 nM PP2 
added 5 min after initiation of stimulation (a. i.) or 20 nM, 200 nM, 2 µM, and 20 µM PP2 added 5 min 
before initiation of stimulation (b. i.). Cells were stimulated for a total time of 10 min.  Lysates were 
immunoprecipitated with antibodies against CD3ε and subsequently blotted with an anti-ZAP-70 antibody. 
(D) Dependence of the inhibition of ZAP-70 recruitment on the timing of the inhibitor application. Anti-
CD3ε immunoprecipitates of lysates of cells left unstimulated (-), or stimulated on anti-CD3ε-coated 
coverslips for a total time of 30 min, without (+) or with 200 nM PP2 added at the indicated time points 
were probed for ZAP-70 by Western blot. 
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3.3.5 Cell detachment is actin independent. In order to address the 
molecular basis for the PP2-dependent cell detachment, we decided to investigate the role 
of actin reorganization on cell attachment, ZAP-70 clustering and cell spreading. 
Reorganization of F-actin at the immunological synapse has been related to the 
stabilization of the cell-APC contact 115. Both LCK and Fyn have been implicated in the T 
cell stimulation-dependent actin reorganization 116;117. T cell spreading on a 
functionalized surface is accompanied by the rearrangement of F-actin into 
circumferential rings 7;109. 
 
 
 
Figure 3.5 Effect of inhibitors on F-actin, cell attachment and ZAP-70 clusters. (A) Untreated controls, (B, 
C) cells exposed to 20 nM PP2 after (B) 5 min (5’ a. i.) and (C) 20 min (20’ a. i.) incubation time, (D) cells 
pre-treated with 10 µM CytD 5 min before exposure to the coverslips (5’ b. i.), (E) incubated after 5 min 
and (F) 20 min of preincubation. In the figure, the time point when the inhibitor was added is given in each 
panel. In each case, including the control, the cells were incubated for a total of 40 min before fixation, i. e. 
a further 35 min when inhibitor was added after 5 min and a further 20 min when inhibitor was added after 
20 min. Actin was visualized using 100 µg/ml biotin-conjugated phalloidin in combination with Cy5-
conjugated streptavidin. The left panels (red) represent actin, the center panels (green) ZAP-70-YFP. In the 
right panels a superposition of both channels is shown. 
 
When cell detachment was induced by addition of PP2 after 5 min of stimulation, a 
fragmentation of F-actin was observed (Fig. 3.5 A, B). In contrast, little effect on F-actin 
was observed when PP2 was added to cells after 20 min stimulation (Fig. 3.5 C). Again, 
the characteristic detachment was visible for the majority of the PP2 treated cells, while 
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only rarely seen in untreated cells. In order to ascertain whether the fragmentation of F-
actin was the reason for cell detachment, cells were incubated with CytD, an inhibitor of 
actin polymerization. In contrast to PP2, preincubation of cells with 10 µM CytD did not 
inhibit the formation of ZAP-70-YFP clusters at the cell-substrate contact and adhesion of 
cells (Fig. 3.5 D). However, consistent with results reported previously for Jurkat cells, 
the actin-mediated spreading of the cells on the surface was inhibited 118. Unlike PP2, 
CytD treatment of cells contacting the coverslips for 5 min did not cause detachment or 
retraction of the cells from the surface. Instead, the cells were spread out on a smaller 
area, demonstrating that only cell extension was inhibited (Fig. 3.5 E). No peripheral actin 
ring formed and actin did not colocalize with ZAP-70-YFP clusters. For cells treated with 
CytD after 20 min, the only visible effect was a mild disruption of F-actin compared to 
the controls (Fig. 3.5 F). In addition, CytD inhibited not only the spreading of the cells, 
but also abolished the dissipation of ZAP-70-YFP clusters, since the ZAP-70-YFP 
clusters appeared brighter in CytD-treated cells than in the control cells stimulated for the 
same total time. In contrast to PP2, ZAP-70 clusters in CytD treated cells persisted over 
the whole 60 min time course of the experiment. In order to address whether this 
persistence of clusters was due to an inhibition of actin-dependent internalization, 
confocal stacks of CytD treated cells and controls were acquired. No evidence for actin-
dependent internalization of ZAP-70-rich vesicles was obtained. The observations made 
for the inhibitors and the loss of colocalization in controls at the 40 min time point 
support the notion that ZAP-70 clustering is only indirectly coupled to F-actin 
polymerization. However, cell spreading driven by stimulation-dependent actin 
reorganization is a prerequisite for the formation of peripheral contacts and clusters.  
 
3.3.6 Cell retraction upon Src-family kinase inhibition occurs by 
detachment of contacts. The results obtained so far indicate that the PP2-induced 
detachment of cells is not due to an inhibition of actin polymerization. Instead, LCK may 
exert a direct activity on the CD3 complex or CD3-associated proteins that act upstream 
and/or independent of actin polymerization and that destabilize the cell-substrate contact. 
In order to probe the intimacy of the cell-substrate contact, cells were fixed but not 
permeabilized and coverslips incubated with a Cy5-conjugated anti-Armenian hamster 
antibody. In the absence of permeabilization the surface of the cover slip underneath the 
cell is accessible for the Cy5-labelled antibody only from the side (Fig. 3.6). In control 
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cells, the area of contact of the cells with the cover slip was completely inaccessible to the 
antibody, indicative of a tight cell-substrate contact (Fig. 3.6). In contrast, in the periphery 
of PP2 treated cells, the anti-CD3ε fluorescence colocalized with ZAP-70-YFP 
fluorescence. This distribution of fluorescence strongly suggests that cell retraction 
induced by PP2 occurs by disengagement of cell contacts from the antibody-coated 
surface. The peripheral CD3 contacts were destabilized to the point that even for the 
contacts themselves the surface became accessible to the antibody. Finally, detachment 
occurred in a highly disordered fashion. Instead of a uniform retraction of the cell edge, 
some contacts were maintained and large bay-like shapes formed. Formation of these 
shapes can be explained by a generalized destabilization of contacts across the contact 
surface and a random detachment of contacts.  
 
 
 
Figure 3.6 Analysis of the mechanism of PP2-induced cell detachment. (A, B) Tightness of cell-substrate 
contacts determined by the accessibility of surface-bound Armenian hamster anti-CD3ε antibody to Cy5-
labelled anti-Armenian hamster antibody. Cells were stimulated for 5 min, followed by incubation for 20 
min in the absence (A) or presence (B) of 20 nM PP2. ZAP-70-YFP fluorescence is shown in green (left 
panels), Cy5 fluorescence of anti-Armenian hamster antibody in red (center panels) and superpositions of 
both channels in the right panels. To the right, schematics of the surface staining by Cy5-labelled anti-
Armenian hamster antibodies are shown. The cells were fixed but not permeabilized. Surface bound 
Armenian hamster anti-CD3 antibodies in the cell-substrate contact were therefore only accessible to the 
anti-Armenian hamster antibody by lateral diffusion of the molecules into the contact area. The bars denote 
10 µm. The scheme on the right was generated by Roland Brock. 
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3.4 Discussion 
 
The results presented in this paper introduce chemical genetics in combination with 
high resolution confocal microscopy for the analysis of the timing of signalling activities 
in cellular signal transduction pathways. The application of inhibitors of Src-family 
kinases as well as microfilament dynamics at various stages before and after contact 
formation provided new insights in the initial steps of CD3-dependent signal transduction 
in T cells. 
 
3.4.1 Maturation of signalling clusters on anti-CD3ε-coated surfaces. In 
our experiments, glass coverslips homogeneously coated with anti-CD3ε antibodies were 
used as a minimal stimulus engaging CD3 complexes in a manner that precludes the 
ordered rearrangement of transmembrane molecules by lateral diffusion. Three different 
stages of susceptibility to inhibition of Src-family kinases by PP2 could be distinguished. 
First, cells pretreated with PP2 failed to establish contacts, which is consistent with the 
finding that PP2 pretreatment inhibits induction of tyrosine phosphorylation upon 
subsequent TCR/CD3 cross-linking119. Second, cells that had established contacts for 5 to 
10 min continued to be sensitive to PP2. Third, at 20 min after initial engagment, the 
ZAP-70 cluster dynamics were no longer sensitive to the inhibitor and the dissipation and 
detachment followed its normal time course. By combination of inhibitors with different 
specificities, especially by taking advantage of the recently described inhibitor SU6656, 
we were able to show that the effect of PP2 could most likely be attributed to inhibition of 
LCK (Fig. 3.7). While PP2 acts as an inhibitor of the Src-family kinases LCK, Fyn, Hck, 
and Src, SU6656 is expected to act on the Src-family kinases Src, Fyn, Yes and Lyn, but 
not on LCK at the concentration used in our experiments 120. In addition, at a 
concentration of 20 nM LCK and Fyn are the primary activities relevant for T cell 
attachment inhibited by PP2. Moreover, the LCK-deficient Jurkat cell line JCaM1.6 failed 
to spread on anti-CD3ε functionalized coverslips, while LCK retransfected cells were 
able to spread, as seen in the second paper in this section. The significance of LCK in the 
maintenance of ZAP-70 clusters is consistent with the observation that the effect of LCK 
mutations on cell adhesion cannot be complemented by Fyn 116. Since LCK is the primary 
kinase involved in CD3-dependent signalling, validation of the inhibitory activity of 
SU6656 had to rely on an independent assay.  
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Figure 3.7 Schematic, summarizing the effects of inhibitors on cell morphology and ZAP-70 aggregates 
observed for addition of compounds before or 5 min and 20 min after contact of cells with the anti-CD3-
coated coverslips. Scheme by Roland Brock. 
 
Using a very similar experimental design, we could demonstrate that this compound 
inhibited the attached of Jurkat T cell lymphoma cells on anti-LFA-1 coated coverslips. 
As expected, given the activity profiles, both PP2 and SU6656 had the same effect. Given 
the importance that has been attributed to the lateral mobility of receptor molecules, the 
formation and maturation of the immunological synapse has most often been investigated 
in the T cell APC contact or for T cells exposed to ligands incorporated into supported 
lipid bilayers 106.Our results show, that stimulation by a well defined and highly 
simplified non-diffusive stimulus, as well, induces a transformation of contacts from a 
stage sensitive to Src-family kinase inhibition to an inhibition-insensitive stage. 
Apparently, CD3 clusters alone undergo a time-dependent maturation.  
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3.4.2 Molecular mechanism of contact maturation and detachment. Actin 
remodelling has been described as a hallmark both of immunological synapse formation 
and contact formation of T cells with anti-CD3-coated surfaces. Both LCK and Fyn have 
been implicated in these processes 117;118;121. Consistent with these prior results, addition 
of PP2 affected the distribution of F-actin, both at the early and late time point. However, 
inhibition of microfilament dynamics by CytD only affected cell spreading. Neither cell 
attachment nor ZAP-70 clustering were affected by this compound. Apparently, the LCK-
dependent regulation of CD3 engagement is controlled by mechanisms acting upstream of 
actin polymerization at the contact site. At present, we can only speculate how such 
disengagement occurs on the molecular level. The failure of cells preincubated with PP2 
to adhere to anti-CD3-coated coverslips indicates that the presence of receptor and ligand 
is insufficient for establishing of strong receptor-ligand contacts and suggests some sort 
of a feedback of early intracellular events necessary to allow adhesion, even to such a 
simplified and strong stimulatory surface. The observations made for the CD3-dependent 
attachment bear ressemblance with the modulation of integrin-mediated cell adhesion 122-
124. The results suggest that Src-family kinases act on the CD3 complex in a way that 
modulates the avidity of these receptors for a polyvalent ligand. 
 
3.4.3 Analyis of T cell contacts by chemical genetics. To this end, contact 
maturation between a T cell and an APC has been based largely on morphological 
criteria. The demonstration that T cell contacts acquire an unsensitivity to the inhibition 
of LCK introduces a pharmacological concept of contact maturation. Moreover, the 
different phenotypes obtained for the inhibition of LCK before and at various stages after 
formation of contacts stress a major advantage of chemical genetics over alternative 
methods for interfering with the function of a protein. Knock-down strategies as well as 
the down-regulation of protein expression by small interfering RNAs (siRNA) precludes 
the analysis of protein signalling activities that are vital for the initiation of a signal.  
In the analysis T cell signal transduction evidence is accumulated that the kinetics of 
signalling critically determines the functional response of a T cell 125. Chemical genetics 
represents a powerful means to investigate in detail the functional implications of such 
signalling kinetics. As an alternative to the application of an inhibitor after a certain 
duration, for low affinity compounds one may also imagine to remove the signalling 
block by wash-out of a compound. In addition to investigating the function of a gene 
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product with compounds of known activity, chemical genetics screens are performed by 
testing of compound collections with unknown targets for the induction of phenotypes, e. 
g. in the development of organisms 98. In these applications, kinetics also plays a role. 
Such screens, as well, therefore greatly benefit from the addition of compounds at 
different time points. 
Interestingly, the cellular phenotype provided a more sensitive sensor to the 
presence of the inhibitor than the biochemical analysis of the recruitment of ZAP-70. 
When cells were preincubated with 20 nM PP2 no spreading of 3A9 cells on anti-CD3-
coated coverslips was detected. Still, ZAP-70 was recruited into the CD3 complex. At 
present, the molecular details of this phenomenon remain elusive. We may only speculate 
that subtle changes in the balance of kinase and phosphatase activities are translated into 
different degrees of cell spreading. Given that T cells react sensitively to differences in 
MHC-peptide complexes and that the kinetics and balance of the recruitment of signalling 
proteins is discussed as the basis for this discriminatory ability, these results are not fully 
surprising 126. In our analyses we aimed at using the same anti-CD3 coated coverslips 
used for cellular experiments for the stimulation of cells used for biochemical 
experiments. Larger number of cells and a more detailed analysis of the pattern of 
phosphorylation may resolve the molecular details of this observation. 
One possible limitation of chemical genetics is the lack of specificity of some 
inhibitors. However, for the LCK-dependent signalling addressed in this study, only two 
members of the group of SFK target proteins have been implicated in the investigated 
signalling pathway. Of these two proteins, LCK and Fyn, LCK was singled out as the 
relevant target by incubation of cells with an inhibitor with a different activity profile. 
Given the availability of diverse compound collections with different activity profiles, a 
strategy, in which the specificity of an observed effect is confirmed by application of 
different inhibitors at various time points, may be realized for a large number of 
molecular targets. In order to perform such analyses efficiently, a robust stimulation 
protocol providing a maximum in information on the respective signalling pathway is 
required. For the analysis of T cell signalling, this prerequisite was fulfilled by exposure 
of cells to anti-CD3-coated coverslips, a stimulus that reproduces major characteristics of 
TCR-dependent signalling events initiated by more complex stimuli. We are well aware 
that cellular experiments using such simplified stimuli cannot replace the analysis of T 
cell signalling in physiological T cell APC contacts. However, our approach may 
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complement the latter in several ways. First, by providing highly defined stimuli 
revealing new and interesting characteristics of components of the signalling machinery. 
Second, by acting as a filter to screen for experimental conditions that are interesting 
enough for a further detailed analysis. The considerable extra effort required for the 
analysis of T cell APC contacts precludes the systematic testing of a large number of 
experimental conditions.  
 
The stimulation and image acquisition protocols presented in this study can readily 
be implemented into automated experimental procedures. Initial experiments have shown, 
that cell attachment, size and kinetics of signalling clusters respond sensitively to 
inhibition of a large number of down-stream events. Moreover, the approach may be 
extended to stimuli other than CD3-directed antibodies. The anti-LFA-1-coated coverslips 
used to confirm the activity of SU6656 were a first step in this direction. By taking 
advantage of a large repertoire of available inhibitors targeting distinct steps in T cell 
signalling it will be interesting to address systematically the involvement and timing of 
downstream signalling components controlling T cell adhesion, cytoskeletal 
reorganization and the dynamics of signalling clusters. 
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4. Functional Profiling of Chemical Inhibitors and Therapeutic 
Antibodies using Cellular Microarrays 
 
4.1 Summary  
 
Pharmaceutical inhibitors play an important role in immunology. In basic research, 
the role of specific enzymatic activities in signal transduction are routinely addressed. In 
addition, there is an ongoing search for immunomodulatory compounds serving as 
therapeutics. Specificity of small molecules is a general concern. For this reason, 
especially in the testing of new compounds, methods are required that sensitively reveal 
differences in biological activities. As a solution to this problem we have developed 
microarrays in which cells are exposed to a multitude of mixtures of stimulatory 
antibodies directed against combinations of cell surface receptors. Microarrays are spotted 
in a microtiter plate format and the response of cells to each combination of stimuli is 
detected by automated fluorescence microscopy. In Jurkat cells, inhibitors of T cell 
signalling with identical primary targets showed remarkable differences in their biological 
effects in the presence of various combinations of CD3- and CD28-directed stimuli, 
validating the potential for a profiling of pharmaceutical inhibitors. Furthermore, the 
application of the microarrays to the functional characterization of a therapeutic antibody 
is demonstrated. The cellular microarrays increase by more than an order of magnitude 
the data obtained for cellular assays and enable a detailed analysis of the interplay of 
signalling pathways requiring a minimum of cells. 
 
All cellular microarray experiments in this section were performed by the author. All 
stimulatory antibodies applied here were produced by Prof. Dr. Gundram Jung and Dr. 
Ludger Grosse-Hovest. Dr. Thomas André was involved in microarray establishment. 
 
4.2 Introduction  
 
The combination of sometimes conflicting signals into a physiologically meaningful 
response is a remarkable characteristic of the molecular signalling machinery. In the past 
years a wealth of information has been accumulated on the molecular events of individual 
signalling pathways and on factors that contribute to linking these pathways into 
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networks. It is now required to validate the functional relevance of these factors and to 
define the interplay of signalling pathways 127. In basic research, such information is 
required in order to identify a functionally relevant network topology, a requirement for 
model building in systems biology 128;129. In drug development, the parallel activation of 
several signalling pathways may induce compensatory activities within a signalling 
network that override the activity of a compound 130. A drug candidate should therefore 
be tested in the presence of a large number of different stimuli in order to obtain 
information with higher physiological relevance. However, using standard protocols for 
cellular assays, i. e. one readout per sample, the testing of large numbers of different 
combinations of stimuli is costly and cumbersome. 
 
Signal transduction in T lymphocytes is paradigmatic for a sensitive dependence on 
the molecular environment. Depending on the nature of the stimulus, the differentiation 
and activation state of a T cell, and the molecular environment, a T cell can respond with 
activation and proliferation, anergy, or apoptosis 3. For the activation of naive T cells, two 
signals are necessary to induce persistent activation (reviewed in 75): The crosslinking of 
T cell receptor (TCR)/CD3 complexes by specific MHC/peptide complexes of antigen 
presenting cells (APCs) and a costimulatory signal that is primarily provided through 
engagement of the CD28 coreceptor. TCR engagement leads to the recruitment of the 
Src-family kinase LCK, which phosphorylates tyrosine residues within the TCR/CD3 
complex 107. The Syk-family kinase ZAP-70 binds to the phosphorylated CD3ε chains 
and propagates the activation by phosphorylating downstream components 131, leading to 
a phospholipase Cγ (PLCγ-mediated increase in intracellular Ca2+ and the 
phosphorylation of membrane lipids by phosphatidylinositol-3’-kinase (PI3K). PLCγ-
dependent calcium signalling leads to the activation of the phosphatase calcineurin, which 
dephosphorylates the nuclear factor of activation in T cells (NFAT), leading to its nuclear 
translocation 82. The activity of calcineurin is antagonized by a glycogen synthase kinase-
3 (GSK-3)-dependent phosphorylation of NFAT which leads to the nuclear export of 
NFAT. GSK-3, in turn, is inhibited by a PI3K-dependent signalling pathway. For 
costimulation by CD28, most signalling molecules involved in this pathway also play a 
role in CD3-dependent signalling. Therefore, it is still under dispute whether CD28 
engagement only quantitatively enhances CD3-dependent signalling or activates 
qualitatively different signalling activities 75. 
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We sought to develop a strategy by which the interplay of signalling pathways in 
generating a cellular response could be analyzed systematically and to apply this strategy 
to the testing of the activity of low molecular weight inhibitors. Given its significance for 
the activation of cellular immunity, the CD3-/CD28-dependent signalling network 
provides a highly interesting target for this approach. In order to sample systematically 
combinations of CD3 and CD28 stimuli, Jurkat T cell leukaemia cells were exposed to an 
antibody microarray in the presence or absence of pharmacological inhibitors. Jurkat cells 
are a human T helper cell leukemia line 132;133 that has been extensively used for the 
research on T cell signalling in the past 25 years 134.  The arrays were produced in a 
microtiter plate format, enabling an efficient processing of multiple samples. Each spot of 
the array contained a distinct mixture of stimulatory anti-CD3 and anti-CD28 antibodies. 
As a substitute for the APC, antibody-functionalized surfaces have been shown to 
reproduce major T cell signalling events 118;135. Cell spreading and NFAT translocation 
were recorded by immunofluorescence microscopy followed by automated image 
analysis. For the entire microarray, the cellular responses were a function of the 
composition of the stimuli. The selected pharmacological inhibitors, including several 
well-established compounds used for the analysis of T cell signalling, showed remarkable 
difference with respect to their response profiles. Moreover, different response profiles 
were obtained for pairs of inhibitors for which the same primary targets had been 
described, providing new information on the specificity of these compounds. In addition, 
the application of the method to the functional profiling of the supraagonistic anti-CD28 
antibody rM28136 is demonstrated. The rM28 represents a bispecific single-chain antibody 
directed to a melanoma-associated proteoglycan (MAPG) and the CD28 receptor, which 
has shown to induce T cell stimulation independent from TCR/CD3 stimulation. 
 
4.3 Results 
 
4.3.1 Implementation of cellular microarrays. For the immobilization of 
stimulatory antibodies on different surfaces, we first evaluated the effect of different 
surfaces on the stimulatory properties of immobilized antibodies using an enzyme-linked 
immune assay (ELISA). Also, we analyzed the effect of stimulating antibodies on IL-2 
expression in this experiment. We compared the effect of different surfaces on the 
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functional immobilization of different antibodies: Untreated glass coverslips, the 
hydrophobic but noncovalent-binding octadecylsilane surface, GOPTS (100 %, and 2.5 % 
(v/v) in ethanol), and an aminopropylsilane-based, noncovalently absorbing hydrogel 
(Nunc). Taking into account the surface to volume ratio, for the macrostructured format a 
concentration of 2 µg/ml of the stimulatory anti-CD3 and/or anti-CD28 antibodies was 
considered sufficient for surface saturation. In addition, a BSA-coated coverslip was 
included as a negative control. 1.25*105 cells/surface were stimulated for 16 h, then the 
supernatants were removed and IL-2 expression quantified by ELISA (performed by 
Ludger-Grosse Hovest and Elke Hoffmann).  On all surfaces, the IL-2 expression induced 
by anti-CD3 engagement was higher than that for anti-CD28 engagement alone (Fig. 4.1). 
The most intensive IL-2 signal was observed for anti-CD3 stimulation plus anti-CD28 
costimulation and was much higher than the sum for both single stimuli.  The 
supraagonistic anti-CD28 antibody induced a much stronger signal than the clone 9.3. On 
the untreated slides and the hydrogel, the IL-2 signal was more intense than anti-CD3 
engagement alone. The most intensive IL-2 signal was observed for anti-CD3 plus anti-
CD28 stimulation for the untreated slides, the hydrophobized slides, and the hydrogel 
surface, while the epoxy-functionalized slides only generated weak signal. 
 
 
Figure 4.1 Evaluation of different functionalization methods for the immobilization of stimulatory 
antibodies. Surfaces were functionalized with 2 µg/ml of each of the stimulatory antibodies, and blocked 
with BSA. PBMC cells were stimulated for 16 h on the surfaces and IL-2 expression quantified by ELISA.  
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The different surfaces were also tested for the suitability for antibody spotting. Solutions 
of anti-CD3 antibodies (OKT3) were spotted as described for the stimulatory antibody 
microarrays in the experimental procedure section, blocked with 1 % BSA, washed with 
PBS and stained with fluorescently-labelled secondary anti-mouse antibodies. 
Microscopy showed that the unfunctionalized glass slides only provide relatively low 
binding including wash-out effects. Coating of protein surfaces with 2.5 % epoxy-silane 
provided high protein binding, but due to difficulties in the removal of residual silane 
from these surfaces, detectable by impurities, self-produced epoxysilane surfaces were 
not suitable for the reproducible spotting of antibodies (data not shown), and also were 
only able to induce weak stimulation of the cells as determined by ELISA. Providing the 
best spot quality, hydrogel substrates were selected as substrates for the cellular 
microarrays. The substrates from Nunc and Schott-Nexterion both showed a highly 
homogeneous distribution of antibodies within a spot over a wide concentration range. 
The Schott-Nexterion Slide H hydrogel, a succinimidyl ester-activated polyethylenglycol-
based hydrogel was selected as an antibody microarray substrate because of its 
insensitivity for the adhesion of cells on non-functionalized areas, enabling a direct 
correlation of attachment and spreading to activation. The saturation binding capacity of 
this hydrogel was determined at an antibody concentration of about 200 µg/ml, which 
represents a concentration of about 6.4*10-6 ng per µm2 hydrogel, which is about 700 
molecules per µm2. 
 
 
Figure 4.2 Quantification of antibody binding to a succinimidyl-ester functionalized hydrogel (Schott-
Nexterion). Anti-CD3 antibodies (OKT3) were spotted in different concentrations and bound antibodies 
detected by anti-mouse Alexa 488 staining, fluorescence microscopy and quantified using Image Pro Plus. 
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The composition of the spotting and blocking buffer was adapted from the manual for 
Hydrogel Slides H. In order to enhance spot homogeneity and to prevent evaporation, 
0.5% (w/v) trehalose was added to the spotting buffer. In addition to the blocking of the 
reactive groups by ethanolamin, an additional blocking step against unspecific adhesion 
of proteins and cells with the albumine supplement 1% (w/v) Top Block (Sigma) was 
incorporated 137. 
 
4.3.2 Attachment of cells to the microarrays. To systematically probe the 
interplay of CD3 and CD28 in T cell activation a matrix of mixtures of anti-CD3 and anti-
CD28 antibodies was spotted. A polylysine spot served as a negative control to determine 
NFAT translocation in the absence of a stimulus. In addition rM28, a single-chain 
bispecific antibody against anti-CD28 and the melanoma-associated proteoglycan 
(MAPG) 136, was spotted. This protein has been shown to induce a CD3-independent, 
supraagonistic stimulation of the CD28 molecule on human T cells, resulting in tumour 
cell killing. After pipetting of the arrays, a frame was attached to the microarray substrate, 
yielding 16 wells in a standard microarray-plate format per microarray substrate         
(Fig. 4.3). In this way, in each well a multitude of different conditions, corresponding to 
the number of spots of the microarray, could be tested. Cell spreading, serving as a 
measure for activation-dependent reorganisation of the actin-cytoskeleton 118 and 
translocation of the transcription factor NFAT were quantitated by laser scanning 
microscopy and image processing. One multi-channel fluorescence image was recorded 
for each spot. An overview of a typical cellular antibody microarray, scanned in a mosaic-
like fashion is shown in Fig. 4.3. 
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Figure 4.3 Anti-CD3/anti-CD28 antibody microarray. (A) Overview: Mixtures of anti-CD3 and anti-CD28 
antibodies were spotted at the indicated concentrations and visualized by staining with an Alexa546-labeled 
anti-mouse antibody (red). Jurkat cells are visualized by nuclear TOPRO staining (blue). As a control to 
mediate cell-attachment without activation, polylysine was spotted. The supra-agonistic anti-CD28 antibody 
rM28 had little reactivity for the secondary antibody. The scale bar represents 400 µm. (B) Spreading and 
NFAT translocation of Jurkat cells on spots functionalized with 200 µg/ml of anti-CD3, anti-CD28 or a 
mixture of both antibodies. The immobilized antibody is visualized in grey. Nuclei are colored red, NFAT 
green, resulting in yellow color in the case of colocalization. The scale bar represents 20 µm. 
 
 
Cells were incubated on the microarrays for 60 min before fixation, a time required 
to observe pronounced NFAT translocation. In some cases, 20 µg/ml of either antibody 
was not sufficient to induce the attachment of a sufficient number of cells to determine 
NFAT translocation. Overall, the number of cells per spot showed a positive correlation 
with antibody concentration in the range of about 5 to 200 cells with measurable 
properties present on each spot. Initial experiments had shown that spreading of Jurkat 
cells on anti-CD3 reached its maximum after about 10 min of cell stimulation and was 
strongly reduced after 60 min, in accordance to 118, while on anti-CD28 spreading was 
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stronger after 60 min than after 10 min (Fig. 4.9). This suggests a higher persistence of 
the anti-CD28-induced spreading compared to that induced by anti-CD3. The 
observations for the 60 min time point were extended by the concentration matrix (Fig. 
4.4). Interestingly, cell spreading was reproducibly weaker on the 200 µg/ml anti-CD3 
spot than on the 60 µg/ml anti-CD3 spot at that time point. For mixtures of both 
antibodies cell spreading was observed for total antibody concentrations at which each of 
the antibodies alone failed to induce a response. With regard to NFAT, anti-CD28 alone 
induced a stronger translocation than anti-CD3 alone. Again, cells exposed to a mixture of 
both antibodies showed an enhanced response, which was reproducibly strongest for the 
spots with maximum anti-CD28 concentration and intermediate anti-CD3 concentrations. 
For both, cell spreading and NFAT translocation a gradient of activation was obtained for 
the whole array, confirming that the antibody concentrations were appropriately selected 
for probing the interplay of both stimuli. The data on cell spreading and nuclear 
translocation were obtained on a single cell level. However, for individual cells, no strong 
correlation between both responses was observed (Fig. 4.8 A). In contrast for the average 
of all cells on one spot, for those spots for which a significant average cell spreading was 
observed, (>60 µg/ml total antibody) spreading showed a weak positive correlation with 
the translocation of the transcription factor (Fig. 4.8 B). 
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Figure 4.4 Cellular responses on an anti-CD3/anti-CD28 concentration matrix and on the supraagonistic 
single chain fragment rM28. (A) Cell spreading expressed by the average number of pixels covered per cell, 
with 1 pixel corresponding to 0.05 µm2. (B) Nuclear NFAT translocation expressed by the average of the 
ratios of fluorescence in the nucleus and fluorescence in the cytoplasm for each cell. An increased 
translocation is reflected by a higher ratio. Top panels: bar graphs, error bars correspond to the mean 
deviation of 3 (translocation) and 2 (spreading) experiments. Bottom panels: The respective array depicted 
in a colour matrix, each coloured field corresponds to one spot in the microarray. The brown hue indicates 
that on this spot cell spreading could not be quantified. The data for the polylysine spot was included as a 
negative control. 
 
4.3.3 Effects of small molecule inhibitors. Having established that the anti-
CD3/anti-CD28 antibody microarray yielded a gradient of the cellular response over the 
whole concentration range, we next aimed at determining the effects of signalling 
inhibitors on this response profile. Pharmacological inhibitors are a frequently used tool 
for addressing the involvement of a specific enzyme in T cell signalling. However, 
specificity of these compounds is a general concern and most compounds inhibit several 
targets 138. We intended to explore to which degree the matrix of stimuli would reveal 
functionally relevant differences between inhibitors, especially for those having the same 
primary target. The latter case reflects a typical situation in drug development, where a 
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screening of molecules in vitro produces several ‘hits’ inhibiting an enzyme, however, 
these hits may have different in vivo activities due to the inhibition of further secondary 
targets. The collection of inhibitors included established inhibitors of T cell signalling as 
well as compounds for which little information on specificity was available (See Fig.4.5 
for an overview of inhibitor interferences in the T cell signalling network). Cytochalasin 
D inhibits actin polymerization 139 and thus the formation of stable T cell-APC contacts 
on anti-CD3-coated surfaces 118. The Src family kinase inhibitor PP2 is a prototypical 
inhibitor of early CD3-dependent signalling with LCK as the primary target 110, while 
piceatannol inhibits ZAP-70 140, but has also been reported to inhibit PKC 141. Ro-31-
8220 142 and alsterpaullone 143 were both described as inhibitors of GSK-3, albeit with 
different activity profiles for the inhibition of further kinases 112; 144. PD98059 acts an 
inhibitor of MAPK1 (= MEK1), by disrupting its activation via Raf or MEK kinase 145. 
FK506 is an inhibitor of the NFAT activator calcineurin 146. (For the PI3K inhibitor LY-
294002 an inhibitory effect on T cell activation had been reported 147. ML-3403 148 and 
SB-203580 149 have been described as highly potent inhibitors of the MAP kinase p38 
with similar IC50 values for inhibition of LPS-dependent TNF release in human PBMCs 
(SB-203580, IC50 0.6 µM; ML-3403, IC50 0.2 µM) 148. With respect to NFAT, p38 has 
been shown to play a dual role. First, the kinase phosphorylates the transcription factor 
thereby promoting nuclear export. Second, a p38-dependent induction of of NFATc 
expression leads to an overall activation of NFATc-dependent transcription 150. The 
concentrations applied for the individual inhibitors were selected based on concentrations 
commonly used in the literature or on known IC50 values.  
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Figure 4.5 Schematic of T cell signalling and the principal targets of the inhibitors applied in this 
study. The scheme gives a simplified overview about the components involved. 
 
In addition to the NFAT translocation and cell spreading, which represent a signal at a 
certain time point, an IL-2 ELISA was additionally performed in order to yield a 
quantitative signal integrated over time. For all inhibitors, except Ro-31822 we observed 
a clear inhibitory effect on anti-CD3/anti-CD28 dependent IL-2 secretion in the 
concentrations applied to the cellular microarrays (Fig. 4.6). As expected for a compound 
directly targeting actin, 10 µM cytochalasin D exerted a uniform inhibitory effect on cell 
spreading. In contrast, NFAT translocation was not affected (Fig. 4.7). This result 
correlates with findings, that cell spreading, but not the formation of signalling-active 
clusters is inhibited by cytochalasin D (Fig. 3.5). The LCK-inhibitor PP2, on the other 
hand, uniformly inhibited NFAT translocation, and weakly inhibited cell spreading at the 
60 min time point. Previously, a pronounced effect of PP2 on cell spreading had been 
reported 118. In fact, spreading was much more strongly inhibited by PP2 when cells were 
fixed after 10 min (Fig. 4.12), consistent with these earlier results. For piceatannol (10 
µM), cell spreading was reduced for all combinations of stimulatory antibodies, while 
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NFAT translocation was more strongly reduced for spots containing anti-CD28. For the 
calcineurin-inhibitor FK506, we observed a strong inhibition of NFAT translocation. For 
alsterpaullone, as expected for a GSK-3 inhibitor, a potentiation of NFAT translocation 
was observed. Cell spreading was not affected. For Ro-31-8220 a strong fluorescence of 
the compound compromised an automated analysis of NFAT translocation. By eye, no 
effect could be detected. Ro-31-8220, with an IC50 of 6.8 nM for GSK-3 142 was the only 
inhibitor analyzed in this study for which we could not detect a significant inhibition of 
CD3/CD28 dependent IL-2 expression (Fig. 4.6).  For the PI3K inhibitor LY-294002, 
which acts upstream of GSK-3 and should act as an inhibitor of NFAT translocation, no 
strong effect on NFAT was observed. Surprisingly, the p38 kinase inhibitor ML-3403 
exerted a pronounced concentration-dependent effect on NFAT translocation. At 1 µM a 
slight inhibitory effect on NFAT translocation was observed for spots containing only 
anti-CD28. With increasing concentration the inhibitory effect successively also affected 
spots containing a higher fraction of anti-CD3. The NFAT inhibition profile for 3 µM 
ML-3403 was similar to the one of 10 µM of the Syk/ZAP-70 inhibitor piceatannol. 
While for the second p38 inhibitor, SB-203580 only a slight inhibitory effect on NFAT 
translocation was present even at 30 µM, both p38 inhibitors inhibited IL-2 expression. 
The MEK inhibitor PD98059 induced a weak, but reproducible inhibitory effect on NFAT 
translocation. 
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Figure 4.6 ELISA quantitation of the IL-2 expression of Jurkat cells that were stimulated with plate-
bound anti-CD3 + anti-CD28 for 16 h. The A450 value corrected by that of the unstimulated control is given. 
Cell vitality after inhibitor incubation was controlled by an MTT assay. 
 
4.3.4 Functional characterization of the supraagonistic antibody. The 
recombinant supraagonistic anti-CD28 antibody rM28 elicits a strong T cell activation in 
the absence of the primary CD3-dependent signal. We employed the antibody microarray 
to determine to which degree cellular signals elicited by the supraagonistic antibody rM28 
combined features of CD3- and CD28-dependent signalling. rM28 consists only of the 
variable regions of heavy and light chains for each binding specificity, i. e. anti-CD28 and 
anti-MAPG and lacks all constant immunoglobulin domains. For this reason, this protein 
was poorly detectable by the secondary antibody used for surface staining. In our case, 
the MAPG-directed specificity was irrelevant. Quantification of cell spreading by the 
automated protocol was therefore impossible. Optical evaluation indicated that the cells 
were clearly spread after 60 min. Only little NFAT translocation was observed compared 
to the anti-CD28 clone 9.3. Nevertheless, the effects of the inhibitors on NFAT 
translocation corresponded to the effects of these compounds exerted on spots with high 
anti-CD28 content (Fig. 4.7). In no case was the effect similar to a spot with an excess in 
anti-CD3.
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Figure 4.7 Response profiles in the presence of inhibitors.  NFAT translocation, the ratio of nuclear versus 
cytoplasmic fluorescence in the presence of inhibitor was divided by the ratio in the absence of inhibitor. 
Blue hues represent an inhibitory effect, yellow and red hues an activating effect on NFAT translocation. 
For spreading, absolute values instead of ratios inhibited/non-inhibited are shown. The figure legends are 
the same as for Fig. 4.4. 
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Whereas different intensities of stimuli influence cell spreading and NFAT translocation 
of untreated Jurkat cells in the same way, for the cell population on one spot NFAT 
translocation and cell spreading are not correlated (Fig. 4.8).  
 
 
Figure 4.8 Correlation between cell spreading and NFAT translocation. (A) Cell spreading plotted against 
NFAT translocation for a population on the spot containing 200 mg/ml of anti-CD3 and anti-CD28 each. 
(B) Cell spreading plotted against NFAT translocation for the mean of cell populations on different peptide 
spots of a representative array, with the first number representing the anti-CD3 concentration immobilized 
on the spot, and the second number the anti-CD28 concentration. The x-axis represents the NFAT 
fluorescence in the nucleus compared to one in the cytoplasm 
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.  
 
Figure 4.9 Time dependent changes in the spreading of Jurkat T cells under the influence of 20 µM 
of the SFK inhibitor PP2.  Single anti-CD3 and anti-CD28 antibodies were spotted at a concentration of 200 
µg/ml each, the antibody mixture contained 60 µg/ml anti-CD3 and 200 µg/ml anti-CD28. Cells were left 
untreated (black line) or either pretreated with PP2 (dotted line), or treated after 10 min after the initiation 
of contact formation (dashed line). 1 pixel corresponds to 0.05 µm2. The data are from one representative 
experiment. 
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4.3.5 Analysis of protein clustering by confocal microscopy.  With the 
NFAT translocation being a relatively late readout for T cell activation, it was our goal to 
extend the application of microarrays to further and earlier readouts for signalling. For 
this purpose, we analyzed the CD3-dependent recruitment of different proteins involved 
in T cell activation to the site of contact formation using confocal microscopy. In Jurkat 
cells stimulated by immobilized anti-CD3 antibodies for 10 minutes, we observed intense 
clusters of the phosphoproteins LAT (phosphorylated on tyrosine 226) and 
PLCγ (phosphorylated on tyrosine 783) as well as for the GADS protein. Clusters of these 
proteins localized mainly to the outer rims of the cell at the 10 min time point. The 
observed clustering of the proteins is in accordance with findings by the peptide 
microarray experiments on the molecular level, which shows a strong and parallel 
tendency in the association of LAT, PLCγ and GADS to signalling complexes upon CD3 
stimulation or pervanadate stimulation (see Figs 7.3 and 7.5).  A weak protein clustering 
was observed for the proteins GRB2, ZAP-70, LCK and SHP2 and PI3K under these 
conditions. In contrast to the other proteins, PI3K clusters localized strongly to the centre 
of the cell. Upon CD3 engagement, GRB2 also strongly localizes to a perinuclear 
compartment, which may be involved in cytoskeletal reorganization, and Gab2 also 
shows nuclear localization for a part of the cells. The partially fibrous distribution of Nck 
and Vav may indicate an association with the cytoskeletal components. As an enzyme 
which is partially constitutively associated with the plasma membrane, SHP-1 shows a 
membrane-associated staining.  
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Figure 4.10 For the analysis of TCR/CD3-dependent protein clustering Jurkat cells were exposed to anti-
CD3 coated surface for 10 min. White represents the immunostaining against the represented antigen with 2 
µg/ml of the respective antibody (see table 8.1). The white bar corresponds to 10 µm for all images. 
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4.3.6 Quantification of protein clustering.  The activation of PLCγ is mediated 
bythe TCR-induced recruitment into the LAT signalosome on the one hand, and by PIP3-
dependent phosphorylation of tyrosine 783 by Itk on the other hand, and thus might be 
involved in the integration of stimulatory signals from the TCR and the CD28 coreceptor. 
Due to the central relevance for the spreading of the activation signal via calcium, the 
activation of PLCγ is a central event in T cell activation. Due to this relevant function as 
an integrator of CD3 and CD28-dependent signalling, we selected the recruitment of 
PLCγ phosphorylated on tyrosine 783 to the site of surface antibody engagement as an 
activation marker. Protein clustering was analyzed by confocal microscopy using the 10 
min time point for different stimuli. Compared to anti-CD3 stimulation, both cell 
spreading and clustering of phospho-PLCγ was weaker in anti-CD28 stimulated cells at 
that time point (Fig. 4.11). Also, clustering and phosphorylation of PLCγ and cell 
spreading were strongly reduced in cells pretreated with 20 µM of the SFK inhibitor PP2. 
In contrast, the actin inhibitor cytochalasin D completely abrogated cell spreading, but in 
some cases very intensive phospho-PLCγ staining at the areas of antibody engagement 
was visible, indicating no inhibitory effect of the actin inhibitor on PLCγ activation. 
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Figure 4.11 Overview of the effects of signalling inhibitors on the spreading and phospho-PLCγ clustering 
(light grey) of Jurkat cells stimulated on different surfaces for 10 min. The surface antibody was detected by 
staining with a secondary antibody (dark grey), resulting in a dark patch at sites of cell attachment. The 
white scale bar represents 20 µm. 
 
Image quantitation shows that CD28 coengagement augments the anti-CD3 induced 
phospho-PLCγ staining per area (Fig. 4.12). The effects of anti-CD3 engagement are 
completely counteracted by the inhibitor of TCR-dependent signalling, PP2. In contrast, 
the supporting tendency of the effect of CD28 coengagement on PLCγ activation seems to 
be reproduced even under the conditions of impaired cytoskeletal functions. The effects 
of both inhibitors on PLCγ recruitment correspond to those observed for the NFAT 
translocation.    
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Figure 4.12 Quantification of the density per area of the immunostaining against PLCγ phosphorylated on 
pY783. The contact site of Jurkat cells with different stimulatory surfaces after 10 min of contact was 
imaged by confocal microscopy. Before stimulation, cells were treated with PP2 (20 µM), Cytochalasin D 
(10 µM), or the respective DMSO control. The threshold for protein clusters was adjusted manually for 
each set of experiments. The figure represents the combined and normalized data from two experiments. 
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4.4 Discussion 
 
In order to understand the activation of cells, it is required to understand how 
different signals are integrated into a cellular response. The cellular antibody microarrays 
provide the means to systematically probe different combinations of stimuli in a multiwell 
format. With one array per well an order of magnitude more data is generated for a 
limited number of cells – in our case typically 100,000 per well. For combinations of 
different concentrations of CD3- and CD28-directed stimuli a gradual response matrix for 
the activation of T cells was obtained (Fig. 4.4). This demonstrates that for T cell 
activation, unlike e. g. for epidermal growth factor-dependent signalling 151, the cellular 
response strongly depends on the strength of the signalling activities. Crosslinking of 
CD28 in addition to anti-CD3 stimulation induced not only a higher protein tyrosine 
phosphorylation, for example for PLCγ1 at the contact surface, but also enhanced the 
persistence of cell spreading. 
 
4.4.1 Inhibitor effects on cell spreading and NFAT translocation. NFAT 
translocation was affected negatively by PP2, ML-3403 and FK-506 and positively by 
alsterpaullone, while for all three compounds cell spreading remained nearly unchanged 
at the 60 min time point. PP2 strongly delayed the kinetics of cell spreading, leading to a 
strong inhibitory effect at early time points (Fig. 4.7, Fig. 4.11), and only a weak effect at 
later time points (Fig. 4.9, 4.11), which corresponds to published observations 118. For the 
Jurkat-derived LCK-inactive JCaM 1.6 cells, cell spreading and NFAT translocation on 
all stimuli were also strongly inhibited but not fully abolished  (not shown), again 
indicating partial compensation for the loss of LCK activity by other enzymes. 
Piceatannol clearly reduced cell spreading also at later time points. In accordance with its 
key role in the initiation of T cell receptor-dependent signalling, the inhibition of LCK by 
PP2 strongly affected NFAT translocation for all stimuli. At the concentrations of 10 µM 
piceatannol and 20 µM PP2, similar levels of inhibition for the anti-CD3/anti-CD28 
containing spots were obtained. Though both inhibitors of the upstream kinase activities 
strongly inhibit CD3+CD28-dependent NFAT translocation and IL-2 expression, their 
response profiles (Fig. 4.7) show clear differences for CD3 stimulation alone, which were 
also present at higher concentrations of piceatannol (50 µM, not shown). On the spot 
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containing only polylysine, PP2 also reduced NFAT translocation, indicative of some 
basal level of NFAT translocation, while piceatannol was without effect.  
 
While the PI3K inhibitor LY-294002 inhibits IL-2 expression, its lack of effect on NFAT 
translocation might be due to the fact that Jurkat cells do not express the phosphatase 
PTEN that antagonises the action of PI3K 152. Alsterpaullone also inhibits LCK 112, in 
addition to inhibiting GSK-3. Concerning TCR-dependent NFAT translocation, the 
inhibitory effect of alsterpaullone on LCK was obviously compensated by the stimulatory 
activity on GSK-3 inhibition. In contrast, the IL-2 expression is inbibited by 
alsterpaullone, suggesting that its stimulatory effect on NFAT translocation is irrelevant 
for induction of IL-2 expression.As the GSK-3 inhibitor Ro 31-8220 does not inhibit IL-2 
expression, we assume that GSK-3 inhibition alone exerts no effect on IL-2 expression.  
 
The comparison of the activities of ML-3403 and SB-203580 illustrates the potential of 
the stimulatory cellular microarray in the functional profiling of inhibitors. The pair of 
inhibitors was selected as p38 kinase inhibitors and both inhibited IL-2 expression, but 
exerted very different effects on NFAT translocation. At concentrations higher than 1 µM 
ML-3403 had a pronounced inhibitory effect on NFAT translocation while not affecting 
cell spreading. In contrast, for SB-203580 (30 µM) only a weak inhibitory effect was 
observed. Of the 15 kinases against which ML-3403 had been screened, only for JNKs 
was a considerable inhibitory activity of ML-3403 (10 µM) observed, while the in vitro 
GSK-3 activity was enhanced by 30 ± 9% (S. Laufer, personal communication). SB-
203580 was screened against a panel of 119 kinases 138. For this reason, one has to 
assume that for ML-3403 the observed activity should be due either to GSK-3 stimulation 
or to inhibition of a kinase not included in this large scale screen. 
 
Fig.4.8 a shows that, on the single cell level, NFAT translocation and cell spreading are 
not correlated. This observation is in accordance with the effects of the actin inhibitor 
cytochalasin D, which completely inhibited cell spreading but had no significant effects 
on NFAT translocation (Fig. 4.7) and PLCγ activation (Fig 4.12) considering the single-
cell level. On the other hand, cytochalasin D inhibited IL-2 expression.  This observation 
is consistent with reports that the disruption of the contact between the CD3 and the actin 
cytoskeleton does not affect phosphorylation cascades, which eventually lead to NFAT 
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translocation, but 153. Thus, the integrity of the actin cytoskeleton a prerequisite for the 
integration of TCR stimulation and CD28 costimulation into signalling leading to IL-2 
expression 154 
 
In summary, very similar inhibitory profiles were obtained for cells exposed to anti-CD28 
alone or a combination of anti-CD3 and anti-CD28. These data illustrate that 
pharmacologically, CD28-dependent signalling is very similar to CD3/CD28-dependent 
signalling, but different to CD3-dependent signalling. Consistently, CD28 initiated 
different cellular response kinetics than CD3. In early signalling (first minutes), 
engagement of CD3 is therefore a prerequisite for CD28 to exert its auxiliary role, for 
prolonged and strong engagement CD28 also acts as an independent signalling unit, at 
least with respect to cell spreading and NFAT translocation. For ML-3403 the relative 
cellular response was affected more strongly on spots with a high density of stimuli. The 
higher the inhibitor concentration, the lower was the concentration of stimuli at which an 
effect could be observed. However, one should also note that for the spots with higher 
antibody densities, inhibition did not increase any further. As a consequence, even at high 
inhibitor concentrations, activation at these spots was still higher than at spots with little 
stimuli (Fig. 4.13), an observation with major relevance for the action of 
immunosuppressants 130. These data illustrate the capability of the cellular antibody 
microarrays to reveal the environment dependence of drug action, a phenomenon that is 
mostly neglected in classical cellular screens.  
 
 
 Figure 4.13 Dependence of NFAT translocation on ML-3403 concentration. Shown are absolute values for 
nuclear versus cytoplasmic fluorescence. The data represent the mean of three independent experiments. 
The data shown for the control corresponds to the data given in Fig. 4.4, albeit with a different scaling for 
the look-up table.  
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4.4.2 Functional profiling of a supraagonistic antibody. The supraagonistic 
anti-CD28 antibody rM28 induced only a low NFAT translocation. It is not fully clear, 
whether this observation is a functional characteristic of this molecule or due to a lower 
density of rM28 binding sites on the array than for anti-CD28. With a molecular weight 
of 55 kDa and one CD28 binding site per molecule, the concentration of 50 µg/ml used 
for spotting corresponds to a concentration of 70 µg/ml of an IgG, a concentration at 
which for anti-CD28 a stronger NFAT translocation was observed. Moreover, in spite of 
weak NFAT translocation, the inhibitory effects exerted by the different compounds 
corresponded to the ones observed for spots with high anti-CD28 and anti-CD28/anti-
CD3 densities. The pronounced inhibitory effects in the presence of little translocation 
indicate that even though rM28 stimulates qualitatively similar signalling pathways, 
functional differences exist. When tested in a conventional ELISA, rM28 induced a 
significantly higher IL-2 expression than anti-CD28 (Fig. 4.1). Further analyses will be 
required to determine the basis for the strong IL-2 expression in the presence of weak 
NFAT translocation. It has been demonstrated that CD28 upregulates IL-2 expression via 
two pathways: A PI3K-dependent pathway leading to an increase in gene expression and 
a second one inducing the stabilization of the IL-2 mRNA 83.  
 
The cellular antibody microarray adds a further dimension to functional cellular 
analyses in T cell immunology. The simultaneous testing of many different stimuli in 
combination with two readouts, i. e. cell spreading and NFAT translocation, provides 
abundant information on the interplay of stimuli in generating a cellular response. In 
addition, the technology is readily compatible with further multidimensional readouts 
such as the testing for the translocation of other transcription factors or for the 
phosphorylation of a large number of signalling proteins 155;156. Compared to ELISA 
experiments integrating signal intensities over time, cellular microarrays with 
microscopical readouts allow signal quantification at different, defined time points in a 
parallel manner. In drug development the response profiles for drug candidates reveal 
differences in the target spectrum of these compounds. By exposing cells to many 
different environments the technique yields important information on the range of 
potential activities of a compound that may be elicited in the physiological context. 
Therefore the stimulatory microarrays should assist in the selection of promising 
compounds in preclinical drug development.  
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Our analyses confirm that the specificity of small molecule inhibitors is indeed a 
concern when using these compounds for the analysis of signalling pathways. Given 
highly selective compounds, including siRNA for the down-modulation of protein 
expression, the cellular antibody microarrays may provide information on the role of a 
specific protein in the interplay of different signalling pathways.
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5. T Cell stimulation using microstructured surfaces  
5.1 Introduction 
Previous experiments performed in this thesis concerning CD3 and CD28 costimulation 
analyzed the immobilizations of mixed antibodies. Both the TCR/CD3 complex 84 and the 
CD28 coreceptor 157 have been described to reside in special membrane areas described as 
“lipid rafts”, or GEMs, with anti-CD28 facilitating the clustering of lipid rafts at the sites 
of TCR engagement 84. This observation raises the question, if a spatial proximity of the 
stimuli and costimuli is necessary for optimal TCR-dependent stimulation. In order to 
analyze the interplay of CD3 stimulation and CD28 costimulation in the respect of spatial 
engagement, we tested the effect of spatially distinct stimuli on cell activation. For the 
microstructured manufacturing of stimulatory surfaces, we introduced the method of 
microcontact printing using polydimethylsiloxane (PDMS)-stamps onto glass slides. The 
stimulation of cells with microstructured has the potential for the analysis of cells in 
contact with spatially defined arrays of stimuli systems, such as the immunological 
synapse. Also, it allows the exposition of cells to stimuli of different sizes, geometries and 
intensities.  
All cellular experiments described in this section were performed by the author. The 
PDMS stamps were produced by Günter Roth and Alexander Ganser, and the stimulatory 
antibodies were kind gifts from Dr. Ludger Grosse-Hovest, Prof. Dr. Gundram Jung and 
Alexander Ganser. 
 
5.2 Results and Discussion 
 PDMS stamping allows a spatially confined transfer of proteins to glass surfaces. The 
glass areas printed with protein (Fig. 5.1, top left) are blocked against attachment of 
further protein (Fig. 5.1, top right). Image inspection also shows also that no blurring of 
border occurs during also during longer incubation times and protein remains associated 
to the stamped area also during following washing, incubation and staining steps. 
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Figure 5.1 Determination of the spatial separation of printed and overlayed stimulatory antibodies. A 
mixture of 100 µg/ml anti-CD3 antibody and 15 µg/ml Alexa 633-labelled goat anti-rabbit antibody (top 
left) was printed by PDMS stamps to a glass surface. Subsequently, the glass was overlayed with 15 µg/ml 
Alexa 488-labelled goat anti-rabbit antibody (top right), and incubated with Jurkat cells (transmission 
chanel, bottom left). The spectral properties of the antibody pair for visualization was selected to minimize 
quenching, and thus to maximize sensitivity for the detection of overlayed antibody. The white bar 
corresponds to 20 µm. 
5.2.1 Actin cytoskeletal rearrangements. Fluorescence microscopy indicates 
that printed stimuli are able to induce the specific attachment of cells (Figs 5.1 and 5.2). 
Phalloidin staining of filamentous actin shows that CD3 engagement initiates local actin 
polymerization to a higher degree than CD28 (see Fig. 8.2). The effects of local anti-CD3 
stimulation on global actin reorganization are limited. This observation corresponds to 
findings that stimulation on an anti-CD3 surface leads to cell spreading mediated by 
widespread actin polymerization 109, while anti-CD28 coated surfaces induces the 
formation of local “mikrospikes” 135. 
5.2.2 Analysis of influences of local stimulation on local and global 
protein phosphorylation. With tyrosine phosphorylation representing an essential step 
in the generation of a T cell response, it was our goal to find out about the local and 
global effects of spatially distinct CD3 and CD28 engagement on the formation of 
phosphotyrosine-rich signalling clusters. When the surface outside the stamped area was  
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Figure 5.2 Phosphotyrosine clustering on contact areas of Jurkat cells with different stimuli. Anti-CD3 
antibodies (100 µg/ml) were stamped to glass slides, which then were overlayed with IgG2a control 
antibodies, anti-CD28 or anti-CD28 (with a total concentration of 15 µg/ml). Jurkat cells were stimulated 
on the microstructured surfaces for 10 min. The localization of tyrosine-phosphorylated proteins on the 
plane of surface contact was analyzed by staining with a Zenon-Alexa 633 labelled anti-pY antibody and 
confocal microscopy. A) Fluorescent images, with the grey lines representing the stamped antibodies B) 
Quantification of pY staining on different areas (combined from three experiments). The white bar 
corresponds to 20 µm. 
blocked with non-binding control antibodies, cells established only firm contacts at sites 
of stimulatory antibody engagement, leading to a “catamaran shape”. Intracellular 
tyrosine phosphorylation depends on the type of the stimulus. Anti-CD3 engagement 
induced higher phosphorylation than anti-CD28 engagement (Fig.5.2), This was also the 
case for the direct comparison of stamped antibodies. Contact of Jurkat cells with surfaces 
and areas functionalized with a mixture of anti-CD3 and anti-CD28 antibodies resulted in 
a stronger pY clustering than anti-CD3 areas (Fig. 5.2). 
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This result demonstrates that, while anti-CD28 stimulation induces only a very weak 
tyrosine phosphorylation, accounting for an additive effect on simultaneous anti-CD3 
engagement. A possible mechanism for this is the CD28-mediated activation of PI3K, 
which is involved in the phosphorylation and activation of PLCγ1 (see introduction, 
compare Fig. 4.12). The first question was, whether a proximal, but spatially distinct 
engagement of CD3 and CD28, possibly within one lipid raft, initiated an enhanced 
tyrosine phosphorylation. Spatially separated engagement of stimuli occurs on the CD3 
borderlines between surfaces functionalized with different antibodies. In many cases, an 
enhanced localization of pY-rich clusters was observed on the border-proximal anti-CD3 
functionalized area (see Fig. 5.3). However, image quantification did not yield a 
significant result, possibly because the direct contact area is relatively small compared to 
the whole area of cell contact.  
Figure 5.3 Confocal image indicating enhanced 
phosphotyrosine clustering (white, indicated by 
arrows) at the borders between stamped 
surfaces of anti-CD3 (middle grey) and anti-
CD28 generated by overlay (dark grey).  The 
white bar represents 10 µm. 
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enhanced localization of pY-rich clusters was observed on the border-proximal anti-CD3 
functionalized area (see Fig. 5.3). However, image quantification did not yield a 
significant result, possibly because the direct contact area is relatively small compared to 
the whole area of cell contact.  
The second question was, whether the local engagement of CD3 quantitatively affected 
the tyrosine phosphorylation induced by contact with anti-CD28 surfaces in trans, such as 
by the means of diffusible factors. In order to test this question, we stamped mixtures of 
anti-CD3 antibodies and IgG2a isotype control antibodies with a total antibody 
concentration of 100 µg/ml. The stamped antibodies were overlayed with 15 µg/ml anti-
CD28, and analyzed for the effect on tyrosine phosphorylation at the cell/antibody contact 
surface for the total area of each stimulus. Data were analyzed in a similar manner as 
depicted in Fig. 8.3.  
We observed a strong dependence of tyrosine phosphorylation on the intensity of anti-
CD3 engagement with signal saturation occurring at concentrations higher than 30 µg/ml. 
In contrast, on areas with CD28 engagement, the induced phosphorylation was only 
marginally higher than on unfunctionalized areas (Fig. 5.4). This suggests that anti-CD3 
engagement does not have intense effects on areas of only anti-CD28 engagement. This 
corresponds with results, that, in contrast to engagement of CD3 and CD28 in the 
immunological synapse, anti-CD28 engagement outside the immunological synapse only 
causes indirect effects leading to IL-2 expression by enhancing IL-2 mRNA stability 158. 
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Figure 5.4 Effect of local CD3 engegement on CD28 phosphorylation in trans. Dependence of global 
phosphotyrosine clustering on local anti-CD3 engagement. Anti-CD3 antibodies in different concentrations 
were mixed with with isotype control antibodies adding up to a total concentration of 100 µg/ml and 
stamped to glass slides. Slides were subsequently overlayed with anti-CD28 (15 µg/ml). Jurkat cells were 
stimulated on the microstructured surfaces for 10 min. The localization of phosphotyrosine on plane of 
surface contact was analyzed by staining with a Zenon-Cy5 labelled anti-phosphotyrosine antibody and 
confocal microscopy. 
5.3 Effects of stimulus size on phosphotyrosine clustering. As the 
stimulation intensity of Jurkat cells depends on the density of the anti-CD3 antibody, we 
were interested if stimulation also depends on the size of the stimulus. In this context, it 
was our goal to distinguish the effect of the size of the site of CD3 engagement on the 
tyrosine phosphorylation in general and per area. For this, we employed PDMS stamps 
with round studs of diameters between 2 and 20 µm. Due to instability of stud units 
smaller than 2 µm during stamping, these protein spots of that size could not be employed 
successfully. Evaluation of immunofluorescence microscopy indicates that, concerning 
the area of the stimulatory surface, the mean phosphotyrosine intensity appears more 
intense and evenly located on anti-CD3 spots of smaller size than on bigger spots (Fig. 
5.5). While on spots allowing full spreading of cell (>15 µm in diameter), 
phosphotyrosine localized preferentially at the outer rim of the cell, the staining on 
smaller spots was more intense and covered the whole area of cell contact with the anti-
CD3 antibody (see Fig. 5.5 A). Quantification of phosphotyrosine intensity followed the 
same protocol as for the lines, with only taking surface of the stamped antibody 
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representing the area of TCR stimulation into account. Quantitative analysis shows that 
the total fluorescence intensity is higher on bigger spots, but the relative phosphotyrosine 
staining intensity per area is higher on smaller spots (see Fig. 5.5 B). A possible 
explanation for this is that the number of proteins actively and passively involved in 
tyrosine phosphorylation might be the limiting factor. Because only limited cell spreading 
is allowed to occur on the stimulus, the contact area on which signalling proteins are 
distributed is reduced. This observation may correspond to the effect of Cytochalasin D 
(Fig 4.12), for which we observe often a higher phospho-PLCγ staining intensity per area 
than in the control, but with an overall weaker effect on T cell stimulation.
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Figure 5.5 Dependence of intracellular phosphotyrosine fluorescence on stimuli size. Jurkat T cells were 
stimulated for 10 min on stamped anti-CD3 surfaces (100 µg/ml), which had been overlayed with anti-
CD28 antibodies (15 µg/ml). Phosphotyrosine fluorescence in the contact surface was imaged using 
confocal microscopy in fixed cells.  A) pY staining (light grey) on studs of 20 and 5 µm diameter. B) 
Quantification of the mean pY intensity per pixel, and C) total pY intensity per spot. On the graphs, the x-
axis defines the stud size, with “full” representing representing conditions that allow full spreading on a 
homogeneously anti-CD3 functionalized surface. The data represent the means of two experiments. 
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6. Label-free Characterisation of Cell Adhesion using Reflectometric 
Interference Spectroscopy (RIfS) 
 
 
6.1 Summary 
 
Reflectometric Interference Spectroscopy (RIfS) is a label-free, time-resolved technique 
for detecting interactions of molecules immobilized on a surface with ligands in solutions. 
Here we show that RIfS also enables the detection of the adhesion of tissue culture cells 
to a functionalized surface in a flow system. Jurkat T cell leukemia cells rapidly attached 
to a transducer functionalized with a monoclonal antibody directed against the T cell 
receptor (TCR)/CD3 complex followed by activation-dependent cell spreading. For the 
Jurkat derivative JCaM 1.6 that lacks the key signalling protein LCK, cells preincubated 
with the inhibitor of actin polymerization cytochalasin D, and for surfaces functionalized 
with an antibody directed against the co-receptor CD28, RIfS curves were obtained that 
differed with respect to the maximum signal and the initial slope of the increase in optical 
thickness. Interactions of T cells with other leukocytes or epithelial cells of blood vessels 
are crucial steps for the regulation of the immune response and inflammatory reactions. 
The testing of chemical inhibitors, cell surface molecules and gene products relevant for a 
key event in T cell immunity illustrates the potential of label-free techniques for the 
analysis of activation-dependent cell-surface contacts.  
 
 
This chapter has been adapted from: 
Möhrle, B., Köhler, K., Jaehrling, J., Brock, R., Gauglitz, G. (2006): Label-free 
characterisation of T cell adhesion using reflectometric interference spectroscopy. Anal. 
Bioanal. Chem. 384 (2):407-13 
 
Cellular and microscopy experiments in this section were performed by the author. All 
RIfS measurements themselves, and the generation of RIfS transducers were performed 
by Bernd Möhrle. 
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6.2 Introduction 
 
Cell-cell contacts are mediated through specific receptors that, in addition to establishing 
a physical link between cells, also act as signal transducing molecules. Due to the 
significance of cell-cell interactions in health and disease there is a keen interest in the 
development of analytical techniques that enable the analysis of contacts with respect to 
kinetics, strengths and the underlying signalling processes. Reflectometric Interference 
Spectroscopy (RIfS) is a label-free, time-resolved technique, which is able to detect 
biomolecular interactions of molecules immobilized on the surface of a transducer with 
analytes in solution 159. The binding of the analyte leads to an increase in the so-called 
optical thickness of the transducer-bound layer of molecules. The increase in thickness 
results in a change of the interference spectrum of light reflected at its boundaries. In 
contrast to surface plasmon resonance spectroscopy (SPR) the RIfS method is 
temperature independent 160 and has a higher depth of penetration into the solution (about 
300 nm for SPR and up to 40 µm for RIfS, depending on the wavelength) 161. RIfS has 
been employed to measure the interaction kinetics of a variety of biomolecular 
interactions such as antibodies 162, biotin 163 and peptides 164 . The RIfS setup is described 
in detail in the work of Schmitt et al. 8. In spite of their potential for detecting interactions 
of molecules, cellular applications have been limited. SPR has been used for the analysis 
of the adhesion of bacteria 165;166 and erythrocytes 167 to surfaces. So far label-free 
techniques have not been used for the analysis of activation-dependent cellular 
interactions. Moreover, there is little information in which way the signal depends on the 
molecular and morphological characteristics of a cell in contact with the transducer.  
 
Cell-cell contacts play a key role in the immune system and especially in the 
immune surveillance exerted by T lymphocytes: T cells continuously circulate in the 
blood and lymphatic system, and engage in transient contacts with other cells mediated by 
interactions of their T cell receptors (TCR) with major histocompatibility complex 
(MHC)-peptide complexes on the target cell, and by interactions of other surface 
receptors 2. The molecular mechanisms of contact formation between T cells and antigen-
presenting cells have been investigated in great detail under static conditions, i. e. in the 
absence of flow. Activation of a T cell is a function of the affinity of the interaction, the 
density of specific MHC-peptide complexes on the cell surface, and the differentiation 
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and activation state of the T cell 3. Activation of cytotoxic T cells leads to the killing of a 
target cell and cytokine expression; T helper cells interact with professional antigen 
presenting cells and contribute to the orchestration of an immune response. The cytokine-
mediated guidance of T cells to their targets proceeds via adhesion-molecule contacts to 
the surface of the blood vessel epithelia, followed by active migration of the cells into the 
surrounding tissue 168;169. 
 
In order to better understand the events that precede T cell activation, such as 
extravasation, approaches that enable an analysis of T cell contacts under flow conditions 
are required. Ideally, such approaches should simultaneously provide information on the 
kinetics of an intercellular interaction and the cellular response. In drug development such 
analyses will provide the basis for the screening of compounds that interfere with contact 
formation of T cells and therefore be useful for the identification of immunomodulatory 
compounds. 
 
Here, we demonstrate the application of RIfS to the analysis of T cell contacts and 
activation in a flow system. With ligand-functionalized surfaces, T cells form contacts 
that vary in intimacy and contact area depending on the nature of the ligand and the cell 
activation. T cells are therefore also especially suited for evaluating to which degree 
cellular responses to different stimuli can be discriminated based on a RIfS signal. 
Transducers were functionalized with different antibodies that served as well established 
and well defined stimuli. Antibodies directed against the CD3ε chain of the TCR/CD3 
complex represent a strong T cell stimulus. Contact of T cells with anti-CD3-
functionalized surfaces leads to a rapid spreading of cells on the surface within 2-5 
minutes (Fig. 3.2). This process depends on the reorganization of the actin cytoskeleton 
and thus can be completely inhibited by the addition of 10 µM cytochalasin D, an 
inhibitor of actin polymerization 109. Surfaces functionalized with antibodies directed 
against the CD28 coreceptor were described to mediate specific T cell attachment but, 
instead of cell spreading, the formation of small “mikrospikes” was observed 135. 
Characteristic RIfS curves were obtained for Jurkat T cell leukemia cells perfused over 
anti-CD3- and anti-CD28-functionalized transducers and for cells inhibited with 
cytochalasin D and cells lacking the CD3-dependent upstream kinase LCK. Correlation of 
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the results obtained by the label-free technology with those obtained by fluorescence 
microscopy yielded the morphological basis for these findings.  
 
 
 
6.3 Results and Discussion  
 
6.3.1 Spreading of T cells on antibody-functionalized surfaces. Antibody-
functionalized coverslips represent a well-defined T cell stimulus that enables the analysis 
of T cell signal transduction and the effect of chemical inhibitors under highly controlled 
conditions 170. First, the spreading of Jurkat T cells on antibody-functionalized surfaces 
was determined using immunofluorescence microscopy in a stopped flow protocol. 
Antibodies were immobilized on epoxy-activated glass surfaces in order to mimick most 
closely the conditions used for the immobilization of antibodies on the RIfS transducers. 
The high reflectivity compromised the analysis of cell contacts on RIfS transducers using 
fluorescence microscopy. Cells were allowed to settle on antibody-functionalized 
coverslips and were fixed after 20 min. On anti-CD3-functionalized coverslips, for most 
cells the formation of tight contacts with the surface was observed, and about 15% of the 
cells showed a spreading of more than twice the cell diameter (Fig. 6.2 A). The detection 
of surface contacts was based on by staining fixed but not permeabilized cells as 
described in the first paper of this section. In the presence of tight contacts, a 
fluorescently labelled secondary antibody, directed against the antibody used for 
stimulation of cells, can only stain the part of the surface of the coverslip that is not 
shielded by the cells.  
 
In contrast, on an anti-CD28 functionalized surface, the cells attached to the surface, but 
spreading and contact formation were strongly reduced (Fig. 6.2 B). The difference in cell 
spreading was also evident in a phalloidin staining of the actin cytoskeleton. On the anti-
CD3-coated surface a strong polymerization of actin was present in the leading edge of 
the spread cells. Little actin was present in the contact zone (Fig. 6.2 A). On anti-CD28-
coated surfaces, cells adhered tightly, however no spreading was observed, and the 
contact zone was poor in polymerized actin. JCaM 1.6 cells, a Jurkat derivative cell line 
deficient in the CD3-dependent upstream kinase LCK, showed a strong reduction of cell-
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spreading, and polymerized actin was distributed around the periphery of the cells, 
especially in the contact zone (Fig. 6.2 C). Pretreatment of cells with the inhibitor of actin 
polymerization cytochalasin D completely abolished firm cell attachment and spreading 
and inhibited the actin localization to contact sites (Fig. 6.2 D). The cells showed little 
contact with the surface. Finally, on BSA the cells attached, but no spreading was 
observed (Fig. 6.2 E), and actin was localized evenly in the membrane-proximal region of 
the cell. In conclusion, each surface led to a distinct pattern in spreading and 
reorganization of the actin cytoskeleton. 
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Figure 6.2 Contact formation of cells on antibody- and BSA-functionalized surfaces. Jurkat cells (A, B, D, 
E) or the LCK-deficient Jurkat derivative JCaM 1.6 (C) were exposed to coverslips functionalized with 
anti-CD3 antibodies (A, C, D), with anti-CD28 antibodies (C) or BSA (E) in the absence (A-C, E) or 
presence (D) of the inhibitor of actin polymerization cytochalasin D (10 µM). Cells were allowed to 
establish contacts for 20 min before fixation. The immuno-fluorescence staining of the antibody used for 
surface functionalization is shown in grey; the Cy5-phalloidin staining of filamentous actin is represented in 
light grey. Cells were fixed but not permeabilized. For this reason, parts of the surface in close contact with 
a cell are not accessible to the secondary antibody. In each panel, an x-y section and orthogonal projections 
through the confocal image stack along the indicated lines are shown. The bar corresponds to 10 µm.  
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Figure 6.3 A) RIfS measurements of the adhesion of Jurkat T cells on different surfaces. 5*105 Jurkat 
cells/ml were pumped in a flow chamber over different surface in a flow of 20 µl/min over differently 
functionalized transducer surfaces. The time-dependent changes in optical thickness for Jurkat attachment 
on anti-CD3- (dashed line), Jurkat on anti-CD28- (solid line) and Jurkat on BSA-functionalized surfaces 
(dotted line) are plotted. B) Bar chart of the RIfS-Signal of the attachment of Jurkat cells on anti-CD3- 
(n=4) and anti-CD28-functionalized (n=3) surfaces referenced against the non-specific binding to BSA at 
the 2000 s time point. The signal difference between both surfaces is significant (t-test, P=0.05). Picture 
generated by Bernd Möhrle. 
 
6.3.2 Label-free detection of cell attachment by RIfS. Having established 
that wild type Jurkat cells showed different phenotypes on anti-CD3-, anti-CD28- and 
BSA-coated surfaces, next the adhesion of these cells to functionalized RIfS transducers 
was detected in a flow system with a flow rate of 20 µl per minute. On each type of 
surface the RIfS signal showed similar general characteristics. In each case, a steep initial 
increase was followed by second phase of a slower increase. For the anti-CD3-coated 
surface the maximum increase in optical thickness at 2000 s was about 1.5 times as high 
as the one detected for the anti-CD28 and BSA-coated surfaces. Once the perfusion of the 
cell suspension was stopped and instead, the flow cell was perfused with medium alone, 
very similar absolute decreases in optical thickness were observed in each case (Fig. 6.3 
A). 
 
The signals of the adhesion to anti-CD3 and anti-CD28 surfaces were referenced against 
the non-specific adhesion on BSA surfaces, at the 2000 s time point (Fig. 3 B). The RIfS 
signal of the adhesion of the T cells on both surfaces was significantly different (t-test, 
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P=0.05). This high reproducibility was obtained in spite of the use of different 
transducers, freshly prepared cell suspensions for each experiment and the fact that a 
complete series of measurements could not always be performed in direct succession. 
This may also account for the rather high variability of the RIfS signal. Interestingly, on 
anti-CD28-coated surfaces the maximum optical thickness was slightly but reproducibly 
smaller than on BSA-coated surfaces. 
 
In addition to the maximum increases in optical thickness a comparison of the initial 
slopes of the RIfS curves (∆OT) yielded additional information. Even though the 
maximum increase of the optical thickness was smaller on the anti-CD28-coated surface 
than on the BSA control, the initial increase of the RIfS curves for Jurkat cells was much 
higher on the anti-CD28-coated surface (∆OT=(5.8 ± 0.4)*10-3 nm/s) than on the BSA-
coated surface (∆OT= (2.6 ± 1.3)*10-3 nm/s) (Fig.3). The increase in optical thickness for 
the anti-CD3-functionalized surface had the highest slope (∆OT= (6.8 ± 1.6)*10-3 nm/s). 
 
 
6.3.3 Characterization of mutant cell lines and chemical inhibitors. The 
initial measurements demonstrated that RIfS enabled a discrimination of the adhesion 
behavior of the Jurkat T cells on surfaces functionalized with antibodies that either induce 
a strong activation of cell spreading or mediate specific adhesion but little spreading, and 
on surfaces functionalized with BSA that induce only unspecific interactions.  
We therefore also explored to which degree the label-free time-resolved detection of cell 
attachment enabled a characterization (i) of the adhesion behaviour of different cell lines 
and (ii) of the effects of pharmacological inhibitors of cell attachment and spreading. 
Each condition was characterized with respect to the maximum increase in optical 
thickness and the initial slope of the RIfS curve (Fig. 6.4). For JCaM 1.6 cells perfused 
over the anti-CD3-coated surface the maximum RIfS signal was reduced by 11 % in 
comparison to the signal of wild type Jurkat cells (Table 1) but still higher than the one of 
the wild type cells on BSA- and on anti-CD28-coated surfaces. The initial slope of the 
RIfS curve (∆OT= (4.1 ± 0.6)*10-3 nm/s), was lower than the one for Jurkat cells 
contacting anti-CD28-functionalized coverslips. 
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The spreading of the Jurkat T cells on the immobilized anti-CD3 antibodies surface is an 
actin-dependent process. For this reason, the inhibitor of actin polymerization 
cytochalasin D was selected as a compound to evaluate RIfS for the detection of 
pharmacological interventions. Cytochalasin D treatment does not inhibit the attachment 
of cells to anti-CD3-coated surfaces and the formation of signalling clusters, but 
completely abolishes cell spreading. Preincubation of cells with cytochalasin D led to a 
reduction of the maximum RIfS-signal by 21.5% ± 12.9% (Table 6.1). Interestingly, the 
initial slope of the RIfS curve (∆OT=(4.2 ± 0.6)*10-3 nm/s), was in the same range as the 
one observed for JCaM 1.6 cells. Similar to the JCaM 1.6 cells, for cytochalasin D-treated 
cells, even though the initial kinetics of attachment were slow, the maximum increase in 
optical thickness was higher than the one for Jurkat cells on anti-CD28-coated surfaces.  
 
Table 6.1  Reduction of the RIfS signal for the 2000 s time point relative to the signal of Jurkat cells on 
anti-CD3 antibody surface (n=3). 
 Reduction of the RIfS-signal in % 
Jurkat cells on anti-CD28 antibodies surface   47.3 ± 15.8 
Jurkat cells on BSA surface 31.0 ± 4.4 
Jurkat cells on anti-CD3 antibodies surface pretreated with 
10 µM cytochalasin D 
  21.5 ± 12.9 
 
JCaM 1.6 cells on anti-CD3 antibodies surface 11.5 ± 3.2 
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Figure 6.4 Correlation of the maximum optical thickness after 2000 s and the initial slopes of the tangents 
to the optical thickness curves (∆OT). JCD3, JCD28 and JBSA indicate Jurkat cells adhering to a surface 
functionalized with anti-CD3, anti-CD28 antibodies or BSA, JCCD3 the LCK-deficient JCaM 1.6 cells on 
an anti-CD3 surface and JCD3CytD Jurkat cells pretreated with 10 µM of the actin inhibitor cytochalasin D 
before perfusion over an anti-CD3-functionalized surface. The average values of the maximal optical 
thickness were normalized to the spreading of Jurkat cells on anti-CD3-coated transducers.  
 
6.3.4 Correlation of kinetics of cell attachment and cell spreading. 
 
 The time-resolved RIfS measurements yielded information on the kinetics of T cell 
attachment and spreading in the presence of flow. We therefore asked whether 
correlations existed between the behaviour of the cells in the flow system and in the 
stopped flow configuration. Interestingly, the initial kinetics of cell attachment rather than 
the maximum RIfS signal showed a strong positive correlation with the cell spreading 
determined by immunofluorescence microscopy (Fig. 6.5). The lower maximum RIfS 
signal in spite of the larger average area for Jurkat cells on anti-CD28-coated surfaces in 
comparison to JCaM 1.6 cells, cytochalasin D-treated cells and cells on BSA is a non-
trivial result that may not be explained by the RIfS analysis alone.  
 
In the analysis of cell attachment and spreading, three factors may contribute to an 
increase in optical thickness: (i) Cell attachment, (ii) spreading of an already attached cell, 
and (iii) the refractive index in the contact area. The higher maximum optical thickness 
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for the latter three cases may readily be explained by the fluorescence microscopy data: 
For each condition the number of cells was the same even though a loss of cells during 
fixation and washing cannot be fully excluded. However, in contrast to the anti-CD28-
coated surface, for the JCaM 1.6 cells on an anti-CD3-coated surface and the Jurkat cells 
on BSA, a strong enrichment of filamentous actin in the contact area was observed. The 
higher RIfS signal is therefore most likely a consequence of the local enrichment of 
protein.  
 
Especially through the combination of results from immunofluorescence microscopy and 
RIfS it is now possible to distinguish between modes of binding in which (i) unspecific 
contacts are formed – as for BSA-coated surface, (ii) contacts establish quickly and 
induce firm attachment, but no cell spreading, even though contacts are less intimate/or 
the membrane proximal region is less enriched in protein – as for anti-CD28-coated 
surfaces, (iii) contacts establish slowly and cells do not spread or spread only in little 
extent, but the contact area still has a high optical thickness – as for JCaM 1.6 cells and 
possibly for cytochalasin-treated Jurkat cells, and where (iv) contacts establish quickly 
and cells spread strongly as for Jurkat cells on anti-CD3-coated surfaces. 
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Figure 6.5 Correlation of RIfS and immunofluorescence microscopy. A) Maximum RIfS signal after 2000 s 
versus the average cell spreading determined by immunofluorescence microscopy and digital image 
processing. B) Slopes of the tangents to the optical thickness curves (∆OT) versus average cell spreading 
determined by immunofluorescence microscopy. 
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6.4 Conclusion 
 
The results demonstrate that the label-free RIfS technique enables a sensitive distinction 
between various states of cell adhesion and activation in a flow system. Cells responded 
differently to surfaces functionalized with different stimulatory antibodies. Moreover, 
cells lacking a signalling protein and cells treated with an inhibitor of cell spreading 
yielded characteristics signatures of kinetics and maximum optical thickness. A 
correlation of the results obtained by RIfS with fluorescence imaging provided an 
explanation for the increases in optical thickness observed for the individual conditions, a 
prerequisite for a wider application of label-free techniques in cell biology. Remarkably, 
the cell spreading observed in a stopped-flow protocol correlated with the initial increase 
of the RIfS signal rather than with the maximum increase in optical thickness. There is 
evidence that in T cell receptor-dependent signal transduction the association kinetics of 
the TCR with the MHC peptide complex is a major determinant for the activation of a T 
cell 171. The flow system and especially the correlation of the dynamic data with 
fluorescence imaging as exemplified in this contribution should enable to address these 
questions in a highly robust experimental set-up. Finally, the analysis of T cell attachment 
in the presence of flow enables the screening for compounds that interfere with T cell 
interactions in a flow system. 
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7. Analysis of T cell signalling using peptide microarrays   
7.1 Abstract 
In cellular signal transduction multiprotein complexes play an essential role in the 
propagation and integration of signals. In spite of enormous progress in the identification 
of protein complexes and the definition of interaction motifs, systems-based analyses of 
signalling-dependent changes in the pattern of molecular interactions are still missing 
(still very limited). In order to overcome this deficit we have implemented peptide 
microarrays comprising a set of known interaction motifs of signalling proteins. Lysates 
of resting or stimulated cells are incubated on these arrays and the binding of signalling 
proteins detected by indirect immunofluorescence. Masking of binding sites or 
recruitment of proteins into complexes can lead to signal changes. Competition with 
peptides corresponding to interaction motifs provides detailed information on the 
architecture of signalling complexes and the functional relevance of individual interaction 
motifs in the organisation of the interaction network. For molecular interactions in T cell 
signal transduction this approach reveals detailed information on the presence of 
preformed complexes and the functional effect of a protein on molecular interactions 
patterns. 
 
This section has been adapted from: 
 
 
Stoevesandt, O., Elbs, M., Köhler, K., Lellouch, A.C., Fischer, R., André, T., Brock, R. 
(2005): Peptide microarrays for the detection of molecular interactions in cellular signal 
transduction.  Proteomics 5 (8):2010-2017 
 
The author of this thesis designed and synthesized the bisphosphorylated peptides used in 
this study and was involved in the microscopical analysis and image quantification. 
 
 
Stoevesandt, O., Köhler, K., Wolff, S., Hummel, W., André, T., Brock, R.: Dissection of 
T cell-activation dependent protein complex formation using peptide microarrays. 
Manuscript submitted 
 
The author of this thesis designed the peptides used in this study, produced the peptide 
microarrays and was involved in the cellular stimulation experiments and data analysis. 
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7.2 Introduction 
 
In recent years the molecular characterization of cellular processes has moved to the 
systemic level. Highly parallel analyses of changes in gene expression using 
oligonucleotide microarrays and various methods for detecting changes in protein 
expression have been applied to numerous biological questions. Also, signalling-
dependent changes in the pattern of protein phosphorylation have been mapped 
extensively. T cell signalling has been systematically characterized at the level of 
transcription 79, translation 172, and protein phosphorylation 173.  
In contrast, systems-based approaches for analysing signalling-dependent changes in 
protein interaction networks are still missing. Complexes of signalling proteins are key 
determinants for the integration of signals from different cell surface receptors. So far, 
interaction networks have been inferred by mapping of binary interactions, as exemplified 
by two-hybrid screens or by mapping of molecular complexes through tag-based pull-
down. The physiological relevance of two-hybrid data has been questioned, as partners 
interact in a foreign molecular and functional context. Pull-down approaches require the 
introduction of tagged proteins into many separate cell populations and therefore do not 
provide comprehensive information on the overall pattern of molecular interactions in an 
unmodified cell population.  
Compared to these approaches, the highly parallel detection of signalling-dependent 
changes in the pattern of molecular interactions in an unmodified cellular system would 
provide a more physiological data set for systems biological analyses. Here we 
demonstrate the use of peptide microarrays for this purpose. T cell receptor-dependent 
signal transduction is representative for signalling pathways in which interactions 
mediated via linear peptide motifs play a major role. Src homology 2 domains (SH2) 
interacting with phosphotyrosine (pY) peptide motifs and Src homology 3 domains (SH3) 
interacting with polyproline (polyP) peptide motifs are prominent examples. 
T cell receptor (TCR) crosslinking via a specific MHC/peptide complex initiates T cell 
activation through different signalling pathways in which kinases mediate 
phosphorylation-dependent protein-protein interactions. Src homology 2 domains (SH2) 
interacting with phosphotyrosine (pY) peptide motifs and Src homology 2 domains (SH3) 
interacting with polyproline (polyP) peptide motifs figure prominently in this network, 
making its analysis by peptide microarrays attractive. A key step following TCR 
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crosslinking is the phosphorylation of tyrosine motifs in the TCR/CD3 complex by the 
Src family kinase LCK, leading to the formation of sites for the binding and activation of 
ZAP-70 174. ZAP-70 in turn phosphorylates various downstream targets, among them the 
adapter proteins LAT and SLP76. Tyrosine-phosphorylated LAT forms a scaffold for the 
recruitment of various SH2 proteins (PLCγ1, GRB2, GADS and Vav) 175; 27; 36; 176. By 
interaction of pY motifs of LAT with SH2s of PLCγ1 and GADS, and polyP motifs of 
SLP76 with the SH3s of PLCγ 177 and GADS 35, these four proteins form the core of a 
protein complex called the LAT signalosome 36;178. Via further adapter proteins, the LAT 
signalosome composes a scaffold for the indirect recruitment of other proteins to the 
TCR, which are involved in dephosphorylation (SHP2 via Gab 37), cytoskeletal 
remodelling (e.g. via WASP 179) and TCR degradation (Ubiquitinylation via Cbl 180).  
 
7.3 Results 
7.3.1 System establishment. Direct detection of protein binding as judged by the 
intrinsic YFP-fluorescence of the ZAP-70-YFP fusion protein to its immobilized 
recognition peptide CD3ζpY72/83 shows a linear dependence from the protein 
concentration up to the highest applicable lysate concentrations (Fig. 7.1 A). However, 
the detection of endogenous ZAP-70 by immunofluorescent staining showed saturation 
tendencies for ZAP-70 concentrations below those of ZAP-70-YFP (Fig 7.1 B), most 
likely due to diffusion-limited binding of antibodies and incubation times below those 
necessary to reach equilibrium 181. Binding of ZAP-70-YFP from a pervanadate treated 
lysate prepared at 10 x 106 cells / ml was strongly reduced and showed also a clear 
reduction of immunostaining. This observation is likely a consequence of the depletion of 
free ITAM binding SH2 domains for ZAP-70, induced by the recruitment of ZAP-70 to 
intracellular phosphorylated ITAMs. This effect corresponds to the enforced recruitment 
of ZAP-YFP towards the plasma membrane in pervanadate-treated cells (data not shown).
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Figure 7.1 Relation between the concentration of ZAP-70 in the lysates of resting cells and array-bound 
fluorescence on pITAM spots after incubation on microarrays. (A) Lysates of resting cells expressing ZAP-
70-YFP were prepared at cell densities of 2, 5, 10, 20 and 50 x 106 cells / ml lysate (black diamonds). The 
concentration of ZAP-70-YFP was determined by fluorescence correlation spectroscopy. Array-bound 
fluorescence of ZAP-70-YFP increased linearly over the concentration range tested. The open diamond 
represents the signal of the lysate of 10 x 106 cells / ml treated with PV. (B) pITAM spots on arrays 
incubated with lysates of 1, 10 and 50 x 106 cells / ml displayed an increasing fluorescence intensity of 
ZAP-70-YFP, while indirect immunostaining against phosphotyrosine using a Cy5-labelled secondary 
antibody revealed that pITAM was not saturated by ZAP-70-YFP. (C) Western blot analysis of endogenous 
ZAP-70 from lysates of untransfected cells prepared at cell densities from 2 to 50 x 106 cells / ml. Equal 
volumes of lysate were loaded. Pervanadate treatment of the cells prior to lysis is denoted by PV. (D) ZAP-
70 Western bands shown in (C) were quantitated by integrating their density and area. The ZAP-70 content 
inceased linearly with the density of cells in the lysate. (E) Aliquots of the lysates depicted in (D) were 
incubated on arrays and the arrays indirectly immunostained for ZAP-70. A correlation between ZAP-70-
content as determined by Western blotting and intensity of the immunostaining on the array was established 
for lysates of resting cells (black diamonds) and PV treated cells (open diamond). Error bars represent the 
mean deviation from the mean.  Western blots and FCS measurements were performed by Oda Stoevesandt. 
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7.3.2 Experimental design. 16 identical peptide arrays were nanospotted per glass 
slide. The peptides comprised a set of known binding motifs for interaction domains of 
proteins involved in T cell signal transduction, with a focus on interactions up- and 
downstream of the scaffolding protein LAT. A 16-well clip-on frame allowed the 
individual incubation of arrays with cell lysates and indirect immunostaining for various 
bound proteins. Per array, two proteins were detected simultaneously, using primary 
antibodies from mouse and rabbit and species-specific distinctly labelled secondary 
antibodies (Fig 7.2 a, b). To limit redissociation of weakly bound proteins, antibody 
incubation and washing were kept as brief as possible.  
Judged by the intensity of immunostaining on the array, proteins showed a strong 
preference for peptides representing binding motifs for the respective domain subtype of 
the protein, notably peptides derived from known binding partners (Fig. 7.2 c). For 
example, PLCγ1 contains an SHP/PLC type SH2 domain and correspondingly its signal 
on the peptide LATpY132 (SHP/PLC motif) was about twice as intense as on LATpY191 
(GRB2/SFK/PLC motif) and nondetectable on LATpY226 (GRB2/SFK motif). The 
signal of GADS on the peptide SLP228 (atypical SH3 motif182) was about 300fold higher 
than on SLP179 (type2 SH3 motif). 
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Table 7.1 Peptides used for peptide microarrays 
Peptide 
 Sequence Source 
Inter- 
acting 
Partner 
Binding 
domain 
PAG421 CSDLQQGRDITRL-OH 183 PAG 421-432 EBP-50 PDZ 
ZAPpY296 CIDTLNSDG(pY)TPEPARIT-NH2 21 ZAP-70 284-300 Cbl PTB 
SHP1pY564 CSKHKEDV(pY)ENLHTKNK-NH2 184 SHP1 557-572 LCK  SH2 (GRB2 type) 
LATpY226 CEVEEEGAPD(pY)ENLQELN-NH2 36 LAT 217-233 GADS, GRB2, Vav 
SH2 (GRB2, SFK-
type) 
ZAPpY319 CVYESP(pY)SDPEELKD-NH2 185 ZAP-70 314-327 LCK 
SH2 (GRB2, SFK 
type) 
LATpY191 CEASLDGSRE(pY)VNVSQEL-NH2 27;176 LAT 181-198 Vav, GADS, GRB2,PLCγ1 
SH2 (GRB2, 
SHP/PLC, SFK 
type) 
CD3zpY72/83 C-Ahx-NQL(pY)NELNLGRREE(pY)DVL-NH2 186 
CD3ζ ITAM1 
69-86 ZAP-70 
Tandem-SH2 
(ITAM) 
PLCγpY783 CEGRNPGF(pY)VEANPMPT-NH2 187 PLCγ1 775-791 
PLCγ 
intramol. SH2 (SFK type) 
FYBpY595 CEDDQEV(pY)DDVAEQD-NH2 188 FYB 589-604 Fyn, SLP76 SH2 (SFK type) 
FYBpY625 CDDDI(pY)DGIEEED-NH2 188 FYB 621-634 Fyn SH2 (SFK type) 
FYBpY651 CLDMGDEV(pY)DDVDTSDF-NH2 188 FYB 644-663 SLP76 SH2 (SFK type) 
LCKpY505 CVLEDFFTATEGQ(pY)QPQP-NH2 189 LCK 493-509 LCK SH2 (SFK type) 
LATpY132 CEDEDDYHNPG(pY)LVVLPDSTP-NH2 27;175 LAT 121-141 PLC-γ1 SH2 (SHP/PLC type) 
SIGpY437 CGEEREIQ(pY)APLSFHKG-NH2 190 Siglec-7 430-445 SHP1, SHP2 
SH2 (SHP /PLC, 
SFK-type) 
GAB2pY614 CKSTGSVD(pY)LALDFQPS-NH2 191 Gab2 607-622 SHP1 SH2 (SHP/PLC type) 
CD28pY202 CTRKHYQP(pY)APPRDFAA-NH2 192 CD28 196-210 GRB2 SH2 (atyp.) 
CblpY699 CEGEEDTE(pY)MTPSSRPL-NH2 193 Cbl 693-707 Vav SH2 (atyp.) 
PI3K84 CPTPKPRPPRPLPVAPGSSKT-NH2 194 PI3Kp85 84-104 Fyn SH3 (type I + atyp.) 
SLP179 CSGKTPQQPPVPPQRPMAAL-NH2 195 SLP76 179-197 PLCγ1 SH3 (type II) 
PAK6 CLDIQDKPPAPPMRNT-NH2 43 PAK1 6-20 Nck SH3 (type II + atyp) 
GAB2-509 CQPPPVNRNLKPDRKAKPTPLD-NH2 53 Gab2 509-529 GRB2 SH3 (atyp.) 
SLP228 CAKLPAPSIDRSTKPPLDRS-CONH2 182 SLP76 228-246 GADS SH3 (atyp.) 
UBP8-403 CNVPQIDRTKKPAVKLPEE-NH2 196 UBPY 8 403-416 Hbp 
SH3 (atyp., Hbp 
type) 
WIP446 CEDEWESRFYFHPISDLPPP-NH2 197 WIP 446-464 WASP WH1 
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7.3.3 Phosphorylation-dependent changes in interaction profiles. To initiate 
signal transduction by protein phosphorylation, we employed the phosphatase inhibitor 
pervanadate, a strong supraphysiological stimulus of T cell signalling 198. Lysates of 
resting or pervanadate-treated Jurkat cells were incubated on separate arrays (Fig. 7.2 b,c) 
and signal ratios of corresponding peptides were calculated (Fig. 7.3 a). For interactions 
of SH2-domain containingproteins on pY peptides representing known binding partners, 
pervanadate induced a moderate signal decrease, as for GADS, GRB2, and PLCγ1 on the 
respective LATpY motifs. This decrease was in line with our previously demonstrated 
concept, that phosphorylation-dependent complex formation masks binding sites of 
proteins and therefore reduces binding to cognate immobilized phosphopeptides199. 
Remarkably, for GRB2 an increase was observed on SIGpY437, representing an pY-
motif of the PLC/SHP subtype. For proteins directly binding to cognate polyP-motifs 
through SH3 domains, we observed only moderate signal changes, as for example for 
PLCγ1 binding to SLP179 or Grb2 binding to GAB2-509 53. In most cases, these changes 
were minor signal increases. 
In addition, most proteins lacking SH3 domains were also detected on the SH3-binding 
polyP peptides (Fig. 7.3), suggesting that they were recruited to the array in a complex 
with a direct binding partner for an immobilized polyP peptide. Remarkably, signal 
increases for these proteins were much stronger than those of proteins for which direct 
binding was possible. Signals for which the subtype preference of the respective domain 
was violated could also originate from the binding of complexes rather than direct 
interactions. For example, LAT, which has no interaction domains at all, displayed a 
stimulation-dependent median 74-fold increase of binding of on the polyP peptide 
SLP228. This binding could be mediated by an SH2/SH3 adapter like GADS or GRB2, 
which were also detectable, albeit with moderate median signal changes. The LAT-
interactor PLCγ1 was detected on SLP228 with a median increase upon stimulation of 
4400. Likewise, the increase of the GRB2 signal on SIGpY437 could be explained by a 
phosphorylation-dependent interaction between GRB2 and SHPTP2, and binding of 
SHPTP2 to SIGpY437. On LATpY191, the median signal of GADS decreased to 0.7, 
while the median signals of the GADS-interactor SLP76 and the SLP76-interactor PLCγ1 
decreased to 0.2 of the unstimulated control (Fig. 7.2a). Similar tendencies were found for 
GRB2 (0.7) and its binder Cbl (0.3), which contains a PTB domain, unlikely to mediate 
direct interactions with LATpY191 21.  
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The absolute signal intensities provided further evidence for the binding of protein 
complexes to the arrays (Fig. 7.2 c). For lysates of resting cells, immunostaining for 
PLCγ1 was intense on SLP179 and PAK6 and negligible on SLP228 and GAB2-509. For 
lysates of pervanadate-treated cells, signals on SLP228 and GAB2-509 were stronger than 
signals on SLP179 and PAK6. If a mere change in the availability of the SH3 domain of 
PLCγ1 was the reason for a signal increase, then the signal should increase uniformly on 
all peptides. The reversal in the order of signal intensities therefore suggests that a portion 
of PLCγ1 was contained in complexes recruited to the array via the SH3 domain of 
another protein.  
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Figure 7.2  a) One coverslip holding 16 identical peptide microarrays, incubated with cell lysates and 
different antibodies for immunostaining. Each subarray was incubated with lysate of 106 Jurkat cells. 
Green: secondary immunostaining with anti-mouse-Alexa546; red: secondary immunostaining with anti-
rabbit-Alexa633. For the total of 31 different immobilized peptides, binding of key proteins in T-cell signal 
transduction could be detected on 24 peptides, comprising 16 pY-motif peptides, 6 polyP-motif peptides, 
one PDZ-binding peptide and one WH1-binding peptide. b) Detailed view of the arrays used for 
determining background binding of anti-PLCγ1 and anti-LAT antibodies, and binding of PLCγ1 and LAT 
from resting and pervanadate (PV) treated cells. c) Fluorescence intensities F derived for resting and PV 
treated condition were corrected for background binding of antibodies. Median values of 5 experiments are 
shown, if in minimum of 4 out of 5 experiments produced a signal above threshold for either one of the 
stimulated or unstimulated condition. Figure prepared by Oda Stoevesandt. 
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Figure 7.3 Changes in protein signal intensity on the peptide microarrays upon treatment of Jurkat cells and 
derivative cell lines with sodium pervanadate. Peptides immobilized on the array are plotted vertically, 
proteins probed by immunostaining horizontally. Above the proteins, their numbers of SH2 and SH3 
domains are listed. Ratios of background-corrected fluorescence intensities were calculated for PV-treated 
to resting cells. a) Jurkat cells. The median ratio of 5 experiments is shown, if a minimum of 4 out of 5 
experiments produced a signal above threshold (see Materials and Methods). b) Jgamma1 cells and c) 
JCaM1.6 cells. The median ratio of 4 experiments is shown, if a minimum of 3 out of 4 experiments 
produced a signal above threshold.  
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7.3.4 Dissection of complex architectures by peptide competition and 
titration. Next we sought to confirm experimentally the binding of complexes on the 
array and to obtain information on the architecture of these complexes. On the SLP228 
peptide spot, we detected GADS, LAT, and PLCγ1 (Fig. 7.4 a). If the proteins were 
bound as a complete, then incubation with peptides corresponding to individual motif 
should selectively remove each one, two or all three proteins from the array. We had 
shown previously, that the PLCγ1-LAT interaction was competed by incubation of lysates 
with the LATpY132 peptide and less effectively with LATpY19110. Peptide 
concentrations for competition on the arrays were chosen accordingly (Fig 7.4 a). The 
signals of GADS, LAT and PLCγ1 were all sensitive to SLP228. Upon addition of 
LATpY191, the signals of LAT and PLCγ decreased, while the signal of GADS was not 
affected. In contrast to the LAT signal, the PLCγ1 signal was also sensitive to the 
LATpY132 peptide. Taken together, this suggested the following order of binding: 
SLP228 directly bound GADS, the SH2 of GADS bound LAT via LATpY191, LAT 
bound the SH2 of PLCγ1 via LATpY13227. Moreover, these results confirm that the 
binding of PLCγ1 to SLP228 is indirect. 
Peptide competition of the signals of GADS, SLP76 and PLCγ1 on the immobilized 
peptide LATpY191 enabled the dissection of the same set of interactions from yet another 
perspective (Fig. 7.4 b): All proteins contain SH2 domains. Therefore, instead of binding 
as a complex, these proteins might bind the peptide independently. Detection of GADS, 
SLP76 and PLCγ1 was all sensitive to LATpY191. However, only SLP76 and PLCγ1 
were sensitive to SLP228. PLCγ1 was also sensitive to SLP179, even though this peptide 
had some effect on all three proteins. Finally, the sensitivity of PLCγ1 to LATpY132 may 
suggest that further SH2-interactions stabilize the complex. In contrast to the LAT-
containing complex described above, all three proteins were detected on LATpY191 also 
upon incubation of lysates of resting cells. Inhibitory peptides had similar effect in lysates 
of resting and pervanadate-treated cells (Fig 7.4 b), indicating the existence of a 
preformed complex of GADS, SLP76 and PLCγ1. However, the effect of all disrupting 
peptides on PLCγ1  was weaker in lysates from resting cells, suggesting that direct 
binding of PLCγ1 to immobilized LATpY191 accounted for a larger part of the signal 
than after stimulation. 
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Titration with the peptides LATpY132 and LATpY191 yielded further information on the 
organisation of signalling complexes through comparison of titration curves obtained (i) 
for several proteins on the same array spot, or (ii) for one protein on a range of arrayed 
peptides (Fig 7.4 c). (i) For LAT and PLCγ1 on the SLP228 spot, signal losses upon 
addition of LATpY191 occurred with the same concentration dependence, while for 
LATpY132 only PLCγ1 dissociated, supporting the binding order inferred from the 
simple peptide competition experiment (Fig. 7.4 a). (ii) Upon titration with LATpY132, 
PLCγ1 fully dissociated from GAB2-509 and SLP228 (atypical SH3-binding motifs), but 
only partially from PAK6 and SLP179 (type 2 SH3-binding motifs), suggesting different 
modes of PLCγ1 binding. On SLP228, indirect binding of PLCγ1 as a part of a large 
complex can be assumed as shown by the competition experiment (Fig. 7.4 a). SLP179 
represents a favoured binding motif of PLCγ1 SH3 domains. Still, titration with pY-
peptide decreased the signal of PLCγ1, suggesting a role for the SH2-domain of PLCγ1 in 
the stabilization of binding to the array.  
 
 
7.3.5 Effect of single protein deficiency on the interaction network. The 
titration experiments had revealed the significance of individual interaction motifs for the 
functional organisation of the network. Next, we examined the impact of a loss of a 
multidomain protein on the organisation of the network, using the PLCγ1-deficient 
Jurkat-derivative JGamma1 200. 
Loss of PLCγ1 affected the formation of various complexes, notably on the preferential 
PLCγ1-interacting peptides. SLP76 on LATpY132 and LAT on SLP179 became 
undetectable, supporting the role of PLCγ1 for their recruitment in Jurkat cells. To 
analyze the role of PLCγ1 in complex formation, ratios of signal intensities from 
JGamma1 to Jurkat lysates were calculated for resting and stimulated cells (Fig.7.5). For 
proteins supposed to bind directly to immobilized peptides (e.g. GADS and GRB2 on 
LATpY191 and SLP228), only marginal changes were observed. However, PLCγ1-
deficiency strongly inhibited phosphorylation-dependent recruitment of LAT to polyP 
peptides. Furthermore, in JGamma1-lysates, SHPTP2-signals on polyP-peptides were 
increased compared to WT Jurkat lysates, with no significant differences of SHPTP2 
expression detected by Western Blot. As the SH2-domains of SHPTP2 and PLCγ1 share a 
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common consensus motif, the lack of competing PLCγ1 may enable increased binding of 
SHPTP2. 
 
The Jurkat derivative cell line JCAM 1.6 displays no LCK activity, due to a mutation 
affecting the kinase domain of LCK 201. JCaM1.6 cells were used as a model for generally 
impaired TCR-downstream signalling capacity. For JCAM1.6 cells (7.3 c), the 
predominant signal decrease observed on pY peptides for Jurkat cells (Fig. 7.3 a) was 
largely missing, agreeing with the role of LCK in starting a phosphorylation cascade. A 
similar reduction of the decrease of  PLCγ1 binding to LAT pY-peptides was also 
observed for cells pretreated with the SFK-Inhibitor PP2 before PV stimulation (not 
shown). Effects of LCK deficiency were observed for ZAP-70, a binding partner of 
activation motifs phosphorylated by LCK, and for proteins further downstream the kinase 
cascade, such as the ZAP-70 substrates SLP76 and LAT. PLCγ1 became undetectable on 
most polyP peptides, likely due to missing phosphorylated LAT and SLP76 as mediators 
of binding. By contrast, pervanadate-dependent recruitment of SHPTP2 to polyP peptides 
was not affected. This suggests an LCK independent, but phosphorylation-dependent 
formation of a complex between SHPTP2 and an SH3-SH2 adaptor protein.  
 
. 
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Figure 7.4 Effects of signalling peptides on the detection of proteins in a complex on the array. Jurkat T 
cells were treated with 0.5 mM pervanadate and lysed in presence of the interactor-peptides in the following 
concentrations, unless indicated otherwise: (LATpY191 (20 µM), LATpY132 (0.5µM), SLP228 (20 µM) 
and SLP179 (20 µM)). A) Effects of the different peptides (x axis) to protein detection on the SLP228 
peptide B) the LATpY191 peptide under the influence of different interfering peptides. For A and B, 
relative changes in protein signal compared to the control without peptides are indicated. C) Titration of 
different proteins associated to the signalling peptides with the LATpY132 and the LATpY191 peptide. A 
cross represents a signal decrease under the influence of the respective peptide for more than 50 %. The 
example right to the colour plot represents the recruitment of different proteins to the SLP228 peptide, 
while that under the colour plot represents that for PLCγ1 on different polyP peptides. On the graphs, the 
relative signal change to the unstimulated control is given on the y axis.  
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Figure 7.5 Changes in protein signal intensity on the peptide microarrays between PLCγ1 deficient 
JGamma1 cells and “wildtype” Jurkat cells, expressed as background-corrected ratio JGamma1/WT. 
Lysates of resting (-) and pervanadate-treated (+) cells were used. The median ratio of 4 experiments is 
shown, if a minimum of 3 out of 4 experiments produced a signal above threshold. 
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7.3.6 Stimulus-dependence of protein interactions in T cell activation. We 
next employed the peptide arrays to profile the time course of protein complex formation 
in a more physiological model of T cell activation. Jurkat cells were stimulated for 
variable times with stimulatory anti-CD3 antibodies (clone OKT3), costimulatory anti-
CD28 (clone 9.3), or both. On the arrays, distinct and reproducible changes in signal 
profiles were obtained for PLCγ1, LAT, SLP76 and PI3K (Fig. 7.6). For PLCγ1, signal 
increases on polyP peptides were strongest after 2 min of CD3-stimulation, and then 
diminished. Only on SLP228, CD28 stimulation alone induced slight increases in PLCγ1 
recruitment. CD3-CD28 costimulation augmented signal increases compared to CD3 
stimulation without affecting their kinetics. For LAT, analogous signals were observed 
for CD3 stimulation, suggesting fast pY-dependent complex-formation with PLCγ1 and 
corecruitment to the array. For SLP76, signal decreases on LATpY peptides were 
detected upon CD3 stimulation. Interestingly, this decrease was most pronounced after 10 
min of stimulation, indicating that recruitment of SLP76 to the LAT complex occurred 
with a slower kinetics than the phosphorylation of LAT and recruitment of PLCγ1. In the 
presence of antiCD28, signals of murine detection antibodies could not be quantified 
because of high overall backgrounds, accounting for the data points missing for LAT and 
SLP. For PI3K, no systematic signal changes were observed upon stimulation with CD3 
or CD28 alone, whereas costimulation led to a signal decrease. Pervanadate stimulation 
was conducted in parallel as a positive control, yielding signal changes consistent with the 
antibody effects. Pervanadate effects were weaker than in the experiments presented 
above (Fig. 7.3). Antibody stimulation required preincubation on ice, a condition that 
apparently also affected pervanadate-dependent cell activation.  
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Figure 7.6 Signal changes on the peptide microarrays following treatment of Jurkat cells with stimulatory 
antibodies against the TCR/CD3-complex (αCD3) and the CD28 coreceptor (αCD28) for different time 
points. Ratios of stimulated versus resting cells. Negative control by mock-stimulation with an isotype 
antibody (IgG), positive control by incubation with 0.5 mM pervanadate (PV). Signals for the protein 
indicated on top of each column of graphs, derived from the peptide spot indicated in each graph. Means 
and mean deviations of the mean of 3 experiments. 
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7.4 Discussion 
 
Signalling processes downstream of transmembrane receptors typically occur in a 
timeframe of minutes through rearrangement of a given repertoire of signalling 
components. While signal-induced fast degradation of single components may occur, the 
levels of most components remain unchanged and expression of further components is 
still far downstream. However, the molecular interactions of signalling components 
change significantly. We demonstrate how these changes in interaction can be detected in 
cell lysates using peptide microarrays. 
We have shown previously that change in the availability of a protein domain involved in 
a signalling-dependent protein-protein interaction can be detected by a capture peptide 
probing for the availability of the binding domain 199. This approach was now generalized 
for the parallel detection of different interactions. In addition, we exploit that proteins 
directly binding to capture peptides bring along their interaction partners, making 
microarrays a highly parallel variant of co-purification techniques. In a typical experiment 
(Fig. 7.6), proteins bound by 24 capture peptides were probed with 8 different antibodies 
under 16 different conditions, yielding 3072 data points for the analysis of interactions in 
T cell signalling using only 106 cells per array. In contrast to high throughput tag-based 
affinity purifications, the array-based approach does not require the introduction of 
recombinant components into the signalling network. Therefore, the molecular system 
under scrutiny is not already manipulated before the experiment begins.  
On the molecular level, inducible tyrosine phosphorylations trigger the onset of complex 
formation. Therefore, additional pY sites generated through stimulation compete for SH2-
proteins with the pY peptides on the array, while the total cellular level of polyP motifs is 
not changed through stimulation. This may explain a general trend we observed for 
stimulation-dependent signal changes on the arrays: On pY peptides, signal decreases 
were dominant, while on polyP peptides signal increases dominated. 
Especially on polyP peptides, we detected proteins without a cognate binding motif. 
Indeed, we were able to dismantle supposed complexes on the arrays in a stepwise and 
dose dependent manner through competition and titration with peptides corresponding to 
binding motifs between the proteins in the complex. This finding demonstrates, that 
detected proteins need not interact directly with the peptide, but may instead be brought 
along by another protein directly binding the peptide. 
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In lysates of resting cells, we detected the presence of polyP-SH3 domain mediated 
preformed complex ‘nuclei’. For example, on LATpY132, representing a direct binding 
motif for PLCγ1, we observed stimulation-dependent decreases to the binding of PLCγ1 
and SLP76 in Jurkat lysates. In lysates of PLCγ1-deficient Jurkat cells, both proteins were 
not detectable on LATpY132, suggesting PLCγ1-dependent recruitment of SLP76. For 
LCK-defective cells, both proteins were detectable, but their signals did not decrease 
upon stimulation. On LATpY191, corresponding observations were made for the 
preformed complex of GADS and SLP76. Taken together, these observations suggest that 
upon stimulation, the preformed complexes contributed to the assembly of larger, 
phosphotyrosine-dependent signalling complexes. 
We realized that complex architectures inferred from the peptide competition experiments 
were correlated to the different magnitudes of signalling-dependent signal changes for the 
different proteins detected on a given peptide. The more distant from the peptide, the 
more pronounced was the relative signal change for the protein (Fig. 7.4, Fig. 7.7). 
Assuming a linear chain of protein-protein interactions, this observation can be explained 
by the potentiation of changes from one level of protein binding to the next: If each of the 
interactions contributing to a linear complex on the immobilized peptide (peptide-A-B-C) 
occurred with a different probability after stimulation (peptide-A changing x-fold, A-B 
changing y-fold, B-C changing z-fold), then the chance to find the outermost protein C on 
the immobilized peptide would change x*y*z-fold. Per se, x, y, and z may each be larger 
or smaller that 1. While situations are conceivable where the increases and decreases 
balance, we found that the relative magnitude of signal changes as described above was a 
useful indicator of the interaction architectures.  
For the interplay of stimulation of TCR/CD3 and CD28 by stimulatory antibodies, our 
peptide microarrays allowed the analysis of timecourses of protein complex formation in 
a parallel manner. We demonstrate that the recruitment of SLP to the LAT signalosome 
follows a different timecourse than the recruitment of PLCγ1. Recently, an analysis of 
phosphorylation kinetics in early T-cell signalling showed, that phosphorylation of LAT-
residues Y132 and Y191 reaches maximum levels within two minutes 17. 
Our data shows that the arrayed LATpY191 is maximally competed by its cellular 
counterpart after 10 minutes of stimulation, suggesting that LAT-phosphorylation is not 
the rate-limiting step for formation of the LAT-signalosome. Co-stimulation with anti-
CD28 and anti-CD3 led to more distinct, and additional signal changes concerning PI3K, 
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compared to CD3 stimulation alone. This finding demonstrates the potential of the 
peptide microarrays for integrated network analysis in systems with multiple stimuli. 
Likewise, for the analysis of signalling systems missing single proteins, peptide arrays 
provide a means to uncover effects of molecular links on interaction subsystems.  
In conclusion, peptide microarrays provide a tool for the highly parallel analysis of 
protein-protein interactions in cellular signal transduction, bridging the gap between 
binding studies with single proteins and complex interactomics experiments. Quantitative 
analysis of signal changes upon stimulation and competition experiments provide a 
wealth of information on the functional organisation of protein complexes. This approach 
will benefit from the use of arrayed peptide libraries derived from the literature as well as 
by motif prediction 202;203. In combination with antibody libraries, the simultaneous 
probing for all potential molecular interactions in a molecular signalling network can 
deepen our understanding of signal transduction in a systems biological view. 
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Figure 7.7 Schematic diagram for selected proteins detected on the arrays and their proposed hierarchy of 
binding based on the relative signal change upon pervanadate treatment of cells (represented by the colour 
of proteins, taken from Fig. 7.4). The immobilized peptides are depicted at the basis of the protein stacks. 
White circles depict a phosphorylation-dependent binding motif, grey pentangle a polyP motif. 
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8. Experimental procedures 
 
8.1 General 
 
8.1.1 Inhibitors. ML-3403 was supplied from Stefan Laufer (University of 
Tübingen). PP2 and piceatannol were from Calbiochem (Schwalbach, Germany), 
Cytochalasin D, Ro-31-8220, SB-203580, Alsterpaullone, PD98059 and LY-294002 from 
Sigma (Taufkirchen, Germany). FK506 was purchased from LC Laboratories, Woburn, 
MA, USA. All inhibitors were added as indicated from freshly prepared aqueous 
solutions prepared from DMSO stock solutions, and added to the cells 15 min before the 
initiation of stimulation, unless indicated otherwise. Common chemicals of analytical 
grade were purchased from Sigma-Aldrich and Merck, Darmstadt, Germany.  
 
8.1.2 Stimulatory antibodies. The stimulatory anti-CD3 (clone OKT3) and anti-
CD28 antibodies (clone 9.3) were purified by Protein A affinity chromatography 
(Pharmacia, Freiburg, Germany). rM28, a recombinant single chain FV bispecific 
antibody-fragment directed against CD28 and a melanoma-associated proteoglycan 
(MAPG) was purified from the supernatant of the stably transfected mouse myeloma cell 
line Sp2/0 by Protein L affinity chromatography (Perbio, Bonn, Germany). All antibody 
solutions were dialyzed against PBS and stored at 4°C after filter-sterilization (0.22 µm). 
All stimulatory antibodies against human epitopes used for this study were produced by 
Ludger-Grosse Hovest and Gundram Jung.  
 
 
8.1.3 Cell culture.  For the analysis of T cell activation, we used the Jurkat human T 
cell leukemia cell line133. Using random mutagenesis, various Jurkat-derived mutants 
deficient for key signalling molecules have been generated. Moreover, Jurkat cells are 
deficient for the phosphatases SHIP (SH2-domain-containing inositol polyphosphate 5’ 
phosphatase) and PTEN ((phosphatase and tensin homologue), 204. While the effect of 
SHIP deficiency on T cell signalling is still unclear, PTEN deficiency might induce a 
hyperactivity of the PI3K signalling pathway 205;206. However, the function of PI3K in 
early T cell signalling is still poorly understood. Jurkat cells, the LCK-deficient derivative 
JCaM 1.6 201 and the PLCγ-deficient derivative line J.gamma1 200 (ATCC, Manassas, VA, 
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USA;were cultivated in RPMI 1640 (PAN, Aidenbach, Germany) supplemented with 
10% fetal calf serum (FCS; PAN). at 37°C/5% CO2 Expression of CD3 and CD28 surface 
antigens was validated using anti-CD3 (clone OKT3) and anti-CD28 (clone 9.3; both 
antibodies were kindly provided by G. Jung, Institute for Cell Biology, Tübingen, 
Germany) at a concentration of 2 µg/ml for 1 h at 4°C each.with subsequent detection by 
flow cytometry (BD FACSCalibur System, Becton Dickinson, Heidelberg, Germany) 
using an Alexa 488 goat anti-mouse secondary antibody (2 µg/ml). 3A9 hybridoma T 
cells and derivatives were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplement with 10% FCS (PAN, Aidenbach, Germany), 100 µM sodium pyruvate, non-
essential amino acids, 45 nM β-mercaptoethanol, 200 µM L-glutamine, 100 U/ml 
penicillin, and 100 µg/ml streptomycin 207. Plat-E packaging cells were cultured with the 
addition of 1 µg/ml puromycin and 10 µg/ml of blasticidin. Supplements were from 
Gibco BRC (Karlsruhe, Germany) and Sigma (Deisenhofen, Germany). Jurkat JCaM1.6 
and derived cell lines were cultivated in RPMI 1640 (PAN) with 10 % FCS 208. Cell 
vitality after inhibitor incubation was controlled using an MTT assay. 
 
 
8.1.4 Generation and characterization of 3A9-fusion protein cell lines. 
To insert EYFP into the retroviral expression vector pMFG, the SacI- NotI fragment from 
the EYFP-N1 vector (Clontech, Heidelberg, Germany) containing the EYFP coding 
region was ligated into the SacI-NotI site of pBluescript KS+. The EYFP coding region 
was then recovered as a NcoI-BamHI fragment and cloned into the corresponding unique 
sites of the retroviral vector pMFG 209. The murine ZAP-70 gene was amplified by PCR 
from murine thymic cDNA using the forward primer: 5'atacatgtccgatcccgcgg-
cgca containing an AflIII restriction site at its start codon. The reverse primer: 
5'ccacatgttggccgatcccccaccgccagacccgccacatg cagcctcggccac 
includes the last 6 codons of ZAP-70 fused to a linker sequence (GGSGGGGSAN) and 
an AflIII restriction site. The PCR product was purified, ligated into pGEM-TZ and 
sequenced (Genome Express, Grenoble, France). The ZAP-70 AflIII fragment was 
recovered from pGEM-TZ and cloned into the NcoI site of pMFG-YFP to give ZAP-70 
with a C-terminal fusion of YFP (ZAP-70-YFP). The CD3ζ-CFP fusion was derived from 
a pMFG-CD3ζ-YFP (pAPVR1, M. Malissen, CIML) construct by exchanging YFP for 
CFP via unique NcoI-NotI sites. 3A9 hybridoma T cells were infected with retrovirus 
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generated with the pMFG vector via the Plat-E packaging cells as described by Morita 210. 
YFP fusion protein expression was monitored by flow cytometry 48 h post infection. 
Cells were expanded, sorted by flow cytometry and sub-cloned by limiting dilution. For 
double labeling with CD3ζ-CFP, the wild type 3A9 cells were first infected with CD3ζ-
CFP DNA, as described above. Immediately after infection, cells were cloned by limiting 
dilution. Clones expressing labeled CD3ζ-CFP at the plasma membrane were selected by 
visual inspection under an epifluorescence microscope. These clonal populations were 
then infected with pMFG-ZAP-70-YFP, sorted for YFP expression and subcloned. To 
verify the integrity of the YFP and CFP chimeras expressed in the 3A9 cells, post nuclear 
cell lysates were prepared, run on 10 % SDS-PAGE, transferred to PVDF membrane and 
probed for GFP expression using an anti-GFP mAb (Clontech) followed by using donkey 
anti-mouse HRP conjugate (Immunotech Beckman Coulter, Fullerton, USA) and ECL / 
autoradiography. Anti-phosphotyrosine mAb 4G10 was a kind gift of Dr. H.-T. He, 
CIML, Marseille, France.  
 
8.1.5 Western Blots and coimmunoprecipitation. In order to analyze the 
cellular ZAP-70-YFP content at different time points of cell stimulation, 2.5*105 cells per 
coverslip were stimulated as described above for a given time and lysed (5*106 cells/ml) 
in lysis buffer (1 % Triton X-100, 20 mM Tris, 1mM EDTA, 150 mM NaCl, 1 mM 
Na3VO4, protease inhibitor cocktail (Roche, Mannheim, Germany), pH 7.5) on ice for 30 
min. The crude lysates were clarified by centrifugation at 20,000 x g for 15 min, 
separated by SDS-PAGE on a 10 % polyacrylamide gel 211 and transferred to a PVDF 
membrane. The blots were probed for ZAP-70 expression using a ZAP-70-YFP antibody 
(BD Transduction Labs, Franklin Lake, USA) in combination with a goat anti-mouse 
alkaline phosphatase conjugate for detection (Sigma). In order to analyze the activation-
dependent recruitment of ZAP-70 to the CD3/TCR complex, cells were stimulated as 
described above. Anti-CD3ε antibodies (final concentration of 10 µg/ml) and µMACS-
beads functionalized with protein G (Miltenyi Biotec, Bergisch Gladbach, Germany, 
dilution 1:20) were added to the lysates. Samples were incubated on ice for 20 h and 
precipitated by centrifugation. The pellets were washed twice with lysis buffer and once 
with PBS, and analyzed on a Western Blot as described above. 
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8.1.6 ELISA. For the quantitation of IL-2 expression under the influence of 
different inhibitors, 200 µl per well of Jurkat cell suspension (6.25*105/ml) was added to 
a freshly prepared aqueous antibody solution of the inhibitor and preincubated at 37°C for 
15 min. For stimulation, a Falcon 3075 ELISA plate was coated for 2 h at 37°C with 5 
µg/ml each of anti-CD3 (OKT3) and anti-CD28 (9.3), blocked with 1% BSA/PBS for 15 
min, washed with PBS. Cells were stimulated for 16 h at 37°C. The anti-IL-2 ELISA was 
performed on a 96 well ELISA plate (Greiner, Frickenhausen, Germany), using a pair of 
capture/biotinylated detection antibodies from BD Pharmingen (San Diego, USA). 
 
8.2 Imaging of cells in contact with immobilized stimuli 
 
8.2.1 Production of surfaces for antibody immobilization. For 
functionalization of 12 mm coverslips (Fluka, Seelze, Germany) with 3-
(glycidyloxypropyl)trimethoxysilane (GOPTS) enabling covalent binding of proteins, 
coverslips were cleaned with 1 M NaOH for 30 min. Then, the coverslips were treated 
with freshly prepared Piranha solution (mixture of 30 % hydrogen peroxide and 
concentrated sulphuric acid at a ratio of 2:3 (v/v); Caution: Highly aggressive!) for 30 
min, washed with H2O, and dried before being overlayed with GOPTS (100 %, or 2.5 % 
in ethanol) for 1 h. Then, coverslips were washed with ethanol and subsequently 
overlayed with the protein to be immobilized. In order to produce a hydrophobic surface 
for the noncovalent binding of antibodies, coverslips were silanizedwith trimethoxy-
octadecylsilane in the same manner as described previously 212.  
 
 
8.2.2 Antibody microarray procedures. Antibody microarrays were generated 
by pipetting (6 nL/spot) solutions of antibodies in 300 mM sodium phosphate buffer, pH 
8.5 with 0.005% Tween-20 (Fluka) 0.01% BSA (Sigma, Steinheim, Germany) and 0.5% 
trehalose (Sigma) on hydrogel microarray substrates (Slide H, Schott, Jena, Germany) 
using a piezo-electric nanopipettor (NP2.0 GeSiM, Dresden, Germany) at dew point 
(16°C). As a negative control 100 µg/ml poly-L-lysine (MW 150,000-300,000; Sigma) 
was used. rM28 was spotted at a concentration of 50 µg/ml. Subsequently arrays were 
stored for 16 h at 4°C with 70% relative humidity. Afterwards, arrays were washed for 5 
min with PBS containing 0.5% Tween-20, then for 2x5 min with PBS. Subsequently, 
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reactive groups were quenched with 50 mM ethanolamine (Sigma) in 50 mM borate 
buffer, pH 8 for 1 h. After three washes with PBS, the surface was blocked with 0.1% 
BSA for 15 min.  
 
8.2.3 Cellular antibody stimulation experiments. For parallel processing of 
several microarrays, a 16-well superstructure (ProPlate Multiarray System, Grace 
Biolabs, Eugene, OR, USA) was clamped onto the hydrogel slide. Cells suspended in 
serum-free RPMI medium (5x105 cells/ml) were preincubated with inhibitor for 15 min at 
37°C before being added into the well. After 60 min at 37°C/5% CO2 the medium was 
removed, cells were fixed with 4% PFA in PBS, first for 10 min at 4 °C, then for 15 min 
at room temperature, and washed 3 x with PBS. In order to quantify the spreading of the 
cells on the surface, the surface not shielded by adherent cells was stained by incubation 
with an Alexa546-labeled anti-mouse antibody (Molecular Probes, Eugene, OR, USA) 4 
µg/ml in PBS, 0.1% BSA) 30 min at room temperature. For visualization of NFAT 
translocation cells were then washed with PBS, permeabilized with saponin buffer (PBS, 
0.1% saponin (Sigma), 0.1% BSA) and incubated with a FITC-labeled anti-NFAT IgG 
(BD Pharmingen, 1.25 µg/ml) in combination with the nuclear stain TOPRO (Molecular 
Probes, 100 nM) for 30 min in saponin buffer. After washing 3 x with saponin buffer, 
samples were fixed with 4% PFA for 15 min, and washed 3 x with PBS. Subsequently, 
the superstructure was removed and the arrays were embedded in anti-fading reagent 
(10% Mowiol, Aventis, Frankfurt, Germany, in 100 mM Tris-HCl, pH 8.5, and 25% 
glycerol 213) and sealed with a coverslip.  
8.2.4 PDMS stamps. Stamp masters were designed and produced by Günter 
Roth, and stamps manufactured by Günter Roth and Alexander Ganser. The procedures 
for the generation of the stamp master PDMS stamps are adapted from 214. The production 
of the PDMS stamp (Fig. 8.1) started with the demolding of the stamp master by 
deposition of perfluorinated alkyl-trichlorosilane, such as (1-H, 1-H, 2-H, 2-H)-
Perfluorodecyltrichlorsilane SIH5841.0 (ABCR). A few drops of the 
perfluorodecyltrichlorsilane were put in a small plastic container and put together with the 
stamp master into an exsiccator, which was subsequently evacuated under a hood, and left 
standing for 10 minutes. A 10:1 mixture of PDMS Sylgard 184 silicone elastomer and the 
respective curing agent (Dow Corning, Midland, MI, USA) was prepared, and degassed 
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in an exsiccator. The mixture was poured into a hydrophobic Petri dish containing the 
master up to the desired level, remaining in a horizontal position. After escape of the air 
bubbles, the PDMS was polymerized by incubation at 60°C for 20 h. After peeling the 
stamps off the master, the desired PDMS stamps were cut out and overlayed with 
stimulatory antibodies of a total concentration of 100 µg/ml, plus 15 µg/ml Alexa 546-
labelled anti-mouse IgG (Molecular Probes) for 1 h to generate a protein monolayer on 
the surface. Then, supernatant was removed, stamps thoroughly washed with Millipore 
H2O, and dried in an air-stream. Stamps were then placed on polished glass slides 
(Marienfeld, Lauda-Königshofen, Germany) that had been thoroughly cleaned by ethanol 
and aceton (p.a.). The stamp was softly pressed onto the slide so that adhesion was 
visible, and left there for 20 s. Then, stamps were removed, the printed area sealed with 
Gene Frames (Peqlab, Erlangen, Germany) and slides quickly overlayed with antibody 
solution or blocking buffer (1% BSA inPBS), each step for 30 min. 200 µl of cell 
suspension (2*106  cells/ml) was added to the arrays. The following steps of fixation and 
permeabilization were as described above. Cells were stained with 5 µg/ml anti-
phosphotyrosine antibody (Cell Signalling, Danvers, MA, USA) for 1 h , which had 
previously been labelled according to the manufacturer's direction with Zenon-Alexa 633 
(Molecular Probes), and surface-associated mouse IgG antibody detected by staining with 
Alexa 488-labelled goat anti-mouse IgG (2 µg/ml). Following permeabilization and 
fixation, slides were mounted with MOWIOL with a glass coverslip. Imaging was 
performed as described for protein clustering at a resolution of 1024 x 1024 pixels using a 
C-Apochromat 63 W x 1.2 NA water immersion objective.  
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Figure 8.1  Schematic of the generation of microstructured surfaces. 
8.2.5 Fluorescence microscopy of living cells. For live cell microscopy of 3A9 cells, 
silanized coverslips were coated with 200 µl 5 µg/ml anti-mouse CD3ε mAb (mAb145-
2C11, BD Pharmingen) for 16 h at 4 °C. After coating, the surface was washed twice for 
5 min with phosphate-buffered saline (PBS) followed by blocking with PBS containing 1 
% bovine serum albumine (BSA) for 30 min at RT. Finally, coverslips were washed three 
times 5 min with PBS and stored at 4 °C until use. For control experiments, silanized 
slides were left uncoated, coated with BSA (Sigma) or with poly-L-lysine (Sigma). 
Confocal microscopy of living cells was performed on an inverted LSM 510 laser 
scanning microscope (Carl Zeiss, Göttingen, Germany) using a C-Apochromat 63 x 1.4 
Oil lens (Carl Zeiss) in a custom-made chamber, using CO2-independent serum-free 
DMEM (Gibco). YFP was imaged by excitation at 514 nm and detection with a BP 530-
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600 nm band pass filter. For the parallel detection of CFP and YFP, the spectrally 
resolving META detector of the instrument was also used. CFP was excited at 458 nm 
and detected at 465-518 nm when using the META detector or with a BP 475-525 band 
pass filter. YFP was excited at 514 nm and detected at 518-604 nm when using the 
META detector or with a 530-600 band pass filter. For parallel detection of YFP and Cy5 
the 514 nm line of the Argon ion laser and the light of the 633 nm HeNe laser were 
directed over an HFT 514/633 beam splitter in combination with an NFT 635vis beam 
splitter and a BP 530-600 band pass filter for YFP detection and an LP 650 long pass 
filter for detection of Cy5. 
 
8.2.6 Immunofluorescence. After cell stimulation on the surfaces at 37 °C, cells 
were fixed with 3.7 % PFA in PBS first for 10 min at 4 °C, then for 15 min at RT, 
followed by washing and permeabilization with PBS containing 0.2 % saponin (Sigma) 
and 0.1 % BSA (saponin buffer). For the quantification of cell spreading on the surface, 
the surface not shaded by adherent cells was visualized using an Alexa546 labelled anti-
mouse antibody (4 µg/ml in PBS, BSA (0.1 %), Molecular Probes) or Cy5 labelled anti-
Armenian hamster antibody (3 µg/ml), Dianova) directed against the immobilized 
stimulatory anti-CD3 and anti-CD28 antibodies for 30 min before permeabilization.  
Incubations with antibodies were carried out for 1 h at RT in saponin buffer. Actin was 
detected using biotin-labelled phalloidin (50 µg/ml, Alexis, Grünberg, Germany) in in 
combination with 1:1500 Cy5-streptavidin (Dianova) or using Cy5-labelled phalloidin (5 
U/sample, Molecular Probes) in saponin buffer. After washing with saponin buffer 
samples were fixed once more with PFA for 15-20 min, washed three times with PBS, 
and embedded in MOWIOL 213. For the detection of intrinsic fusion protein fluorescence, 
remaining fixative was quenched by 3 washes with 100 mM Tris-acetate buffer (pH 8) for 
5 min prior to mounting in Mowiol (Fluka).  
 
8.2.7 Image acquisition and data analysis for cell spreading and NFAT 
translocation.  Immunofluorescence microscopy performed on an inverted LSM 510 
confocal laser scanning microscope (Carl Zeiss, Göttingen, Germany) using a Plan-
Neofluar 40 x 0.75 NA lens for non confocal and a C-Apochromat 63 x 1.3 NA oil 
immersion objective or a C-Apochromat 63x water immersion objective for confocal 
imaging (both objectives from Carl Zeiss). Alexa 488/546 and Cy5/TOPRO fluorescence 
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were detected using a filter set consisting of an HFT UV/488/543/633 beam splitter in 
combination with an NFT 635 VIS beam splitter, a BP 560-615 detection filter for Alexa 
546, a BP 505-550 detection filter for Alexa 488, and an LP650 long pass filter for Cy5. 
Image analysis of NFAT translocation was performed using Metamorph (Universal 
Imaging, Downingtown, PA, USA). For each cell, nuclear translocation of NFAT and cell 
attachment were quantified using a specially designed macro (Fig.8.2). Determination of 
NFAT translocation followed general protocols for the quantification of protein 
translocation 99. A TOPRO-staining beyond an arbitrary threshold was used to generate a 
mask for the area of the nucleus. In order to get comparable nuclear masks between 
different images, it is necessary to adjust the intensities of the TOPRO fluorescence 
already during imaging. The nuclear mask shrunk with the erode command to generate a 
closed area representing the nucleus (mask N), but containing also small parts of the 
extranuclear area, since the Jurkat cell nucleus often is kidney-shaped.  Also, the nuclear 
mask was dilated with the dilate command, and the resulting mask subtracted with the 
original nuclear mask, forming a ring beyond the nucleus, representing the cytoplasm 
(mask C). Masks N and C were combined with the NFAT staining and to generate the 
NFAT staining intensity for the nucleus and the cytoplasm. NFAT translocation was 
expressed as the ratio of NFAT fluorescence to extract from N and that of the cytoplasm 
concerning mask C. Cell spreading was evaluated by measuring the area of the surface 
shielded against staining with the secondary antibody, which was detectable as a dark 
patch.  
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Figure 8.2 Overview of the macro for NFAT translocation. The fluorescence of the nuclear stain TOPRO 
was used to generate a nuclear mask. This mask was dilated for the generation of a mask around the 
nucleus, representing the cytoplasmic area, and shrunk, to generate an entirely nuclear area. Both masks 
were multiplied with the NFAT image to generate images representing the nuclear and cytoplasmic 
fluorescence. Relations were calculated by dividing the mean cytoplasmic NFAT staining by that in the 
nucleus. Figure c./o. by Roland Brock. 
8.2.8 Imaging of stimulation-dependent protein clustering. For the parallel 
analysis of stimulatory antibody-induced protein clustering, cells were stimulated on 
slides with microstructured stimulatory antibody immobilization, or on hydrogels with 
stimulatory antibody microarrays. After fixation at the indicated time points, cells were 
permeabilized with saponin buffer (in the case of phosphotyrosine imaging supplemented 
with 1 mM Na3VO4) stained with the same rabbit antibodies as used for the detection of 
proteins on the peptide microarray with concentrations of 2 µg/ml each for 1 h (see the 
table in the peptide microarray section) For confocal imaging of PLCγpY783, the rabbit 
polyclonal antibody (Cell Signalling) was applied in an 1/50 dilution. For detection, 
Alexa 488 labelled anti-rabbit secondary antibody was incubated for 30 min, in some 
cases together with a TOPRO staining of the nucleus.  
The quantitative image analysis of protein clustering was performed on Image Pro 
Plus 4.5 using the confocal slices representing the cell/stimulus contact surface. For the 
general analysis of protein phosphoryation, masks representing cells were generated by 
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filtering objects with an area larger than 200 pixels and a mean fluorescence staining 
higher than 20. For the analysis of PLCγ clustering in special, because of low signal 
intensity, the staining intensity was thresholded by a value of higher intensity, which was 
selected to represent only intense protein clusters. The generated masks were multiplied 
with the colour channel of the respective protein staining. For the generated image, the 
number of pixels and the total intensity was counted. The total pixel intensity, divided by 
the number of pixels, represents the mean protein intensity per area, while the number of 
pixels, divided by the number of cells, can be used to represent the area of protein 
clustering. In case of dissecting the influence of spatially distinct stimuli, multi-channel 
images were separated into the channels representing the areas with different types of 
stimulation, and that representing the protein of interest (Fig. 8.3). From the channel 
representing the immobilized antibody, a positive mask (representing the stamp) and 
negative mask (representing the anti-stamp) were generated by manually adjusting the 
threshold. The colour channel to be quantified was filtered by those masks using the AND 
function. For the quantification of clustering using micropatterned stimuli, the mean 
density per area, as depicted in the diagrams, was calculated by dividing the sum of the 
total intensity by area for each individual object by the total area covered by the cells.  
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Figure 8.3 Scheme of the quantification of the effects of spatially distinct stimuli on cell activation. Here, 
Jurkat cells were stimulated for 10 min on microstructured antibody surfaces composed.from anti-CD3 + 
Alexa546 anti-mouse (stamped) and anti-CD28 (overlayed) antibodies. Distinct areas for CD3 and CD28-
stimulation were created of masks representing areas below or above an arbitrary threshold for the Alexa 
546 fluorescence. The positive and negative masks were multiplied with the channel representing the actin 
staining, and the fluorescence intensity quantified. 
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8.2.9 Reflectometric Interference Spectroscopy (RIFS). RIfS-transducer 
chips of 1 mm D 263 glass with layers of 10 nm Nb2O5 and 330 nm SiO2 were purchased 
from Unaxis Balzers AG (Balzers, Liechtenstein). For functionalization, the RIfS-
transducer chips were first cleaned in 1 M NaOH for 2 min, washed with tap water, 
followed by cleaning of the surfaces and mechanical drying with KIMTECH tissues 
(Kimberly-Clark, Reigate, UK). Then the transducer chips were treated with freshly 
prepared Piranha solution (mixture of 30 % hydrogen peroxide and concentrated 
sulphuric acid at a ratio of 2:3; Caution: Highly aggressive!) for 30 min in an ultrasonic 
bath to activate the silanol groups. After rinsing with Milli-Q water and drying in a 
nitrogen stream, the surface was immediately activated for protein binding by incubation 
with 3-(glycidyloxypropyl)trimethoxysilane (GOPTS), Fluka) for 1 h. Thereafter the 
surface was cleaned with water-free aceton and dried in a nitrogen stream.  Solutions of 
anti-CD3 (OKT3) and anti-CD28 antibodies (9.3, 20 µg/ml in PBS) were added onto the 
activated transducer surface and incubated for 16 h at 4 °C. Before assembly into the flow 
cell the transducers were rinsed with Milli-Q water and thoroughly dried in a nitrogen 
stream. Samples were handled with an Automated Sample Injection Analyser - ASIA 
(Ismatec, Wertheim-Mondfeld, Germany). Samples were perfused over the transducer in 
a continuous flow of 20 µl/min. First, FCS-free RPMI 1640 medium was pumped over 
the transducer until the signal showed no further drift. Then the transducer was blocked 
by perfusion of a solution of 0.1 % BSA in PBS until again, the signal showed no further 
drift. The time for a complete measurement of cell adhesion and spreading was 2500 s. 
The first 120 s serum-free RPMI 1640 medium was pumped over the transducer. Then, 
for 1800 s the cell suspension with a density of 5*105 cells/ml in serum-free medium in 
the absence or presence of inhibitor was pumped through the flow cell. Finally, RPMI 
1640 medium was pumped through the flow cell for the remainder of the measurement 
interval. The initial slope of the RIFS curves corresponds to the average increase in 
optical thickness between the 250 s and 350 s time points. All RIfS experiments were 
performed by Bernd Möhrle. 
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Figure 8.4 Scheme of the RIfS detection method. The left part of the scheme shows how the reflected 
beams superimpose and how the binding of cells on the surface changes the optical thickness of the 
transducer surface. The right part shows the change of the characteristic interference spectrum and how this 
shift is transformed into a binding curve. Figure by Bernd Möhrle.  
 
For the comparison of cell spreading by fluorescence microscopy and RIfS 
measurements, the anti-CD3 and anti-CD28 antibodies were immobilized on glass slides 
functionalized with GOPTS in the same way as the RIfS transducers. Solutions of 
antibodies (20 µg/ml in PBS) were incubated on the coverslips for 16 h at 4 °C, followed 
by 3 washes with PBS, and blocked with 0.1% BSA for 1 h.  Cells were added to 
antibody-functionalized coverslips at a density of 5*105 cells/mL in serum-free RPMI at 
37 °C. In order to assess the effect of the inhibition of actin polymerization on cell 
spreading, cells were preincubated for 15 min with 10 µM cytochalasin D.  
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 8.3 Peptide microarrays 
 
8.3.1 Peptide synthesis. All peptides carried an N-terminal Cys residue for 
immobilization to epoxy-activated surfaces. Peptide designations are composed from the 
name of the protein from which they were derived, and either the position of the pY 
residue in the whole protein (for pY-peptides) or the position of the first residue in the 
peptide (for polyP and other peptides).  Standard chemicals for peptide chemistry were 
obtained from Fluka and Merck; solvents were p. a. grade. 9-fluorenylmethoxycarbonyl- 
(Fmoc-) protected amino acids were purchased from Novabiochem (Heidelberg, 
Germany), Senn Chemicals (Dielsdorf, Switzerland), and Orpegen Pharma (Heidelberg, 
Germany). Fmoc-Tyr(PO(OBzl)OH)-OH was purchased from Novabiochem. Automated 
synthesis of the bisphosphopeptide C-Ahx-NQL(pY)NELNLGRREE(pY)DVL-NH2 
(pITAM; Ahx=6-aminohexanoic acid) on Rink amide resin (Rapp Polymere, Tübingen, 
Germany) was performed by solid-phase Fmoc/tert-butyl-chemistry in a 100 µmol scale 
using an automated peptide synthesizer (433 A, Applied Biosystems, Weiterstadt, 
Germany). Coupling of amino acids was carried out using a 10-fold excess of Fmoc-
amino acids activated in situ using 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium 
tetrafluoroborate (TBTU), 1-hydroxybenzotriazol (HOBt) and N,N’-
diisopropylethylamine (DIPEA). The removal of the Fmoc-protecting group was 
performed by treatment with piperidine/DMF, and monitored using UV/Vis spectrometry. 
Synthesis of the other peptides and phosphopeptides was performed by standard multiple 
solid-phase peptide synthesis, partially by Echaz Microcollections, Tübingen, Germany 
215. N-terminal acetylation was performed by treating the resin-bound peptide with acetic 
anhydride/DIPEA/DMF (1:1:8, v/v/v) twice for 30 min. Peptides were cleaved off the 
resin by treatment with trifluoroacetic acid (TFA)/triisopropylsilane/ethanedithiole/H2O 
(92.5:2.5:2.5:2.5, v/v/v/v) for 4 h. Crude peptides were precipitated by adding cold 
diethyl ether (-20 °C), collected by centrifugation and resuspended in cold diethyl ether. 
This procedure was repeated twice. Finally, peptides were dissolved in tert-butyl 
alcohol/H2O (4:1, v/v), lyophilised and analyzed by reverse phase HPLC and MALDI-
TOF mass 215. The synthesis of the fluorescein-labelled control peptide Fluo-Ahx-KAA 
followed a procedure described in 216. If prominent impurities were present, peptides were 
purified by RP-HPLC using optimised H2O (0.1 % TFA)/acetonitrile (0.1 % TFA) 
gradients to > 90 % purity. After lyophilisation, peptides were dissolved to a 
concentration of 3 mM in DMF. Prior to spotting, peptides were freshly diluted from 
Materials & Methods 
 122
DMF stock solutions to a spotting concentration of 100 µM in 0.1 M phosphate buffer 
(pH 8.0). 
 
8.3.2 Generation of peptide microarrays.  For parallel peptide microarrays arrays, 
epoxy-functionalized glass slides were applied(Nexterion Slide E, Schott, Jena), on which 
16 identical arrays of up to 100 spots per array were spotted at 15°C at dew point (70% 
air humidity in the spotter casing), using a GeSiM NP2.0 nanopipettor (GeSiM, Dresden, 
Germany). Per spot, 1.2 nl was spotted in duplicate with a centre-to-centre spacing of 500 
µm. For orientation, a fluorescein-labelled control peptide was spotted. After 60 min 
incubation at room temperature, the slides were incubated with 1 ml of O,O’-bis(2-
aminopropyl) polyethylene glycol 800 (Fluka) at 70 °C for 16 h to quench the remaining 
reactive epoxy groups and block the surface. After cooling, the slides were rinsed with 
deionized water, dried under airstream, and stored at 4° C.  
 
8.3.3 Readouts for peptide microarrays using microscopy and determination 
of protein concentration. Confocal laser scanning microscopy was performed using an 
inverted LSM510 confocal laser scanning microscope (Carl Zeiss, Göttingen, Germany). 
YFP was excited with the 514 nm line of an argon-ion laser and detected using a BP530-
600 nm band pass filter, Cy5 was excited with the 633 nm line of a helium neon laser and 
detected using an LP650 nm long pass filter. Cell images were acquired at a resolution of 
1024 x 1024 pixels using a C-Apochromat 63 x 1.2 NA water immersion objective. The 
coverslips with the arrayed peptides were mounted in a custom-made open measurement 
chamber with the coated surface up, allowing addition of solution to the microarray 
during observation. 100 µl of cell lysate or antibody solutions were used for incubation on 
each cover slip. After addition to the cover slip the solution was mixed by pipetting up 
and down several times. Incubation was carried out for 3 min for the lysates and for 15 
min for antibodies. Antibodies were diluted to 5 µg/ml for anti-ZAP-70, and to 15 µg/ml 
for anti-phosphotyrosine (Cell Signalling) and to 2.8 µg/ml for Cy-5 labelled goat-anti-
mouse-antibody (Dianova, Hamburg, Germany) in TPBS containing 0.5% BSA. Between 
each incubation step, arrays were washed twice with TPBS. Digital images were acquired 
at a resolution of 512 x 512 pixels using a Plan-Neofluar 10 x 0.3 NA objective. For data 
evaluation, the functionalised spots and the surrounding background were defined as 
separate areas-of-interest and the mean intensity within the respective area-of-interest 
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determined using Image Pro Plus 4.5 (Media Cybernetics Inc., Silver Spring, USA). The 
net fluorescence F was calculated by subtracting the mean intensity of the background 
from the mean intensity of the respective spot. The net fluorescence over equally 
functionalised spots was averaged. ZAP-YFP protein concentrations in the lysates were 
determined by Oda Stoevesandt on a Zeiss ConfoCor2 fluorescence correlation 
spectroscope as described in 199. 
 
8.3.4 Parallelized peptide microarray incubation and analysis. For 
antibody stimulation, Jurkat cells and derivative cell lines (107/ml) were resuspended in 
ice-cold HEPES-buffered saline (HBS; 10 mM HEPES, 135 mM NaCl, 5 mM KCl, 1 mM 
MgCl2, 1.8 mM CaCl2, pH 7.4) supplemented with 0.1 % BSA and 5 mM glucose 
containing 10 µg/ml of the anti-CD3 clone OKT3) and/or anti CD28 antibody (clone 9.3) 
or the isotype control (mouse IgG2a, Sigma) and were incubated on ice for 10 min. Then, 
the crosslinking secondary antibody (goat anti-mouse Ig, Calbiochem), was added to a 
final concentration of 20 µg/ml and samples were immediately transferred to 37°C for the 
time indicated. For activation via broad-range phosphatase inhibition, cells were treated in 
the same medium for 20 min at 37 °C with 0.5 mM pervanadate, freshly diluted from a 
reaction between 5 mM Na3VO4 and 5 mM H2O2 in HBS for 15 min at room temperature. 
 
Stimulation was stopped by placing the samples on ice, and washing the cells in ice-
cold HBS. For lysis, 2*107 cells/ml were resuspended in ice-cold lysis buffer (1 % Triton 
X-100, 50 mM n-octyl-β-D-glucopyranoside (Fluka), 20 mM Tris, 1 mM EDTA, 150 
mM NaCl, 1 mM Na3VO4, pH 7.5, and protease inhibitor cocktail (Roche, Mannheim, 
Germany)), and incubated on ice for 60 min. For the assessment of peptide effects on 
molecular interactions, peptides were added to the lysis buffer prior to lysis in the 
following concentrations, unless indicated otherwise: LATpY191 (20 µM), LATpY132 
(0.5 µM), SLP228 (20 µM) and SLP 179 (20 µM) to a maximal DMF concentration of 1 
% in the lysate. Crude lysates were clarified by centrifugation at 20,000 x g for 15 min, 
total protein concentration determined by a standard protein assay (BioRad, Munich, 
Germany), and adjusted to the same concentration. Before incubation, slides carrying 
arrays were shortly washed with lysis buffer and dd H2O and dried by air-stream. A 16-
well clip-on frame was clamped onto the slide to create separate incubation chambers for 
Materials & Methods 
 124
each of the 16 arrays. Arrays were blocked with 1% Top Block (Fluka) in PBS for 1 h. 
Afterwards, the arrays were washed with 100 µl/chamber TPBSB (PBS + 0.05% Tween + 
0.05 % BSA), before being incubated with 50 µl/chamber of the cell lysates at 4°C for 1 
h. Then, the arrays were washed with TPBSB, and incubated with 2 µg/ml of the primary 
antibody (Table 8.1) at room temperature for 15 min.  
 
For each antibody, a negative staining control was taken into account by incubating 
the arrays with antibodies without prior lysate incubation. After washing with TPBSB, 
arrays were incubated with 1 µg/ml of the secondary antibody at room temperature for 10 
min. Subsequently, arrays were washed with TPBSB, rinsed with dd H2O, and dried in an 
air-stream. The slides were stored at 4°C previous to scanning. The specificity of 
detection antibodies was validated by Western Blotting. Slides were scanned at 10 µm 
resolution on a ScanArray array scanner (Perkin Elmer, Rodgau-Jügesheim, Germany) 
using lasers of 543 nm and 633 nm for excitation. Prior to applying the antibodies to the 
microarray, the binding specificity of the antibodies had been validated using a Western 
Blot of Jurkat cell lysates. However, in contrast to the Western blots, the antibodies on the 
microarray are expected to bind to the proteins under a nondenaturing condition, similar 
to that of immunoprecipitations. Correspondingly, not all antibodies that were suitable for 
Western Blot, were able to yield signals on the microarray, compared to all of the 
antibodies described as suitable for immune precipitation (data not shown).
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Table 8.1 Antibodies used for the evaluation of the peptide microarrays 
Primary 
antibodies Antigen Type Source 
 c-Cbl mouse monocl. IgG1 
BD Transduction 
Labs(Heidelberg) 
 GADS rabbit polycl. IgG Upstate/Biomol (Hamburg) 
 GRB2 rabbit polycl. Santa Cruz 
 LAT mouse monocl. IgG1 Upstate/Biomol  
 LCK mouse monocl. IgG2bκ Upstate/Biomol  
 Nck rabbit polycl. IgG USBiological/Biomol (Hamburg) 
 PI3K rabbit polycl. IgG BD Transduction Labs 
 PLCγ1 rabbit polycl. IgG Santa Cruz 
 SHP2 rabbit polycl. IgG Santa Cruz 
 SLP76 mouse monocl. IgG2a USBiological/Biomol (Hamburg) 
 Vav rabbit polycl. Santa Cruz 
 ZAP-70 mouse monocl. IgG2a BD Transduction Labs 
    
Secondary 
antibodies anti-Rabbit IgG Goat polycl. Alexa Fluor 633 Molecular Probes/Invitrogen  
 anti-Mouse IgG Goat polycl. Alexa Fluor 546 Molecular Probes/Invitrogen  
 
 
8.3.5 Image analysis of peptide microarrays. Semiautomatic image analysis 
of microarrays was performed using Array Pro (Media Cybernetics, Silver Spring, USA). 
For each experiment, the image of the array was overlayed with a grid corresponding to 
the array layout. The net signal intensity of each spot was determined by subtracting the 
local background intensity, determined by a ring surrounding the spot, from the raw 
intensity. From signals of each peptide spot and incubation condition, the respective 
signal of the antibody control was subtracted. If a negative value was the result, it was set 
to 1, in order to enable further batch calculations. Corrected signal intensities of the 
stimulated conditions were divided by the corrected signal intensity of the unstimulated 
condition from respective peptide spots, if at least one of the values was above a certain 
threshold. Thresholds were established empirically. For PV-stimulation experiments, a 
threshold of 100 was used, while for antibody stimulation, a threshold of 50 was used. 
Thresholds were employed in order to filter out  error-prone ratios resulting from division 
of one small values by another.  
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